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Abstract 
Khat (a natural stimulant plant) has become a public health concern due to adverse health 
risks and negative social functioning associated with frequent chewing. Increased frequency 
of khat use is associated with use disorder, dependence and increased physical and 
psychological health problems.  Despite the prevalence of khat use and increasing 
consumption and use disorder in Ethiopia, there has been inadequate and insufficient 
research available to understand its potential psychological and health consequences.  In 
the Ethiopian context, very little is known about the nature of khat dependence, the outcome 
of khat cessation attempts and the characteristics of withdrawal symptoms and craving 
during khat abstinence. Hence, the main aims of the studies in this thesis is to validate the 
existence of a khat use disorder syndrome using DSM-5 criteria and to explore the nature 
and the time course of any withdrawal syndrome in relation to the cessation of khat use 
among frequent khat users.  In Study 1 of this thesis, the presence of khat use disorder 
syndrome was validated using DSM-5 criteria and its relationship with increased experience 
of harms was examined on a sample of 400 current khat-chewers (aged 16 and above 
recruited from khat markets and cafes from university and general community in Adama, 
Ethiopia) between September 2014 and January 2015. Accordingly, 10.5% (95% CI=7.9–
13.9) were categorized as experiencing mild, 8.8% (95% CI=6.4–12.0) moderate and 54.5% 
(95% CI=49.6–59.3) severe khat use disorder. Participants demonstrated increased 
financial, academic and self-reported mental health problems associated with use. 
Participants with khat use disorder also   had higher psychological distress and poorer 
quality of life. Despite this, there are low levels of help-seeking for these problems. Only 
one-third (32.9%) of individuals with khat use disorder reported life-time access to help-  
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seeking largely from friends and relatives. Hence, the construct of a substance use disorder 
syndrome for khat using DSM-5 criteria appears valid and performs in a manner consistent 
with other substances of dependence In Study 2, a Cross-sectional data from a sample of 
388 past year khat consumers (same participants used in study 1) were collected to 
determine the efficacy of the Severity of Dependence Scale (SDS) as a screening tool for 
DSM-5 defined Khat Use Disorder. Participants self-completed survey comprising an SDS 
scale, current substance use disorder symptoms (modified Alcohol Use Disorder and 
Associated Disabilities Interview Schedule-IV), and validated measures of health, 
psychological distress, quality of life and academic functioning. Nearly three-quarters 
(73%) of the sample experienced DSM-5 Khat Use Disorder. The SDS demonstrated 
excellent discrimination (AUC=0.92), with an optimal cut-off score of 3 or above. Those 
screened positive had more frequent and higher dose of khat use; greater financial problems 
in relation to khat use; more problems related to academic functioning in daily life; greater 
psychological distress and poorer quality of life than their counter partners. The SDS, as a 
brief and simple screening tool, appears to validly identify individuals with khat use 
disorder syndrome and higher rates of adverse consequences. Hence, there is clear evidence 
that some consumers are both concerned with their use and experience problems in relation 
to khat use. In Study 3, a naturalistic data collected from 59 daily and near daily khat 
consumers (from Adama University in Ethiopia) using electronic diary, were used to 
monitor the outcomes of an unassisted quit attempt and to examine predictors of success of 
khat abstinence. While 80%, reached at least 7 continuous days of abstinence, 93% lapsed, on 
the average, after 11 days post-quit (SD=7) and only 7% maintained continuous abstinence for 
28 days post-quit. Although regular khat chewers have motivation and desire to quit, they  
Abstract  xi 
seem to have difficulties maintaining abstinence with unassisted quit attempts. Treatment aids 
are very likely to assist chewers in their quit attempts. None of the demographic factors were 
predictive of successful abstinence. In Study 4, the elevation and shape of the growth curves 
of the major withdrawal symptoms and craving of frequent khat chewers (participants used 
in study 3) were examined for 3 pre-quit and 14post-quit days. Electronic Diary (ED) was 
used to collect real time data of khat withdrawal symptoms and cravings. The development 
of withdrawal symptoms was evident, and all withdrawal symptoms followed similar overall 
patterns with salient elevations after the quit day and curvatures around the first week of post 
quit period, indicating the persistence and severity of these symptoms over time.  In addition, 
craving, irritability and restlessness had significantly reverted to their baseline level during the 
2nd week of the post quit period. The need for interventions is necessary to support individuals 
during the period of increased symptoms of dysphoria and to reduce the risk of relapse. 
Participants’ anticipation to quit and the initial quitting experience were likely to intensify 
withdrawal symptoms and provoke lapse in the long run. In conclusion, khat chewing has 
multiple effects on frequent and chronic consumers. While khat is a mild stimulant, there is 
clear evidence of khat use disorder and that some khat users are both concerned with their 
use and experience substantial and clinically significant problems associated with their use. 
The SDS, being a brief screening tool, appears to validly identify individuals with khat use 
disorder syndrome and with high rates of adverse consequences. In addition, self-motivated 
individuals for unassisted quit attempts seem to experience difficulties in maintaining 
abstinence since expectation of the quit experience by itself is likely to intensify withdrawal 
symptoms and craving among the chewers and facilitate eventual lapse.  Hence, there is 
considerable scope to intervene at an organizational level to curb and minimize problems 
in relation to khat.  
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Introduction 
Khat (Catha edulis) is a stimulant plant widely cultivated in East African countries and the 
Arabian Peninsula (Luqman & Danowski, 1976). Khat is harvested in the early hours of the 
morning and sold in markets in late morning, often, after being prepared as a bundle of leaves, 
wrapped in banana leaves to preserve freshness  (Luqman & Danowski, 1976). Chewing fresh 
and young leaves of a khat tree, mostly in a social setting, is the most common mode of 
consumption and it is an old and widespread habit in the Horn of Africa (e. g. Ethiopia, Kenya 
and Somalia).  Considering its popularity and its being a major source of foreign exchange, 
khat is deeply engrained in Ethiopian society and culture, and significant for the nation’s 
economy (Gebissa, 2008). It is a high-cash income crop for the producers, for retailers as well 
as for the government revenue through taxation (Getahun & Krikoria, 1973; Kennedy, 1987; 
Lemessa, 2001). In Ethiopia, 85-90% of khat produced is exported (Lemessa, 2001) making a 
very significant input to the country’s foreign income. For instance, in 1999/2000, khat worth 
$ 55 million USD was exported to different countries ranking second in export revenue 
(Lemessa, 2001). 
Distribution and Prevalence of khat use 
Khat circulates freely in Ethiopia and khat chewing is legal (Elmi, 1983; Gebissa, 2010). 
Previously, khat was available only near to where it was grown. However, currently, the fact 
that khat has become a critical commodity for the survival of millions of producers and 
marketers, plays a  vital role in the dramatic expansion of khat production and consumption 
(Gebissa, 2008)  
In Ethiopia, the chewing of khat has a deep rooted socio-cultural tradition (Kalix & Braenden, 
1985). In addition to the use of khat for religious purposes, it is consumed for recreational 
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purposes (Kennedy, 1987). It is most valued for its stimulant effects and usually chewed in 
company to facilitate social interactions (Kennedy, 1987; Elmi, 1983). Occasionally, khat 
may be chewed individually, to improve alertness, (Kalix, 1984a) and to enhance work 
capacity and performance (Kennedy, 1987; Elmi, 1983). Despite the negative attitudes of non-
chewers and critical warnings from the medical community, khat consumption has spread 
from Harar to all parts of Ethiopia in the last three decades (Dachew, Bifftu, & Tiruneh, 2015). 
 
Studies documented that the number of khat chewers in Ethiopia has significantly increased 
over time and now it has become popular nearly in all segments of the Ethiopian population 
(Selassie & Gebre, 1996  ). Khat is used habitually by craftsmen, farmers and labourers during 
physical work in order to facilitate physical and mental alertness; to prevent sleepiness and 
overcome physical fatigue (Alem, Kebede, & Kullgren, 1999; Ayana & Mekonen, 2004). 
More recently, several studies have reported an increased prevalence of khat chewing among 
various parts of the community (Alem et al., 1999; Ayenew, Tadesse, & Azale, 2012). Adults 
from different occupations including university instructors (Ihunwo, Kayanja, & Amadi-
Ihunwo, 2004) and a fairly large proportion of students of secondary and higher education 
chew khat regularly (Adugna, Jira, & Molla, 1994; Cox & Rampes, 2003; Ihunwo et al., 2004).   
 
Research reports suggest that 80–90% of male adult and 10–60% of the female adult 
population in East Africa chew khat on a daily basis (Numan, 2004; Odenwald et al., 2005). 
Similarly, in Ethiopia, the prevalence of past month khat use was estimated at 27.3% among 
men and 11.0% among women (Gebrehanna, Berhane, & Worku, 2014b). More people from 
the age group between  18 and 24 (34.4%) use khat than other age groups (Gelaw & Haile-
Amlak, 2004).  While the prevalence of past month khat use across Ethiopia is estimated at 
15.3%, the life time, current or past month use of khat vary from regions to regions in the 
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country (Gebrehanna et al., 2014b). In the major towns of Oromia regional state, khat chewing 
is growing and becoming a common pastime among youths and adults. A survey of secondary 
school students in some parts of this region (Agaro, Western Oromia), revealed a current khat 
chewing prevalence of 65% and that two thirds of the most frequent users were students 
between the ages of 15 and 22 years (Adugna et al., 1994). A cross-sectional survey conducted 
among university staff, revealed a lifetime and past month prevalence of 46% and 30.8%, 
respectively (Gelaw & Haile-Amlak, 2004; Y. Gelaw & A. Haile-Amlak, 2004). Similarly, in 
Butajira, (Oromia) life time and current khat chewing prevalence were 55.7% and 50%, 
respectively (17.4 % chewing on a daily basis) (Alem et al., 1999). In the Amhara region 
(Bahirdar and surrounding districts in the north), where once khat had been strongly 
discouraged by the community, the consumption of khat has recently become a common 
practice, with a 27% lifetime prevalence rate among college students, of which 46% report the 
onset of the use during their senior years in secondary school (Kebede, 2002). 
 
Khat chewing has also become a common practice among high school, college, and university 
students. The purposes of khat chewing among university students were to increase 
concentration and remain alert and to reduce fatigue while studying (Ayana & Mekonen, 2004). 
Among Ethiopian university students (n=3268), the estimated life-time and past month khat 
use are 24.0% and 7.7%, respectively (Gebrehanna, Berhane, & Worku, 2014a). In some parts 
of Ethiopia the prevalence of lifetime and current chewing of khat among secondary school 
students are 18.4% and 10.9%, respectively (Nigussie, Gobena, & Mossie, 2013).  A national 
study conducted in 2011 revealed that the estimated prevalence of past month khat use for non-
student and student adolescents were 23.0% and 7.5%, respectively (Kebede et al., 2005).  
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Khat chewing sessions are usually accompanied by simultaneous usage of cigarettes, alcohol 
and illicit drugs.  Heavy chewers tend to report using khat to stay awake, increase productivity 
or feel ‘high’ and alcohol to reduce tension from these stimulatory effects or to neutralize the 
stimulating effect and sleeplessness caused by the khat and go to sleep (Griffiths, 1998).  
Studies revealed that 60% of khat chewers (African diaspora-Somalia) in London also smoked 
cigarettes; 75% of these were men, smoking 5–45 cigarettes per day (Griffiths, 1998) Few 
used any other drugs and the most common was cannabis, used by 6% of the sample. Khat 
has also been linked to the misuse of other drugs. In Ethiopia, unlimited access to khat, 
cigarettes and alcohol with no age limits might have contributed to poly drug uses among 
people. The most common poly-drug concurrent uses in the capital city (Addis Ababa) were 
tobacco and cannabis resin (hashish) 14.9%; khat, alcohol and diazepam (valium) 14.9%; and 
khat, tobacco and alcohol 14.8% (Selassie & Gebre, 1996  ).  
 
Pharmacokinetics and Pharmacology of Khat 
The most common and traditional way of consuming khat is chewing the fresh leaves of a 
young shoot. A ball of chewed khat, which is often kept in either side of the cheeks (M. Banjaw 
& Schmidt, 2005), will be masticated slowly and intermittently to release the active ingredients 
and eventually swallowed, or spit out at the end of the chewing session (Cox & Rampes, 2003b; 
Nencini, Ahmed, & Elmi, 1986).  A small proportion of consumers, especially elderly people, 
ingest khat in the form of a drink prepared from fresh and shredded or dried khat leaves and 
very rarely smoke-dried leaves.  
 
In a khat chewing session, initially there is an atmosphere of cheerfulness, optimism and a 
general sense of well-being. After about two hours, tension, emotional instability and 
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irritability appears, later leading to feelings of low mood, and sluggishness. Chewers tend to 
leave the session feeling exhausted (Cox & Rampes, 2003) 
 
In fresh khat leaves, a higher proportion of the more desirable cathinone is normally found; 
as leaves age or become dry, cathinone breaks down into cathine, and the content of cathine 
is relatively higher. As a result, the consumption of non-fresh khat leaves leads to the 
occurrence of more unwanted adverse effects (Kalix, 1981). Hence, khat chewers often prefer 
to chew fresh leaves since they contain a higher ratio of cathinone to cathine and cause better 
psychostimulant effects with fewer systemic adverse effects (Cox & Rampes, 2003)  
 
A typical chewing session on average may last five to six hours and on average 100–500 g of 
khat is chewed (Al-Hebshi & Skaug, 2005; Elmi, 1983; Kalix, 1990; Matloob, 2003; Nencini 
& Ahmed, 1989). The juice of the chewed leaves is swallowed, but not the residues (Toennes, 
Harder, Schramm, Niess, & Kauert, 2003). The chewing process effectively liberates 80% of 
cathinone and cathine, and over 90% of norephedrine (Toennes et al., 2003; Toennes & Kauert, 
2002). The euphoric effect of khat ingestion appears shortly after the chewing begins, often 
after 30 minutes (Widler, Mathys, Brenneisen, Kalix, & Fisch, 1994). This suggests that 
absorption of alkaloids takes place first in the oral mucosa (Toennes et al., 2003). While the 
peak plasma levels for cathinone and other ingredients of khat leaves are attained after 1–3.5 h 
(Brenneisen, Fisch, Koelbing, Geisshusler, & Kalix, 1990; Halket, Karasu, & Murray-Lyon, 
1995), maximal plasma concentrations of cathinone and cathine are reached at 2.3 and 2.6, 
respectively (Toennes et al., 2003). Metabolism of cathinone is rapid, occurring mainly during 
the first passage through the liver. The terminal half-life for cathinone is short-lived (1.5±0.8 
hours) than for cathine (5.2±3.4 hours) (Toennes et al., 2003), which indicates that the longer 
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the time that chewing sessions takes place, the higher the levels of cathine accumulated than 
cathinone and the more the unwanted systemic effects may result.  
 
Khat contains more than 40 alkaloids, glycosides, tannins, amino acids, vitamins and minerals 
(Halbach, 1972). Since khat contains a variety of compounds the chewing of khat may have 
many different effects. The most common effects include those on the gastro-intestinal system 
and on the nervous system (Kalix, 1984). Effects on the autonomic (peripheral) nervous 
system include constipation, urine retention and acute cardiovascular stimulation. In terms of 
effects on the central nervous system, increased alertness and psychiatric symptoms are 
common (Kalix & Braenden, 1985). The most active constituents of Catha Edulis are 
cathinone and cathine and the psychostimulant effect of chewing khat on the nervous system 
is thought to be the result of these two phenylalkylamines, which are structurally similar to 
amphetamine (Nencini, Amiconi, Befani, Abdullahi, & Anania, 1984). As a result, much of 
the research regarding khat use focuses on the pharmacological effects of cathinone and 
cathine.    
 
Khat has been termed a ‘natural amphetamine’ for its sympathomimetic and central nervous 
system stimulation analogous to the effects of amphetamine (Brenneisen et al., 1990; Kalix, 
1988). Studies argue that khat produces similar clinical effects to amphetamine except for 
some difference due to slight pharmacodynamic variations, differences in dosage and the 
mode of consumption (Cox & Rampes, 2003).  Acute ingestion of khat induces dopaminergic 
and serotonergic actions in the central pathways (Kalix, 1981).  Cathinone [(–)-alpha-
aminopropiophenone], is considered to be the most active ingredient of khat. It has been 
isolated and synthesised and its effects have been shown to be similar to amphetamine, but 
with a lower potency - approximately half as potent as (+, dextro) amphetamine (Kalix, 1981). 
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However, cathinone is estimated to be 7–10 times more potent in terms of psychostimulant 
effects than the other primary ingredient, cathine (Nencini, Grassi, Botan, Asseyr, & Paroli, 
1989). Cathine is both milder and briefer in its psychostimulant action than cathinone and 
plays only a minor role in the effects of khat. It is believed that cathine is responsible for many 
of the unwanted adverse effects such as feelings of low mood and sluggishness (Cox & 
Rampes, 2003).  
 
Pharmacological nd Psychological effects of khat chewing 
Khat use is associated with a variety of psychological and behavioural changes in individuals. 
Ingestion of khat is acutely self-limiting that most consumers may typically stop chewing in 4 
- 6 hours. However, chronic and long-term intake can lead to impairment of mental health, 
possibly contributing to ‘mental deterioration’ especially when age of initiation is early (Kalix 
& Braenden, 1985).  Khat chewing may have both short term and long-term psychological 
effects. Short term effects may be positive and negative and are mostly common among those 
who consume small amounts. They may include a feeling of well-being, tiredness , 
hyperactivity,  mild euphoria, excitement, increased alertness/concentration,  restlessness, 
irritability and  increased energy levels (Cox & Rampes, 2003). On the other hand, long term 
effect may include, insomnia schizophreniform psychotic illness, mania (Yousef, Huq, & 
Lambert, 1995) and, very rarely, depression (Pantelis, Hindler, & Taylor, 1989b). Some 
chewers, owing to the strength of the khat variety, also experience unpleasant effects during 
the chewing process, such as anxiety, tension, and restlessness (Cox & Rampes, 2003). In few 
cases, chewers may show a range of experiences, from minor reactions to the development of 
a psychotic illness. Most reports of khat psychosis are of low incidence which may be 
attributed to two fundamental issues. Firstly, in countries where khat is widely used, there are 
very limited health facilities and people are managed at home by their family. Secondly, owing 
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to the mode of consumption, the dose of khat tends to be self-limiting, unlike amphetamines, 
which are available in a pure form for oral or parenteral administration (Yousef et al., 1995). 
Therefore, psychotic reactions due to excessive use are much less frequent with khat than with 
amphetamines. Moreover, some research findings (Alem & Shibre, 1997; Critchlow & Seifert, 
1987)  confirm that adverse effects of khat are dose-related. For instance, (Dhadphale & 
Omolo, 1988) found that when khat was chewed in moderate quantities there was little 
morbidity, but when the amount chewed per day was excess (greater than two bundles), 
morbidity significantly increased. 
 
Several authors report that depression is also associated with the cessation of khat chewing. 
Such behaviour has also been reported following cessation of amphetamine use (Pantelis, 
Hindler, & Taylor, 1989a). Although there are rare events of self-harm and suicide reported 
in the literature during both chewing and the subsequent intoxication phase, suicide have been 
reported in the context of a ‘withdrawal state’ and the distress caused by paranoid symptoms 
due to overdosing of khat (Giannini & Castellani, 1982). Violent acts, including homicide, 
are also documented, usually in the context of paranoid or persecutory delusions (Pantelis et 
al., 1989). A study conducted in Ethiopia by (Alem & Shibre, 1997) and (Alem et al., 1999), 
described two cases where a patient murdered one of his wives and his daughter and another 
case of combined homicide and suicide after chewing increased amounts of khat, respectively. 
 
Changes in neurobiological and psychological functions due to chronic drug use are likely to 
differ as a result of many interrelated factors, such as the class of drugs, the pattern of use, as 
well as the complex interplay with pre-existing neurodevelopmental factors (Nader et al., 
2006). There is some evidence to suggest that primates with pre-existing lowered dopamine 
(D2) receptors are more likely to be at increased risk of using cocaine and becoming addicted 
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(Nader et al., 2006).  Animal studies have also revealed similar results in the rodent model 
(e.g. (Dalley et al., 2007). Similarly, studies on humans, reported that individuals that become 
chronic users of cocaine might be more likely to have pre-existing problems in inhibitory 
control and impulsivity (Verdejo-Garcia, Lawrence, & Clark, 2008). The prefrontal cortex is 
one of the primary structures that has been implicated in drug-related deficits across multiple 
studies and accounts for various deficits of cognitive, behavioural, and emotion functioning. 
Individuals who use multiple drugs, or who are exposed to other high risk environmental 
conditions may particularly show impairments in these domains (Nader et al., 2006). 
Therefore, it may be expected that a similar relationship may well exist between pre-existing 
conditions and behaviour patterns of khat users, which could be considered in future studies. 
 
Studies on neurobiological mechanisms arising from chronic khat use are as rare as those 
which systematically investigated its long-term impact on the specific cognitive functioning 
and cognitive and behavioural deficits. Cathinone and cathine, the two compounds of khat, 
stimulate the central nervous system (CNS) by increasing dopamine (DA), 5-
hydroxytryptamine and noradrenaline (Kalix & Braenden, 1985)  and release DA in both the 
substantia nigra and the ventral tegmental area (VTA). The VTA projects to the ventral 
striatum and the limbic structures and plays a key role in reward-related behaviour. The VTA 
also projects to the frontal cortex, which plays a role in a variety of cognitive functions 
including attention and working memory. It is also hypothesized that excessive dopaminergic 
activity, resulting from chronic consumption of amphetamine-like substances (e.g. khat) may 
produce negative effects on cognitive functioning (Kalix & Braenden, 1985).  
 
Studies on the residual effect of amphetamine use on cognitive functioning suggest that there 
is evidence of decreasing cognitive flexibility due to amphetamine use (van der Plas, Crone, 
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van den Wildenberg, Tranel, & Bechara, 2009). Chronic use of drugs like amphetamine and 
opiates could result in pronounced neuropsychological impairment in the domains of 
executive and memory function; and the impairment persists after several years of drug 
abstinence and may reflect neuropathology in frontal and temporal cortices (Ersche, Clark, 
London, T., & Sahakian, 2006). Clinically, it appears that some chronic methamphetamine 
users and dependent subjects seem to be easily distractible and exhibit some difficulties in 
sustaining attention as well as modest visual-constructional deficits on tasks such as the Rey 
Complex Figure copy task (Kalechstein, Newton, & Green, 2003). Attentional deficits have 
also been noted among chronic amphetamine users on some tasks involving attention and/or 
sustained attention in the Stroop Color Word and Trail making Tests (Kalechstein et al., 2003; 
Simon et al., 2000). Consistent with these findings, a recent study by London and colleagues 
(London et al., 2005), depicted that chronic methamphetamine users significantly committed 
more errors on an auditory version of the Continuous Performance Test (CPT) than drug-free 
controls, which indicated deficits of sustained attention and vigilance (Borgaro et al., 2003). 
Although distractibility and attentional deficits have been reported anecdotally in khat users, 
these areas of cognitive functioning have not been carefully examined in experimental settings 
on khat users. 
 
However, given the similarity of khat and amphetamine in terms of chemical structure, 
pharmacological activity and psychostimulation of the CNS, it is reasonable to assume that 
prolonged and acute consumption of khat would affect the same neurotransmitters and result 
in similar neurobiological, physiological and psychological effects (Colzato, Ruiz, van den 
Wildenberg, Bajo, & Hommel, 2010). This has been demonstrated to some extent by studies 
that attempted to systematically investigate specific cognitive impairments in abstinent khat 
users compared to non-chewers (Colzato, Ruiz, van den Wildenberg, & Hommel, 2011, 
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2012). These studies identified impairments in the inhibition of response conflicts, monitoring 
of working memory and mental flexibility. Consistent with these findings, a very recent study 
that examined working memory and information processing speed (Hoffman & al'Absi, 
2013), indicated impairments in working memory, specifically, on digit backward measures 
of short term working memory among chronic khat chewers. However, contrary to the results 
obtained with chronic methamphetamine users (e.g. (Simon et al., 2000)), the authors found 
no statistically significant impairment in speed of information processing among chronic khat 
chewers. In their experimental study on 16 khat users and 16 khat free controls (Colzato et 
al., 2011) reported that khat users exhibit impairments in the inhibition of response conflicts 
which may eventually lead to inefficient decision making in everyday life. Inhibition of 
response is a cognitive ability to hinder unwanted thoughts and actions and is commonly 
considered as one part of executive control functions (Colzato et al., 2010). 
 
There are significant psychometric relationships between the tests and tasks that are 
commonly used to assess cognitive control in humans. In this regard, (Miyake et al., 2000) 
suggested the existence of three major, separable control functions: the ‘‘inhibition’’ of 
unwanted responses, the ‘‘shifting’’ between tasks and mental sets (also called ‘‘flexibility’’), 
and the ‘‘updating’’ (and monitoring of) working memory (WM) representations, the model 
which has been previously used to investigate cognitive impairments among recreational users 
of cocaine and MDMA (Colzato, Huizinga, & Hommel, 2009; von Geusau, Stalenhoef, 
Huizinga, Snel, & Ridderinkhof, 2004). 
 
Given the link between khat use and impaired inhibitory control, another study that focused 
on cognitive flexibility and updating, tested the hypotheses that monitoring of working 
memory and mental flexibility are impaired in chronic khat users (Colzato et al., 2011) and 
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compared current (non-intoxicated) khat users (at least over the past 12 months) and matched 
khat-free controls (with no history of past or current khat use) in a task assessing the efficiency 
of monitoring information in WM and a task that taps into cognitive flexibility. The result 
revealed that current khat users performed significantly worse than their counterparts on both 
tasks. Khat use has long term negative effect on working memory, specifically, on digit 
backward measures of short-term working memory. However, contrary to the results obtained 
with chronic methamphetamine users, there was no statistically significant difference in speed 
of information processing between chronic chat users and their counter partners (Hoffman & 
al'Absi, 2013).  
 
Overall, although there seem to exist relatively extensive studies and findings on the 
neurocognitive effects of chronic drug use like amphetamine and cocaine, similar studies on 
the chronic use of khat are very scarce, particularly in the Ethiopian context, where the 
substance is widely growing and being consumed by majority of the population including 
students of secondary and tertiary education (Getahun & Krikoria, 1973; Lemessa, 2001; 
Selassie & Gebre, 1996  ). Reasons for chewing include obtaining increased level of alertness, 
ability to concentrate, improved memory, motivation, flow of ideas, improve mental 
performance before exams and ultimately good grades (Ayenew et al., 2012; Ihunwo et al., 
2004; Zein, 1988). However, interestingly, few studies have reported a significant association 
between khat chewing and high educational achievement (Al-Hebshi & Skaug, 2005; Alem et 
al., 1999), though no study has systematically and objectively investigated the interplay among 
the quantity of khat ingested, cognitive function, memory and the level of academic 
performance. These mental states would not be long lasting since khat chewing only provides 
a temporary atmosphere of concentration, mental alertness, cheerfulness, optimism and a 
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general sense of well-being, which would often disappear after a few hours of chewing or at 
the end of chewing sessions (Cox & Rampes, 2003)  
 
Khat Dependence 
Debates exist as to whether khat can actually cause dependence. Some authors describe a 
‘psychological’ dependence rather than a physical one (Halbach, 1972). Most argue that 
cathinone is presumed to be the dependence-producing constituent of khat leaves (Kalix & 
Khan, 1984). In their experimental studies on animals, cathinone is found to be a reinforcer 
and maintains very high rates of responding. In studies using pure cathinone extracts, 
progressive ratio self-administration tests reveal similar break-points for cathinone as for 
amphetamines (Yanagita, 1986), and cathinone induces conditioned place preference in 
rodents (Schechter & Meehan, 1993). These findings suggest the existence of a clear 
dependence potential for cathinone. Tolerance to khat occurs rarely and with the doses often 
increasing quite slowly. This may be due to the physical limits on the amount of khat that can 
be consumed at any given time due to the requirement of chewing and the time-limited 
duration of cathinone vs cathine subjective effects (Kalix, 1988). While the nature of khat 
dependence remains under active debate, there is accumulating evidence indicating the 
existence of a mild withdrawal syndrome and some evidence for tolerance (Cox & Rampes, 
2003).  
 
However, despite these debates as to whether khat can actually produce dependence (Manghi 
et al., 2009), physical and psychological dependence of khat were reported by many authors 
(Griffiths et al., 1997; Kassim & Al'absi, 2016; Kassim & Croucher, 2006; Kassim, Croucher, 
& al'Absi, 2013; Kassim, Islam, & Croucher, 2010; Nencini et al., 1989). Although limited 
use may not be related to serious consequences, prolonged exposure could lead to dependence, 
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psychosis and other psychiatric disorders and physical conditions (Odenwald & al'Absi, 2017). 
In addition, chronic khat use may cause a significant depletion of dopamine in the nigrostriatal 
dopamine terminal projections (Banjaw, Miczek, & Schmidt, 2006; Feyissa & Kelly, 2008). 
Which may result in psychiatric effect which includes depression and psychosis among heavy 
chewers (Odenwald et al., 2005) Psychological dependence features include chewers urge to 
fulfil their need of khat on the expenses of their vital needs like food and mood changes during 
and after chewing (Griffiths et al., 1997; Hassan, Gunaid, El-Khally, & Murray-Lyon, 2002; 
Kassim & Croucher, 2006). The Severity of Dependence Scale (SDS) developed by Gossop 
et al. (Gossop et al., 1995) was used to evaluate psychological dependence to many abused 
drugs through collecting data about the dependence features (Gossop, Best, Marsden, & 
Strang, 1997; Gossop et al., 1995; Topp & Mattick, 1997).  
 
Chronic drug use is associated with the occurrence of craving and withdrawal symptoms 
related to the discontinuation of use after long time exposure or habitual and chronic 
consumption (Giannini & Castellani, 1982). There are conflicting opinions regarding the 
existence of a withdrawal syndrome due to khat abstinence. However, there are some 
evidences for the presence of withdrawal manifestations among khat chewers. Depressive 
moods, drowsiness and hypotension are sometimes seen after khat discontinuation, and khat 
chewers often continue to use khat in order to avoid the withdrawal symptoms (Alem et al., 
1999). Other withdrawal symptoms common among khat quitters were lethargy, feeling 
sleepy, nightmares, feeling hot in the lower extremities, bad temper, and slight trembling (Al-
Habori, 2005; Al-Motarreb, Baker, & Broadley, 2002; Alsanusy & El-Setouhy, 2013). A 
recent study using  the criteria of dependence defined in the American Psychiatric Association 
Diagnostic Statistic Manual (DSM-IV, 1994) (Kassim et al., 2013) has reported that 31% of 
khat chewers had khat dependence syndrome, 13% of them reported an increase in khat 
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chewing, 19% reported cessation attempts, and 17% reported withdrawal symptoms including 
depression, increased appetite, and interrupted sleep. Some studies have also documented 
withdrawal symptoms consistent with these, specifically, in relation to khat, including 
lethargy, anergia, and nightmares, which appear several days after ceasing to chew (Giannini 
& Castellani, 1982).  
 
Findings on the natural course of withdrawal symptoms of khat are very rare. Although, most 
symptoms of amphetamine withdrawal may be over in four or five days, some of the 
symptoms may continue for weeks or months (Watson, Hartmann, & Schildkraut, 1972). 
Despite the similarity of amphetamine and khat in terms of chemical components and 
psychopharmacological effect on brain and behaviour, withdrawal symptoms of khat 
cessation and craving are likely but have yet to be reliably demonstrated.  
 
Craving is viewed as the subjective manifestation of the core motivational processes mediating 
addictive behavior in drug users (Robinson & Berridge, 2001; Wyvell & Berridge, 2001). The 
mechanisms of craving are presumed to be both biologically and psychologically oriented 
reflecting the operation of fundamental brain reward pathways (Baker, Morse, & Sherman, 
1986; Robinson & Berridge, 2001; Wyvell & Berridge, 2001). There have been continuing 
debates among researchers as to the timeframe of craving. While some investigators argued 
that craving is relatively stable (Anton, Moak, & Latham, 1995; West, Hajek, & Belcher, 
1989), others have viewed it as a momentary “pulsitile” state – such a view would suggest that 
using measures that encompass long time intervals may lack the precision to capture changes 
in craving (Gawin, 1991; Shiffman et al., 1996). These assumptions have led to advances in 
assessment methodology which have yielded near real time assessment in the natural 
environment (Shiffman et al., 1996) supporting the view that craving fluctuates substantially 
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even within the course of a day, and that craving reports obtained at different times are 
different in meanings and predictive power (Shiffman et al., 1996). Findings of addiction 
studies (Tiffany, 1990) have linked craving to relapse and considered craving as a necessary 
precondition for relapse (e.g. (Ludwig, Wikler, & Stark, 1974). However, recent accounts of 
addiction have not considered craving as an inevitable concomitant of relapse (e.g. (Kassel & 
Shiffman, 1992; Tiffany, 1990).  
 
Summary 
In summary, khat is a stimulant and highly prevalent drug among youths and adults  (Selassie 
& Gebre, 1996  ). Several people are estimated to be frequent khat users for its euphoric effects 
and become dependent to it despite its adverse psychological and mental effects (Kennedy, 
1987). Dependence is a chronic disease of brain characterized by disrupting the brain reward 
pathway mediated by dopamine. It refers to the reward, motivation, memory and related 
circuitry dysfunctions which have biological, psychological, social and spiritual 
manifestations and are reflected in an individual pathologically needing reward and/or relief 
by substance use and other behaviors (Fainsinger, Thai, Frank, & Fergusson, 2006; Wise, 
1980; Yoshimura & Yamamoto, 1980). People who are substance dependent are likely to lack 
the ability to consistently abstain from drugs due to impaired behavioral control, craving and 
reduced acknowledgment of significant problems with one’s behaviors and interpersonal 
relationships (Beckson & Tucker, 2014). Long-term effects of drugs on the brain may result 
in lack of the ability to experience any pleasure out of regular consumptions. This leads to the 
need for larger amounts of drug (tolerance) to feel the desired effects of consumption.  In the 
worst case scenario, drugs may simply be needed just to feel normal as they no longer make 
the individual experience pleasurable effects which ultimately leads to substance use disorder 
(Hasin et al., 2013; O'Brien, 2011).  Dependence often involves cycles of craving, relapse and 
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remission. Without treatment or engagement in recovery activities, dependence is progressive 
and can result in psychological and mental malfunctioning (Matto, 2005; Wise, 1988). Chronic 
and dependent drug use is likely to change brain structure and function which could be long 
lasting and lead to harmful behaviors which are often characterized by compulsive drug 
seeking and use despite experience of adverse consequences (Lu, Wang, Luo, Zhang, & Shi, 
2009; Volkow & Li, 2004).   
 
Findings obtained from previous studies revealed that khat is a potential drug of dependence 
and that some individuals with chronic use of khat may become severely dependent and face 
a number of psychological problems, indicating that greater risk of harms as being 
significantly related to heavier and more frequent khat chewing (Ihunwo et al., 2004; 
Odenwald, 2007; Odenwald et al., 2007). Dependent khat chewers are more likely to display 
certain psychological symptoms like stress, anxiety, depression, irritability and emotional 
instability more frequently than non-chewers (Odenwald, 2007).  
 
Ethiopia, like many other khat growing countries is facing a wide range of problems of high 
khat use; with the percentage of khat users in the general population increasing (Belew, 
Kebede, Kassaye, & Enquoselassie, 2000). There have been very limited efforts to minimize 
the problem. In 1996, Ethiopia showed an overall prevalence of about 30% and that the use 
of khat has spread among all segments of the population with a house-to-house survey in rural 
areas of Ethiopia giving a comparable figure of 32% (Belew et al., 2000). The struggle over 
khat, in Ethiopia, has always been between two camps: those who believe in the economic 
benefits of khat outweighing the negative social, psychological and health consequences on 
the one hand, and those who maintain strong position that khat is the cause of so much 
idleness, violence, and social immorality that any amount of economic benefit cannot justify 
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its continued use (Gebissa, 2008). Failure to regulate these problems not only threatens the 
health of youths, students and active parts of the population but also the future economic and 
social development of the country as a whole (Lemessa, 2001; Selassie & Gebre, 1996  ).   
 
Prevention of substance abuse in general and khat use disorder in particular for the sake of 
psychological and mental well-being of the community and the students presents a complex 
problem to health professionals, law enforcement agencies, and educators in Ethiopia 
(Lemessa, 2001; Selassie & Gebre, 1996  ). Although khat is a legal drug, possession and 
chewing in the work-place and educational institutions are illegal in most khat-growing 
countries, including Ethiopia (Cox & Rampes, 2003; Elmi, 1983). Hence, people prefer to 
chew khat away from family members, work-places and other commitments and they are likely 
to leave early or miss work or classes for this purpose (Gelaw & Haile-Amlak, 2004). The 
roots of the difficulties in dealing with khat use may be attributed to lack of proper knowledge 
of its multidimensional consequences on the part of the universities and on the part of law 
makers at large since there is a scarcity of evidence in regard to virtually all aspects of khat 
use – such as the nature of khat use disorder syndrome and the related psychological and 
mental health problems, experience of khat dependence and more importantly abstinence 
difficulties and associated withdrawal syndromes. In this regard, the current study aims to 
examine the presence of khat use disorder and the potential psychological and mental health 
consequences related to chronic khat use and make contributions to public health 
professionals, policy makers, administrators and educators in understanding the nature of use 
disorder, the severity of khat dependence and the potential factors that hinder the effectiveness 
of the approaches in attempting to curb khat abuse. The studies further aim to explore the 
successfulness of chewers in their attempts to quit chewing; the extent of chewers’ capability 
of maintaining abstinence and the type and nature of withdrawal syndromes and the level of 
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craving that involve during the quitting process.  These are considered to be major contributors 
to relapse and key obstacles to cessation in chronic khat users and vital components of 
treatment interventions. Understanding these may create opportunities to help design effective 
intervention and treatment mechanisms which involve the changing of deeply imbedded 
behaviors often through a combination of medications and behavioral therapies (Matto, 2005).  
 
Objectives of the studies 
The prevalence of khat chewing and its potential psychological and health related 
consequences have been less investigated among the wide range of population in Ethiopia. 
Very little is known about the presence of khat use disorder and its association with 
psychological and health related harms.  
 
Since khat produces clinical effects similar to amphetamine (Cox & Rampes, 2003), most 
chewers are likely to experience both positive and negative feelings during and after chewing 
sessions (Pantelis et al., 1989b).   The core aspects of the psychological and emotional effects 
of khat use and the level and the severity of khat dependence syndrome have been investigated 
to some extent (Kassim et al, 2010). Withdrawal-like symptoms and tolerance have been 
recently reported and some correlates have also been identified as potential liability factors for 
the spread of khat chewing and for the development of khat dependency (Kassim et al, 2013; 
Halbach, 1972; Luqman and Danwoski, 1976; Douglas et al., 2011; Alem and Shibre, 1997; 
Gelaw and HileAmlak, 2004). Previous studies have provided initial support for the use of 
SDS-khat as a valid research tool for assessing psychological aspects of khat dependence 
(Elmi, 1983; Kalix & Braenden, 1985;Nakajima et al., 2014) To date, however, no previous 
study has attempted to determine a cut-off score of the severity of dependence against 
diagnoses of khat use disorder/dependence, nor to examine the association of the scores on the 
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SDS-khat with the psychological health and other behaviours known to be correlated with 
dependence.                                                                                                
 
Experiences of withdrawal symptoms during periods of abstinence are one of the most 
significant factors in dependent and chronic drug use. Most theories of dependence have 
posited that continued drug use is, at least in part, driven by avoidance of withdrawal 
symptoms. During termination of frequent substance use for a period of time, the dysphonic 
states experienced or the physiological adaptation to the chronic presence of the drug facilitate 
the desire to use a certain drug of dependence (Ferguson & Shiffman, 2009).  The experience 
and severity of withdrawal symptoms is a key factor in craving and a significant barrier to 
cessation/reduction of problem drug use and addressing withdrawal is a key component of 
many treatments of drug abuse (Shoptaw, Kao, Heinzerling, & Ling, 2009). In this regard, 
despite some evidence indicating the presence of a withdrawal syndrome, craving and a degree 
of tolerance related to chronic khat chewing (Cox & Rampes, 2003), very little research works 
have been conducted, to date, on the nature and outcomes of khat cessation attempts as well 
as the trend, severity and time course of withdrawal symptoms in relation to khat, particularly 
in the Ethiopian context.  
 
The general aim of this thesis is to investigate if khat chewing causes problems in individuals 
and to determine the evidence for clinically meaningful khat use disorder and withdrawal 
syndromes. The studies in the subsequent chapters have examined unique but highly 
interrelated subject matters in relation to khat chewing and associated adverse consequences. 
Overall, the studies in this thesis are novel and provide new insights and knowledge in the 
areas of khat research and suggest potential intervention strategies that could help public health 
professionals to effectively identify khat use disorders and to better understand the 
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multidimensional adverse consequences and syndromes associated with the disorder and to 
address the khat problems among individuals in the community in Ethiopia.  
 
Study 1 (Chapter 2): “Is khat use disorder a valid diagnostic entity?”  
This is the first survey study at the community level. It aimed to examine khat use disorder 
using DSM-5 criteria and to determine its relationship with the typical patterns of khat 
consumption, the experience of psychological and academic/behavioural problems and quality 
of life. It addresses the validity of khat use disorder by exploring the structure of this syndrome 
and the relationship between the syndrome and functional consequences. It examined how 
participants with khat use disorder differed from those who do not have the disorder in terms 
of patterns (duration, amount and type) of khat consumption and experience of other harms. 
The study used a survey comprising current clinical symptoms (using a modified Alcohol Use 
Disorder and Associated Disabilities Interview Schedule-IV), and validated measures of health, 
psychological distress, quality of life and academic functioning. 
 
This study has been published as an original research article on Addiction journal (2016, IF 
5.789) − a monthly peer-reviewed scientific journal by the Society for the Study of Addiction 
to Alcohol and other Drugs. The journal covers original research relating to alcohol, illicit 
drugs, tobacco, and behavioral addictions. 
 
Study 2 (Chapter 3): “Using the Severity of Dependence Scale to Screen for DSM-5 Khat 
Use Disorder”.  
The main objectives of this study were to determine the efficiency of the Severity of 
Dependence Scale (SDS) as a screening tool for DSM-5 defined khat use disorder among khat 
chewers and to examine the validity of the cut-off points in identifying a group of individuals 
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who use khat at greater frequency and quantity and experience functional problems associated 
with khat use. The study used a survey comprising of current substance use disorder and a 
severity of dependence scale (SDS) which assessed the psychological components of 
dependence over the past year, 
 
This study has been published as an original research article on Human Psychopharmacology 
Clinical and Experimental (2015, IF 2.44) − an international journal for the publication of 
quality clinical and experimental research on both new and established psychotropic 
medicines; experimental studies of other centrally active drugs including herbal products in 
clinical social and psychological contexts as well as clinical/scientific papers on drugs of abuse 
and drug dependency.  
 
Study 3 (Chapter 4): “Stopping Khat use: Predictors of success in an unaided quit 
attempt.”  
The main objective of this study was, using electronic diaries, to monitor the outcomes of an 
unassisted khat cessation attempts among 59 frequent (daily and near daily) khat users who 
were self-motivated to quit.  
 
This study has been published as an original research article on Drug and Alcohol Review 
(2014, IF 2.294) − a bimonthly peer-reviewed medical journal covering the health effects of 
alcohol and other drugs. 
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Study 4 (Chapter 5): “Khat withdrawal symptoms among chronic khat users following a 
quit attempt: An Ecological Momentary Assessment.”  
The main aim of this study was to determine the nature and the time course of any withdrawal 
symptoms among 59 frequent (daily and near daily) khat chewers in relation to the cessation 
of khat use over 2 weeks period of quit attempts. This study employed Electronic Diaries 
issuing random prompts to collect real-time data from participants 4 to 7 times a day, over 3 
days assessment of pre-quit ad lib khat consumption and 14 days assessment of post quit hat 
use.  
 
This study has been published as an original research article on Psychology of Addictive 
Behaviors (2016, IF 2.543) − a peer-reviewed academic journal of the American 
Psychological Association that publishes original articles related to the psychological aspects 
of addictive behaviors 8 times a year. 
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Abstract 
Aims: This study aimed to validate the presence of a khat use disorder syndrome using DSM-5 
criteria and to examine its relationship with increased experience of harms.  
Design: Cross-sectional, purposive sample of current khat chewers, recruited from khat markets 
and cafes.  
Setting: Participants were recruited from the general community and from Adama Science and 
Technology University in Ethiopia.  
Participants: 400 current khat consumers aged 16 and above were recruited between September 
2014 and January 2015.  
Measures: Survey comprising current clinical symptoms (using a modified Alcohol Use Disorder 
and Associated Disabilities Interview Schedule-IV), and validated measures of health, 
psychological distress, quality of life and academic functioning.  
Findings: A third (35.5% 95%CI 31.0-40.3) of respondents reported daily khat use and a quarter 
(25.4% 95%CI 21.4-30.0) using 3 times or more per week. Using DSM-5 criteria, 10.5% (95%CI 
7.9-13.9) were categorised as experiencing mild, 8.8 % (95%CI 6.4-12.0) moderate and 54.5% 
(95%CI 49.6-59.3) a severe khat use disorder. Confirmatory factor analysis demonstrated good fit 
of symptoms to a single underlying construct, consistent with other substance use disorders. 
Individuals categorised as khat use disordered demonstrated significantly greater frequency (OR= 
45.29; 95% CI = 10.97-19.01) and quantity of khat use (OR= 2.35; 95% CI = 1.29-4.29).  They also 
demonstrated increased financial problems associated with use, greater problems with academic 
functioning, and higher rates of self-reported mental health problems, higher psychological distress 
and poorer quality of life. Treatment access was poor, with only one third (32.9%) of individuals 
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with khat use disorder reporting lifetime access, near-exclusively related to help-seeking from 
friends and relatives.  
Conclusion: The construct of a substance use disorder syndrome for khat using DSM-5 criteria 
appears valid and performs in a manner consistent with other substances of dependence. Individuals 
with khat use disorder experience substantial problems in association with khat use. Despite this, 
there are low levels of help-seeking for these problems. 
 
Keywords Catha, central nervous system stimulants, DSM-5, DSM-IV, khat, khat dependence, 
khat use disorder, stimulant use disorder, substance –related disorders. 
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Introduction 
Khat (catha edulis) is a cathinone-based stimulant which is a controlled substance in most western 
countries but legal in several African countries, including Ethiopia (Kalix, Geisshusler, Brenneisen, 
Koelbing, & Fisch, 1990). A 2011 population prevalence study estimated past month use at 15.3% 
across Ethiopia. Among Ethiopian university students (n=3,268), lifetime prevalence was estimated 
to be 24.0%, while 7.7% reported past month khat use (E. Gebrehanna, Y. Berhane, & A. Worku, 
2014a). Khat chewing has also spread  to the UK, Europe and USA (Kassim & Croucher, 2006). 
Due to the socio-economic and health consequences of khat use without any useful therapeutic 
outcomes (World Health Organization Expert Committee on Drug, 2003), the need for international 
control has become a public health concern, with many countries recently banning use (Kassim & 
Al'absi, 2015).  
 
While fresh khat leaves contain multiple psychoactive constituents, the primary ingredient is 
cathinone. This rapidly degrades after harvesting and on chewing to cathine and norephedrine. 
Subjective effects of both khat chewing (Widler, Mathys, Brenneisen, Kalix, & Fisch, 1994) and 
pure cathinone (Brenneisen, Fisch, Koelbing, Geisshusler, & Kalix, 1990) demonstrate 
amphetamine-like physiological and subjective effects in humans. Cathinone dose-dependently 
increases dopamine levels in vivo (Pehek, Schechter, & Yamamoto, 1990), and demonstrates 
affinities for dopamine (Fleckenstein et al., 1999) and noradrenaline transporters (Cleary & 
Docherty, 2003), as well as having inhibitory effects on monoamine oxidase (Nencini, Amiconi, 
Befani, Abdullahi, & Anania, 1984). Cathine has been noted as the primary contributor to peripheral 
adverse effects from khat (Cox & Rampes, 2003; Yanagita, 1979). 
 
A typical khat chewing session lasts for several hours, during which 100-500g of leaves are chewed 
thoroughly and stored in the cheek for several minutes before being spat out, with juice from the 
leaves swallowed (Feyissa & Kelly, 2008). While this efficiently extracts the alkaloid (Toennes & 
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Kauert, 2002), it is laborious, as typically cathinone concentrations are ~1mg/g/leaf (Feyissa & 
Kelly, 2008). Onset is slow, with peak plasma levels of cathinone after 2.3 hours; and the products 
cathine and norephedrine peaking later at 2.6 and 2.8h respectively (Toennes, Harder, Schramm, 
Niess, & Kauert, 2003). Terminal half-life for cathinone is much briefer (1.5±0.8h) than for cathine 
(5.2 ± 3.4h) (Toennes et al., 2003), meaning that as the length of time that chewing sessions extends, 
cathine levels accumulate to a greater extent than cathinone and more unwanted systemic effects 
may result (Cox & Rampes, 2003). Anecdotal reports from chewers suggest that negative effects 
of khat also increase over the course of chewing, which limits the duration of sessions (and hence 
dose consumed). It is not clear if this relates to any accumulated physiological effects of cathine, 
although continuous self-administration studies in rodents demonstrate a greater rate of cathinone 
infusions in early (cathinone dominated) compared to later (cathine dominated) portions of study 
sessions (Gosnell, Yracheta, Bell, & Lane, 1996), which would be consistent with this hypothesis. 
 
Debates exist as to whether khat can actually produce dependence (Manghi et al., 2009). A recent 
study has revealed that higher frequency of khat chewing was associated with psychological 
dependence (Kassim, Islam, & Croucher, 2010); also see (Nakajima, Dokam, Alsameai, et al., 
2014). In studies using pure extracts, progressive ratio self-administration tests suggest similar 
break points for cathinone as for amphetamines (Yanagita, 1986); and cathinone induces 
conditioned place preference in rodents (Schechter & Meehan, 1993). These and other effects (see 
(Feyissa & Kelly, 2008) for a review) suggest clear dependence potential for cathinone. However, 
given the limited cathinone dose available through khat chewing, there may be substantially lower 
dependence potential from use of the natural plant than from direct administration of cathinone. 
Similarly, tolerance to khat occurs rarely (Kassim, Croucher, & al'Absi, 2013a), potential due to 
the physical limits on the amount of khat that can be consumed during sessions (Kalix, 1988). There 
is accumulating evidence indicating the existence of a mild withdrawal syndrome, consisting of 
anergia, nightmares, depressed moods, drowsiness and hypotension (Alem, Kebede, & Kullgren, 
Chapter 2: Is khat use disorder a valid diagnostic entity?  42  
 
 
1999; Giannini & Castellani, 1982; Pantelis, Hindler, & Taylor, 1989) and khat chewers often 
continue to use khat in order to avoid these withdrawal symptoms (Giannini & Castellani, 1982).  
 
Habitual khat chewers exhibit compulsive behaviours in khat markets and have the tendency to 
secure daily khat supply at the expense of other vital needs (Kalix & Braenden, 1985; Nencini, 
1988). These are described as psychological dependence by some authors (Connor, Rostom, & 
Makonnen, 2002; Gosnell et al., 1996; Kalix, 1990), and some studies of frequent consumers have 
estimated that dependence syndromes may indeed be common (Kassim, Hawash, Johnston, & 
Croucher, 2012). 
 
Despite the prevalence of khat use, and potential psychological and health consequences, there has 
been inadequate study of the nature of symptoms of substance use disorder relating to khat. As 
such, this study aimed to examine the presence, structure, and external validity of a khat use disorder 
(KUD) syndrome using current Diagnostic and Statistical Manual (DSM-5) criteria, as well as the 
more clinically familiar DSM-IV dependence syndrome. Specifically, the study aimed to answer 
the following:  
1. Are use disorder symptoms experienced in relation to khat? This was addressed by using 
DSM criteria to identify cases of use disorder in relation to khat. 
2. Do these symptoms produce a syndrome that performs in the same manner as other 
stimulants? To address this aim, confirmatory factor analysis was used to examine 
symptom structure, to determine if all symptoms relate to a shared latent process.  
3. Does the presence of a khat use disorder syndrome perform validly, relating to an 
increased experience of harms? To address this aim, differences between individuals with 
KUD and Non-KUD in terms of variables such as patterns of consumption, mental health, 
financial, occupational and cognitive functioning problems were examined. 
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MATERIALS AND METHOD 
Design/Study sample size 
Planned sample size was 500; 454 responses were collected using purposive sampling. Responses 
with missing responses on core (DSM) items were excluded, leaving 400 cases. Most of the 
excluded cases provided no data to these core items (n=48), with the inclusion of individuals with 
25% missing data only increasing sample size by 6.  As such, we are confident that the risk of bias 
by the exclusion of these cases is low.  
 
Participants 
Four hundred current khat consumers were recruited from the general community (Adama, 
Ethiopia) and from Adama Science and Technology University between September 2014 and 
January 2015 (26.4% of adults in the region are estimated to chew khat (Haile & Lakew, 2015)). 
Recruitment occurred through posters displayed in khat markets, khat cafes, on campus and on 
social networking sites. Minimum eligibility criteria were ≥16 years and use of khat at least once 
in the past year.  
 
Participants completed either a self-administered online 40-minute khat use survey (19%; n=86) in 
English; or an Amharic paper version (81%; n=368) with overall response rate of 83.9% of those 
receiving the paper survey. The English survey was translated to Amharic and then back translated 
for verification by language experts from Adama Science and Technology University and cross-
checked further with multiple multilingual speakers. 
 
The Tasmania Human Research Ethics Network granted approval for the study (#HO013036), with 
additional local ethical clearance obtained from Adama Science and Technology University. 
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Measures 
Items derived from the Ethiopian national census and from the tool kit for Conducting School 
Surveys on Drug Abuse (Degenhardt et al., 2006) were used to assess age, sex, education level, 
employment status and parental status. Items assessing frequency, quantity, type and perceived 
strength of khat; and frequency of alcohol and tobacco use were adapted from the tool kit for 
Conducting School Surveys on Drug Abuse (Degenhardt et al., 2006). Nicotine dependence among 
tobacco smokers (33; 95%CI 28–37) was assessed using the Fagerström Test (Heatherton, 
Kozlowski, Frecker, & Fagerstrom, 1991) 
 
Past year khat use disorder (KUD) symptoms were assessed using a modified version of the Alcohol 
Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV (Ruan et al., 2008; 
Saunders, Aasland, Babor, de la Fuente, & Grant, 1993), with item content expanded to include 
craving. The reliability and validity of the AUDADIS in relation to abuse and dependence disorders 
for a range of substances is well documented in numerous international studies (Grant et al., 2004; 
Grant, Harford, Dawson, Chou, & Pickering, 1995). To assess withdrawal, 19 symptoms were taken 
from the Composite International Diagnostic Interview (CIDI) Substance Abuse Module to reflect 
the possible range of this syndrome following chronic use of similar stimulants. Positive diagnosis 
of khat withdrawal as operationalized consistently with DSM stimulant withdrawal criteria 
(dysphoria plus at least two additional symptoms present concurrently, at a level considered 
distressing, or withdrawal relief).  
 
To validate the khat dependence syndrome, differences on a range of consumption (frequency, 
duration, and quantity), demographics and problems (mental health, quality of life, financial 
problems) were examined. Sex and education level have also been associated with khat dependence 
in prior studies (Nakajima, Dokam, Kasim, et al., 2014).  
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The Kessler Psychological Distress Scale (Kessler et al., 2002) was used to assess non-specific 
psychological distress. At a cut-off of 30, the scale has high specificity (0.99), and approximately 
86% scoring in this range meet past year criteria for DSM-IV anxiety or affective disorders 
(Andrews & Slade, 2001). 
 
A subjective multi-domain quality of life measure (The Personal Wellbeing Index (PWI-5th 
edition), with Australian normative data was used to assess quality of life (Group, 2013).  The scale 
was recently developed by the International Wellbeing Group (IWbG) and comprised seven items 
that, together, provide a measure of global subjective wellbeing (SWB). Over 150 researchers from 
more than 50 countries and provinces had engaged in this international collaboration to upgrade 
the PWI into a valid cross-cultural instrument, so it can be used for international research purposes. 
This is supported by the large number of international translations of the scale 
(http://www.acqol.com.au/instruments#measures). However, currently there are normative data 
available for Ethiopia nor for any African countries, and as such the most comprehensive normative 
dataset was applied, which originates from Australia. Regardless, the nature of the items is such 
that higher scores will always reflect higher quality of life, and as such the weighting process 
applied for the norms of data will not change participants relative scores. In this series of studies, 
a binary score was created such that people scoring two standard deviations below the population 
mean for the scale (using Australian norms) were classed as reporting ‘low’ quality of life. While 
the absolute values of the extremes of the distribution of PWI scores in Ethiopia are not known but 
it is undoubtable that people scoring in the ranges used in this study to denote ‘low’ perceived 
quality of life validly reported lower levels of quality of life than other participants. Moreover, less 
than one quarter of the survey sample reported scores in the ‘low’ range which has face validity 
and is relatively comparable with levels reported in studies of substance consuming populations in 
Australia (Dietze et al., 2010). 
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Typical frequency of cognitive and academic impairment in the past six months was assessed using 
a 12-item academic functioning questionnaire pilot tested and refined from cognitive and executive 
function questionnaires used in similar studies (Schwartz, 2007). Initially 40 items were developed, 
taken from existing scales (cognitive and executive function questionnaires) in the literature. These 
were examined in a pilot survey at the study site (in Adama Ethiopia). In the main khat study, the 
scale was examined using Confirmatory Factor Analysis (CFA) to ensure that it formed an 
appropriate scale: the reported scale had 12 items with acceptable factor loadings and acceptable 
fit indices (RMSEA=0.086 (0.05); CFI=0.987 and TLI=0.984). In the reported studies, however, 
single survey items were reported. These have clear face validity as measures of perceived 
cognitive problems and are consistent with the literature (Schwartz, 2007). 
 
Statistical Analysis 
Symptom rates were reported using 95% CIs. Chance-corrected concordance between DSM-IV and 
DSM-5 syndromes were assessed using the kappa statistic (Cohen, 1960). Syndrome structure was 
assessed by conducting unifactorial confirmatory factor analysis with additional item-response 
theory (IRT) measures, in Mplus v7.0, using robust estimators to account for skewed data. Model 
fit indices were examined to assess structural fit, including root mean squared error of 
approximation (RMSEA); Tucker-Lewis Index (TLI) and comparative fit index (CFI); RMSEA 
<0.06, TLI >0.95 and CFI >0.95 are considered to indicate good fit (Hu & Bentler, 1999; Mulaik, 
2007; Steiger, 2007). Recent simulation studies suggest that N>200 is sufficient for robust 
estimation of such a structure (Myers, Ahn, & Jin, 2011). To assess whether there were particular 
patterns of symptoms among participants, latent class models were estimated using DSM-5 items. 
Three criteria were used to assess model fit (Ramo, Grov, Delucchi, Kelly, & Parsons, 2010). The 
Lo–Mendell–Rubin adjusted log-likelihood ratio test (LMR-ALRT) statistic (Lo, Mendell, & 
Rubin, 2001), was used to compare models with different number of classes: a value of p<0.05 
suggests that the model with one additional class is a better explanation of the data.  Akaike 
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Information Criterion (AIC) and the Bayesian Information Criterion (sample-size adjusted; BIC) 
were used to assess model fit (lower values indicate better fit). Entropy (range 0.0–1.0) was also 
used, with higher values reflecting clearer classification of individuals (Ramo et al., 2010). To 
assess if khat use disorder relates to increased rates of harms, odds ratios (OR) for experience of 
problems were calculated from independent logistic regression models using SPSS Statistics v22.  
 
RESULTS 
Mean participant age was 30 years [standard deviation (SD) =7, range 17-49], and more than three-
quarters were male. Most had not completed secondary education (see Table 1). One-third of the 
sample was university students (Table 1). Approximately a third of respondents reported daily khat 
use and a quarter reported using three times or more per week. 
 
Khat Use Disorder Symptoms 
‘Continuing to use despite knowledge of physical or psychological harm’ was the most commonly 
endorsed dependence criterion (Table 3). ‘Interference with role obligations’, ‘continued use 
despite interpersonal problems’ and ‘use in larger amounts or for longer than intended’ (50%) were 
also commonly reported. Endorsement of withdrawal symptoms following 24 hours of abstinence 
was prevalent (Table 2). However, symptoms that persisted beyond the acute ‘come-down’ period 
following use and were distressing were less common. Among these, depressed mood (38%), 
hypersomnia (34%), and irritability (31%) were predominant. While only one-quarter (28%) had 
experienced two or more of these symptoms lasting for more than 48 hours, use of khat for 
withdrawal relief was more common (>50%).   
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Khat use disorder diagnostic crosswalk 
Using DSM-IV, 15.3% (95%CI 12.1-19.1) met criteria for abuse and 60.5% (95%CI 55.6-65.2) for 
dependence. Using DSM-5, 10.5% (95%CI 7.9-13.9) were categorised as experiencing mild, 8.8 
% (95%CI 6.4-12.0) moderate and 54.5% (95%CI 49.6-59.3) as a severe khat use disorder. 
Appendix, Table S1 illustrates the degree of diagnostic agreement between DSM-IV and DSM-5 
diagnoses. As would be expected, DSM-5 use disorder captures a broader group than DSM-IV 
dependence, however, agreement between DSM-IV dependence and moderate (or greater) DSM-5 
khat use disorder was good (Kappa=0.90). Similarly, agreement between DSM-IV abuse and 
receiving any DSM-5 Khat use disorder (Kappa=0.84) was acceptable.  
Table 1: Demographic characteristics of the sample (n=400) 
  
Item n % (95%CI)  
Gender 
Male 308 77 (72.6-80.9) 
Student 135 343.8 (29.3-38.5) 
Age 
≤24 113 28.2 (24.1-32.9 
25=34 176 44 (39.2-48.9) 
35-44 98 24.5 (20.5-28.9) 
≥45 13 3.3 (1.9-5.5) 
frequency of khat use 
Daily 141 35.5 (31.0-40.3) 
3 times or more a week 101 25.4 (21.4-30.0) 
Ethnicity 
Amhara 112 28 (23.8-32.6) 
Harari 12 3 (1.7-5.2) 
Oromo 148 37.2 (32.4-41.3) 
SNNP 70 17.6 (14.1-21.5) 
Tigrie 32 8 (5.7-11.1) 
Others d 26 6. 5(0.1-1.8) 
Educational Level 
Completed Grade 11 or less 222 64 (58-68) 
Completed Grade 12 (secondary Educ.) 57 16 (13-20) 
Diploma 66 18.5 (15-23) 
Bachelor’s degree or higher 11 2.8 (1.5-4.9) 
Otherc 44 11 (8.3-14.4) 
Employment Status a 
Unemployed 17 6.3 (4.0-9.9) 
Self-employed 145 53.9 (48.0-59.8) 
Employed for wages 68 25.3 (20.4-30.8) 
Looking for work 34 12.6 (9.2-17.1) 
Others b 5 1.8 (0.8-4.3) 
   
an= 269. bUnable to work, retired, home duty. cNo school. dOther ethnic groups. SNNP = 
Southern Nations and Nationalities People; CI = confidence interval.  
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Structure of Khat use disorder 
Confirmatory factor analyses demonstrated a good fit of a unifactorial model to both DSM-IV 
dependence and DSM-5 substance use disorder items, consistent with patterns for other drugs of 
dependence (Saha et al., 2012) (Table 3). In order to determine whether there were particular 
common patterns of symptoms (or ‘types’), latent class analyses of DSM-5 khat use disorder 
symptoms were conducted.  Model fit indices for 1-6 class solutions are displayed in supplementary 
materials (Table A2). While these do not explicitly support a single solution, on inspection of BIC, 
LMR-ART and structures of each solution, a 3-class model provided the most parsimonious and 
meaningful structure, with higher order solutions largely representing a fragmentation of these 
classes. This model identified consumer classes that differed primarily on severity of dependence, 
in keeping with a unifactorial, dimensional symptom structure. One class, categorised as ‘low 
dependent’ consumers (35%), had a low probability any symptom (all probabilities ≤0.188). A 
second group (33%) had >50% probability of endorsement of abuse, physiological dependence, 
larger/longer and continued use despite physical/psychological harm (Supporting information 
Figure S1). A final group (32%) had high probability of endorsement of all symptoms. 
 
Correlates of DSM-5 Khat Use Disorder 
As a means of external validation of the DSM-5 KUD syndrome, independent logistic regression 
models (Table 4) demonstrated that those classified with KUD were significantly more likely than 
other participants to use khat more frequently and in larger amounts. However, there was no 
difference in duration of khat chewing sessions; age of onset or years of use of khat. Individuals 
with KUD were more likely to have participated in lifetime ‘help seeking’ for khat use, however, 
this related to only one-third of the group with KUD, and almost exclusively related to help from 
family members or friends. Those with KUD were also significantly more likely to be male, daily 
alcohol consumers and dependent or daily tobacco smokers (Table 4). Half of the group with KUD 
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had also recently smoked shisha; and while other drug use was uncommon, rates were elevated in 
this group.  
 
Harms attributed to khat use among the sample were frequent, and were consistently greater among 
respondents with KUD, even after controlling for gender, tobacco use and other drug use (Table 
4). Those with KUD had systematically increased financial problems associated with use, higher 
rates of self-reported mental health problems and one-quarter screened positive to high levels of 
psychological distress. Similarly, this group reported poorer quality of life.  
 
Table 2: Past-year endorsement of withdrawal symptoms (n=400) 
 
Definition 
Symptom present 
% (95%CI) 
Symptom present >24h and 
problematic a 
% (95%CI) 
Core symptoms   
   Depressed mood                               58.5 (53.6-63.2) 37.5 (32.9–42.3) 
   Irritable                                                                   45.0 (40.2-49.9) 30.5 (26.2–35.2) 
   Anxious/nervous                                                45.5 (40.7-50.4) 23.7 (19.8–28.2) 
   Fatigue                                                       53.0 (48.1-57.8) 23.3 (19.4–27.6) 
   Vivid/unpleasant dreams                     55.0 (50.1-59.8) 16.8 (13.4–20.7) 
   Insomnia                                                                56.0 (51.1-60.8) 17.8 (14.3–21.8) 
   Hypersomnia                                                   57.3 (52.4-62.0) 33.8 (29.3–38.5) 
   Increased appetite                      42.8 (38.0-47.6) 27.3 (23.1–31.8) 
   Psychomotor retardation                 42.0 (37.3-46.9) 18.5 (15.0–22.6) 
   Restless                                                                 52.0 (47.1-56.9) 29.3 (25.0–33.8) 
Additional symptoms   
   Hallucinations                                                     21.5 (17.8-25.8) 8.0 (5.7–11.1) 
   Headache                                                            26.5 (22.4-31.0) 14.5 (11.4–18.3) 
   Decreased appetite                                       24.3 (20.3-28.7) 13.8 (10.7–17.5) 
   Concentration problems                               48.0 (43.1-52.9) 27.5 (23.4–32.1) 
Summary   
   Dysphoria and two or more concurrent 
symptoms, lasting ≥48 hours  
 28.0 (23.8–32.6) 
   Withdrawal relief                43.8 (39.0–48.6)  
   Withdrawal present (either concurrent 
dysphoria + 2 or withdrawal relief) 
 50.3 (45.4-55.1) 
 
a Problematic: uncomfortable, upsetting, and caused problems (at work, school, with family or friends).  
CI = Confidence interval. 
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DISCUSSION 
The aim of this study was to validate DSM criteria for khat. Use disorder was identified in almost 
three quarters of this general community sample of frequent chewers. Although there has been 
limited prior research, these rates are comparable with a smaller study identifying DSM-IV 
dependence among 63% of participants recruited through khat cafes in UK (Kassim et al., 2012). 
The khat use disorder syndrome fit well to a unifactorial model, and latent symptom classes were 
consistent with a dimensional process, consistent with findings for amphetamines (Saha et al., 
2012) and other drugs (Compton, Saha, Conway, & Grant, 2009; Kerridge et al., 2011).  
 
Symptom item base rates (IRT ‘difficulties’), however, followed a pattern for khat that contrasts 
strongly with that identified for other substances, likely reflective of the unique mode of khat 
consumption when compared to other stimulants. ‘Continuing to use despite knowledge of 
physical/psychological problems’ was the most frequently reported symptom, despite this being a 
DSM-IV dependence item rather than the conceptually less severe abuse criteria set. This pattern 
has also been identified caffeine use disorder (Striley, Griffiths, & Cottler, 2011). The other most 
commonly reported symptoms were part of the DSM-IV abuse syndrome: ‘failure to fulfil major 
role obligations’ and ‘continued use despite interpersonal problems’. A khat chewing session 
typically lasts 5-6 hours (Cox & Rampes, 2003) and is a social process, albeit typically occurring 
away from home or in khat cafes. While a legal drug, khat possession and chewing in the workplace 
is illegal in most khat growing countries (Cox & Rampes, 2003; Elmi, 1983). As a result, chewing 
is most likely to be conducted away from family members, work places and other commitments. 
Indeed, in a methodologically strong study of university and hospital staff in Ethiopia, half the khat 
consumers reported leaving work early or missing work entirely to chew khat (Yeshigeta Gelaw, 
2004). 
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Table 3: Past year symptom base rate, confirmatory factor analysis (CFA) model fit and item response theory parameters for DSM-IV khat    
dependence and DSM-5 khat use disorder (n=400) 
 
  DSM-IV Khat dependence DSM-5 Khat use disorder 
  CFA Item-response theory CFA Item-response theory 
 Symptoms present 
% (95%CI) 
Loadings a 
α (SE) 
(discrimination) 
β (SE) 
(difficulty) 
Loadings a 
α (SE) 
(discrimination) 
β (SE) 
(difficulty) 
Drug-related legal problems 14.8 (11.6-18.6) - - - - - - 
Recurrent use resulting in failure to fulfil major role obligations  61.5 (56.6-66.1) - - - 0.860 3.06 (0.39) -0.29 (0.08) 
Continued use despite recurrent social/interpersonal problems due to use 56.0 (51.1-60.7) - - - 0.926 4.44 (0.73) -0.09 (0.07) 
Recurrent use in hazardous situations   50.3 (45.4-55.1) - - - 0.689 1.73 (0.21) 0.02 (0.09) 
Craving or a strong desire for khat 45.7 (40.9-50.6) - - - 0.536 1.15 (0.17) 0.20 (0.11) 
Tolerance  40.3 (35.6-45.1) 0.658 1.59 (0.21) 0.38 (0.10) 0.640 1.51 (0.20) 0.39 (0.10) 
Withdrawal  50.3 (45.4-55.1) 0.868 3.17 (0.44) 0.05 (0.07) 0.849 2.91 (0.36) 0.05 (0.07) 
Used in larger amounts or longer than intended  
52.0 (47.1-56.8) 
0.825 2.56 (0.36) 
-0.01 
(0.08) 
0.789 2.33 (0.29) -0.10 (0.08) 
Persistent desire or unsuccessful efforts to reduce use  46.0 (41.1-50.9) 0.892 3.59 (0.54) 0.30 (0.07) 0.901 3.77 (0.52) 0.30 (0.07) 
Social, occupational, other activities reduced due to use 41.5 (36.8-46.4) 0.842 2.83 (0.38) 0.17 (0.07) 0.892 3.58 (0.49) 0.18 (0.07) 
Great deal of time spent using and recovering from use  23.5 (19.6-27.9) 0.806 2.47 (0.40) 0.90 (0.10) 0.832 2.72 (0.44) 0.86 (0.09) 
Continued use despite recurrent physical or psychological problems  
63.3 (58.4-67.8) 
0.891 3.55 (0.54) 
-0.34 
(0.08) 
0.854 2.98 (0.39) -0.35 (0.08) 
CFA model fit indices Chi-square a 240.135**   858.257**   
 AIC a 2808.518   4292.447   
 BIC a 2864.398   4380.260   
 SSA-BIC a 2819.975   4310.452   
 CFI b 0.979   0.979   
 TLI b 0.969   0.973   
 RMSEA b 0.109   0.090   
 WRMR b 1.417   1.390   
% Met Disorder criteria  60.5 (55.6-65.2) 73.7 (69.2-77.8) 
 
**P < 0.01; a Using the robust MLR estimator (maximum likelihood estimation with robust standard errors), AIC = Akaike Information Criterion; BIC = Bayesian Information Criterion; SSA-BIC = sample size-
adjusted Bayesian information criterion. With WLSMV the absolute χ2 value cannot be interpreted or compared. Only the P-value can be interpreted. b Using the WLSMV (weighted least squares estimator with 
degrees of freedom adjusted for means and variances) estimator, CFI = comparative fit index; CFA=Confirmatory Factor Analysis; RMSEA = root mean square error of approximation; WRMR = weighted root mean 
residual. TLI = Tucker–Lewis Index; SE = standard error; CI = confidence interval. 
 Physical withdrawal symptoms and craving were apparent in half the participants, as were 
indications of lack of control over use. Unusually, despite regular khat use in the sample, tolerance 
was the second least commonly reported symptom, and, while those classified with KUD typically 
chewed larger amounts, session duration (on average 5 hours or more) did not differ according to 
KUD presence. The infrequency of tolerance has been identified previously (Kalix, 1988) and may 
relate to the physical limits on the amount of khat that can be ingested at any one time. Additionally, 
the accumulation of cathine during a chewing session leads to adverse experiences the longer a 
chewing session continues, placing a limit on the duration of a session. 
 
Despite the extended duration of a typical khat chewing session, the symptom ‘great deal of time 
spent using’ was uncommon. This is an important reminder of cultural factors in symptom 
identification, as, while participants viewed this as largely an expected behaviour, practitioners 
may be quick to consider the duration of even a typical session for non-problematic khat consumers 
as evidence for the presence of this symptom. The low endorsement of ‘drug-related legal 
problems’ is a reflection of the legality of khat use in the country. 
 
Although there are no controlled studies on khat withdrawal, changes in mood and sleeping 
problems, loss of appetite, fatigue, depression and low mood have been commonly associated with 
khat use (Alem et al., 1999; Cox & Rampes, 2003; Elmi, 1983), consistent with the withdrawal 
syndrome for related psychostimulants. While almost all had experienced at least one clinically 
significant withdrawal symptom, only 28% met core requirements for stimulant withdrawal 
(concurrent dysphoria plus two other symptoms, severe enough to cause distress). Of these 
symptoms, dysphoria was the most common, supporting its centrality within the syndrome. 
Insomnia/hypersomnia and psychomotor agitation/retardation were also common. Notably, the 
inclusion of withdrawal relief (reported by 43.8%) substantially inflates the rates of withdrawal 
symptoms. Care needs to be taken in the consideration of the presence of this symptom from survey 
studies.    
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In this sample, male participants were more likely than female users to have KUD. Cultural norms 
contribute to this: a recent Ethiopian epidemiological study demonstrated substantially greater 
prevalence of past-month Khat chewing among males than females (Haile & Lakew, 2015), likely 
due to cultural acceptability (E. Gebrehanna, Y. Berhane, & A. Worku, 2014b). This provides more 
opportunities for men than women to use khat freely (Brady & Randall, 1999; Kulis, Marsiglia, 
Ayers, Booth, & Nuno-Gutierrez, 2012), putting them at higher risk of developing dependence 
(Baer, Kivlahan, Blume, McKnight, & Marlatt, 2001). 
 
Those categorised as experiencing KUD were using both in larger amounts and more frequently 
(with half using daily), consistent with the notion of loss of control over use. Similarly, those with 
KUD had substantially greater levels of financial problems associated with use. In several surveys 
of khat using communities it was reported that spending excessive time and money on khat were 
major contributors to family conflict (Dhaifalah & Santavy, 2004; Kassim & Croucher, 2012; 
Omar et al., 2015).  
 
Individuals with KUD had systematically elevated rates of self-reported problems with 
concentration, memory, and sustaining motivation. While expectations of higher academic 
performance are common predictors of khat chewing among university students (Ihunwo, Kayanja, 
& Amadi-Ihunwo, 2004; Zein, 1988), studies have identified typically poorer academic 
performance among khat-chewers (Al-Sanosy, 2009; Ayana & Mekonen, 2004). In support of our 
findings, impairments in the inhibition of response conflicts, monitoring of working memory, and 
mental flexibility have been identified in abstinent khat consumers (Colzato, Ruiz, van den 
Wildenberg, Bajo, & Hommel, 2011; Colzato, Sellaro, Ruiz, Sikora, & Hommel, 2013; Hoffman 
& Al'absi, 2013). 
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Individuals with KUD also had higher rates of other substance use than non-problematic 
consumers. However, it is unlikely that these substances were central to the behavioural problems 
reported: only 29% drank alcohol more than weekly, and only very small minorities reported any 
cannabis (10%) use. Smoking of tobacco and/or shisha was substantially more common among 
problematic khat-chewers and are common activities in places where khat is consumed.  
 
Table 4: Correlates of DSM-5 khat use disorder (n=400) 
 
Items 
DSM-5 khat use disorder1 
No (n=105; 
26.3%) 
Yes (n=295; 73.8%) 
% % OR (95%CI) 
Demographics    
   Male 61.9 82.4 2.88** (1.75-4.71) 
   Age (≤24) a 32.4 26.8 0.76 (0.47-1.24) g 
   Full time student 41.9 30.8 0.62 (0.39-0.98) g 
   Unemployed 3.5 10.5 0.94 (0.48-1.87) g 
   Employed 12.8 40.5 1.06 (0.54-2.09) g 
Patterns of Khat use    
   First used khat ≤16 years 9.5 16.3 1.85 (0.90-3.80) g 
   Used khat for ≥5 years 77.1 83.1 1.45 (0.84-2.51) g 
   Used khat daily in past 12 months 1.9 47.3 45.29** (10.97-19.01) f,h 
   Used khat more than once per week 68.9 93.2 6.18** (3.33-11.85) f 
Amount chewed per session    
   Used ≥1.5 bundles of khat daily in past 12months 14.3 28.1 2.35** (1.29-4.29) f 
Chewing session duration    
   5 hours or more 69.5 62.6 0.74 (0.46-1.19) g   
Other drug use in last six months    
   Daily alcohol  0.3 7.8 12.79** (1.72-94.95) g 
   Daily tobacco  1.5 21.0 3.19* (1.21-8.45) f 
   High Fagerstrom test for nicotine dependence b  0.3 4.8 2.62** (0.33-20.89) g 
   Any cannabis use 2.1 10.2 5.25** (1.55-17.75) g 
   Any benzodiazepine use   0.3 5.0 8.08* (1.07-60.96) g 
   Any shisha use  15.4 48.6 5.20** (2.91-9.30) f 
Financial problems in last twelve months     
   Spent money on khat meant for other things 50.5 82.4 4.93** (3.02-8.04) f, h 
   Sold belongings to buy khat 7.6 52.2 13.24** (6.22-28.21) f, h  
   Worried about the amount of money spent on khat 11.4 62.7 13.03** (6.83-24.86) f, h 
   Had khat related debts 11.4 53.6 8.94** (4.70-17.01) f, h 
   Made excuses about money spent on khat 13.3 67.1 13.27** (7.19-24.49) f, h 
Treatment    
   Help seeking 3.8 32.9 12.37** (4.42-34.59) f, h  
Mental health    
   Kessler 10 ≥ 30c  0.3 25.4 56.15** (7.72-41.40) f, h 
   Self-reported mental health problem 2.9 40.4 22.78** (7.05-73.56) f, h 
Quality of life (n=386)    
   Personal wellbeing (PWI 2SD below mean) d 85.4 34.6 0.09** (0.05-0.17) f, h  
   Satisfaction with life (PWI 2SD below mean) e 75.7 28.6 0.13** (0.08-0.22) f, h  
Academic function     
   Trouble keeping attention on activity for     too long  19.6 81.9 18.57** (10.44-33.01) f, h 
   Difficulty in organizing/scheduling routine tasks  40.2 84.4 8.05** (4.83-13.40) f, h 
   Trouble listening in lectures  10.8 54.6 9.95** (5.10-19.41) f, h 
   Trouble making study plans  44.1 77.0 4.23** (2.62-6.83) f, h 
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Table 4: continued 
 
 
Items 
DSM-5 khat use disorder1 
No (n=105; 
26.3%) 
No (n=105; 26.3%) 
% % % 
   Spent lot of time doing nothing  46.1 79.1 4.42** (2.73-7.17) f, h 
   Unable to do two or three tasks in a row  54.9 82.6 3.91** (2.38-6.42) f, h 
   Trouble remembering things to do  8.8 74.1 28.97** (14.85-56.49) f, h 
   Don’t stick to tasks to completion  25.5 79.8 11.54** (6.78-19.64) f, h 
   Lack of attention   11.8 79.4 29.74** (15.26-57.99) f, h 
   Trouble with short term memory 7.8 70.6 28.17** (13.10-60.60) f, h 
   Difficulty sustaining concentration 15.7 79.4 20.76** (11.32-38.08) f, h 
   Lack of concentration on studies 9.8 73.8 25.86** (12.78-52.31) f, h 
 
*P < 0.05; **P < 0.01; a Based on median split for the sample; b score of ≥ 6 on Fagerström Test for Nicotine Dependence (FTND) scale. c Scores 
on K10 30–50 indicating very high psychological distress derived from the K10 cut-offs that were used in the Australian National Mental Health 
and Wellbeing Survey (Australian Bureau of Statistics, 2008); d Personal Wellbeing Index (PWI) cut-off is mean – 2 standard deviations (SD) 
(73.83) based on the generic normal ranges calculated by using the survey mean scores as data from 30 surveys conducted between April 2001 
and August 20013. e LAW (Life as a Whole) cut-off is mean – 2 SD (76.01) based on the generic normal ranges calculated by using the survey 
mean scores as data from 30 surveys conducted April 2001 and August 20013. f These effects remain statistically significant after controlling for 
gender differences. g These effects do not remain statistically significant after controlling for gender differences. h These effects remain statistically 
significant after controlling for any use of tobacco and other drugs (shisha, benzodiazepine, cannabis). OR = odds ratio; CI = confidence interval. 
 
Khat chewing has previously been associated with increased rates of consumption of other drugs, 
mainly tobacco, alcohol and psychotropic agents (Kassim, Islam, & Croucher, 2011; D. Kebede et 
al., 2005; Y. Kebede, 2002; Malaju & Asale, 2013; Reda, Moges, Biadgilign, & Wondmagegn, 
2012; Tesfaye, Byass, Wall, Berhane, & Bonita, 2008); and severity of khat dependence was also 
significantly related to nicotine dependence (Kassim, Croucher, & al'Absi, 2013b). Cigarettes are 
believed to enhance the stimulatory effect obtained during chewing and to reduce its bitter taste.  
 
This study had several limitations; first the diagnostic data was based on survey self-report, rather 
than the gold standard of clinical diagnosis; and survey responses may also be susceptible to social 
desirability and recall bias. However, in multiple studies, the AUDADIS-IV has demonstrated 
good to excellent reliability and validity (Chatterji et al., 1997; Cottler et al., 1997; Grant et al., 
1995; D. Hasin, Carpenter, McCloud, Smith, & Grant, 1997; D. S. Hasin, Van Rossem, McCloud, 
& Endicott, 1997; Pull et al., 1997) for the identification of illicit drug use disorders. We also 
believe that our use of anonymous self-administered survey provided anonymity, and hence 
minimized response bias. Secondly, participants were drawn from a defined geographical region 
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(Adama, Ethiopia) and recruited using convenience sampling, primarily through khat cafes. This 
clearly increased the likelihood of involvement of frequent chewers, hence at elevated risk of khat 
use disorder. As such, the base rates of symptoms identified here will necessarily be greater than a 
population-representative sample. However, this sampling framework was appropriate for the aims 
of this study. Thirdly, there could be some potential interpretive problems arising from the presence 
of polysubstance use. Given the social context of khat use, polysubstance use, especially of 
cigarettes and shisha, is likely unavoidable. While poly-substance use had the potential to 
contribute to symptoms, this is unlikely to have a substantial inflating effect, given the low 
proportion reporting frequent use, low levels of dependence, and the finding that increased rates of 
adverse effects remained after controlling for polysubstance use.   
 
In conclusion, despite the fact that khat chewing is legal, deep-rooted and a culturally acceptable 
habit in Ethiopia, some people clearly experience substantial and clinically significant problems 
related to khat use. There are a range of interventions possible in order to minimize harm in relation 
to khat. Primary prevention activities, such as community-based interventions focusing on 
improving understanding about positive and negative impacts of khat, and strategies to reduce 
negative impacts, may delay initiation or problematic consumption of khat. In this study, among 
those experiencing problems with khat, help-seeking was so poor that this was near universally 
from untrained family/friends rather than from medical centers. While khat plays a substantial role 
in Ethiopia’s economy (Feyisa & Aune, 2003) (for rural producers, regional economies and source 
of foreign exchange), it is associated with health and public safety problems which are addressed 
with weak legislative responses .  Recent khat bans have also lead to the criminalization of users 
and sellers and illegal drug markets (Klein, Beckerleg, & Hailu, 2009). Therefore, promoting 
evidence-based approaches to khat regulation that accounts for positive aspects of the khat 
economy and the needs of rural producers is useful (Klein et al., 2009). One option for improving 
individual and community well-being may be the introduction of a regulatory system that levies 
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the product, whereby the funds raised can be directed toward treatment and harm minimization 
programs, as is the case in many countries in relation to proceeds from gambling. This could also 
be applied to support training of primary care practitioners to improve awareness of the health 
implications of khat and how to provide targeted assessment and intervention.  
 
Finally, according to Ministry of Education policy, khat chewing is banned at schools and higher 
learning institutions (Gebrehanna, Berhane, & Worku, 2014). However, it is reported that students 
are the second largest consumers of khat next to drivers (Kandari, Yadav, Thakur, & Kandari, 
2014); and that even university staff report missing work hours in order to chew khat. As such 
there is substantial scope to intervene at an organizational level in relation to khat use to reduce its 
impact on productivity, as well as negative impacts on academic function and more general 
wellbeing.  
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SUPPORTING INFORMATION 
Table S1: Diagnostic crosswalk between DSM-IV and DSM-5 diagnostic categories (N=400) 
 
 
DSM-IV abuse DSM-IV dependence 
No 
% (n) 
Yes 
% (n) 
No 
% (n) 
Yes 
% (n) 
DSM-5 substance use disorder  (Kappa = 0.838**) (Kappa = 0.706**) 
No 23.0 (92) 3.3 (13) 26.3 (105) 0 (0) 
Yes 3.0 (12) 70.8 (283) 13.3 (53) 60.5 (242) 
DSM-5 severe substance use disorder  (Kappa = 0.592**) (Kappa = 0.867**) 
No 26.0 (104) 19.5 (78) 39.3 (157) 6.3 (25) 
Yes 0(0) 54.5 (218) 0.3 (1) 54.3 (217) 
DSM-5 moderate OR severe disorder  (Kappa = 0.719**) (Kappa = 0.899**) 
No 25.3 (101) 11.5 (46) 35.8 (143) 1.0 (4) 
Yes 0.8 (3) 62.5 (250) 3.8 (15) 59.5 (238) 
* p<.05; ** p<.01; *** p<.001 
 
 
 
Table S2: Latent class fit statistics for DSM-5 Khat use disorder symptom items, with 1 to 6 
classes (N=400) 
 
Model 
 
AIC 
 
BIC 
 
ssaBIC 
 
LMR-
ALRT 
 
LMR-ALRT 
p-value 
Entropy 
 
Percentage in each class 
C
la
ss
 1
 
 
C
la
ss
 2
 
 
C
la
ss
 3
  
C
la
ss
 4
 
 
C
la
ss
 5
 
 
C
la
ss
 6
 
 
1 class 5862 5906 5871 - -  100      
2 class 4386 4477 4404 1531.856  0.001 0.957 61 39     
3 class 4227 4366 4255 180.518 <0.001 0.859 32 33 35    
4 class 4196 4383 4234 54.167 0.383 0.837 26 19 33 22   
5 class 4175 4411 4224 43.254 0.483 0.872 18 14 22 33 14  
6 class 4154 4438 4212 44.547 0.274 0.887 14 7 24 18 4 33 
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Figure S1: Response probabilities according to group for the three-class solution 
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Abstract 
Objective: This study aimed to determine the efficacy of the Severity of Dependence Scale (SDS) 
as a screening tool for DSM-5 defined Khat Use Disorder. 
 
Methods: Cross-sectional, purposive sample of past year khat consumers aged 16 and above 
recruited from khat markets and cafes from university and general community in Adama, Ethiopia. 
Participants self-completed a survey comprising current substance use disorder.  
 
Results: The SDS formed a unifactorial structure, consistent with the dependence construct. Almost 
three-quarters (73%) of the sample were identified as experiencing DSM-5 Khat Use Disorder. The 
SDS demonstrated excellent discrimination (AUC=0.92), and an optimal cut-off as a score of 3 or 
greater, with sensitivity of 81% and specificity of 96%. This classification validly identified a group 
with more frequent and higher dose khat use than participants that did not screen positive. 
 
Conclusion: While khat is a mild stimulant, there is clear evidence that some consumers are both 
concerned with their use and experience problems associated with their use. Consistent with its 
application for other drugs, the SDS is a brief and simple screening tool that appears to validly 
identify individuals experiencing a khat use disorder syndrome and experiencing high rates of 
adverse consequences in association with use.  
 
 
 
Keywords: Drug Dependence; Drug Use Disorders; Drug Overdose; Substance Abuse 
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INTRODUCTION 
Khat (Catha edulis Forsk) contains multiple alkaloids that produce psychostimulant effects similar 
to that of amphetamines (Feyissa & Kelly, 2008; Graziani, Milella, & Nencini, 2008).The main 
constituents—cathinone and cathine—increase dopamine, serotonin and noradrenaline release in 
the central nervous system (Kalix, 1980, 1990; Kalix & Braenden, 1985). Previously, due largely 
to cultural norms, khat use in Ethiopia was largely restricted to males in certain social strata 
(Odenwald, Klein, & Warfa, 2010). Likely reflecting social change and easy access to khat, 
chewing is now more widely spread across social class, age and gender (Alem, Kebede, & 
Kullgren, 1999). Khat is habitually consumed by craftsmen, farmers, and labourers, and also 
academics and students (Adugna, Jira, & Molla, 1994; Alem et al., 1999; Ayana & Mekonen, 2004; 
Ayenew, Tadesse, & Azale, 2012; Ihunwo, Kayanja, & Amadi-Ihunwo, 2004) .These consumers 
report subjective factors such as increased alertness and concentration (Ayana & Mekonen, 2004; 
Zein, 1988) and relief of physical and mental stress as motivating factors for their use 
(Wedegaertner et al., 2010). A 2011 population prevalence study estimated past month use at 
15.3% across Ethiopia (22.6% among males; 9.1% among females). Among Ethiopian university 
students, lifetime prevalence was estimated at 24.0%, while 7.7% reported past month khat use 
(Gebrehanna, Berhane, & Worku, 2014). Global spread of khat use is largely attributed to easy air 
transportation for khat export and migration of people from East Africa and Yemen to the UK and 
other Western countries (Griffiths et al., 2010; Stevenson, Fitzgerald, & Banwell, 1996). 
 
Khat has become a public health concern due to adverse health risks and negative social functioning 
associated with frequent chewing. Multiple studies have demonstrated that chewing is associated 
with increased strain in family relationships and poorer Productivity (Omar et al., 2015). It has also 
been associated with cardiovascular disease such as hypertension, and oral cancer (Aden, Dimba, 
Ndolo, & Chindia, 2006; El-Wajeh & Thornhill, 2009). Several studies have identified khat use 
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disorder at high rates among samples of frequent chewers, including adverse physical and mental 
health effects (Duresso, Matthews, Ferguson, & Bruno, 2016; Omar et al., 2015), but only small 
proportions of these seeking help for their problems associated with use (Duresso et al., 2016). 
 
Core physiological aspects of dependence, such as withdrawal symptoms and tolerance, have been 
recently reported among regular users (Duresso et al., 2016) and identified as potential liability 
factors for the spread of khat chewing (Douglas, Boyle, & Lintzeris, 2011; Halbach, 1972; Kassim, 
Croucher, & al'Absi, 2013; Luqman & Danowski, 1976). Studies which have used the Severity of 
Dependence Scale (SDS) (Gossop et al., 1995) to assess for psychological aspects of khat 
dependence (Griffiths et al., 1997; Kassim & Croucher, 2006; Kassim, Islam, & Croucher, 2010) 
identified that increased khat use frequency is associated with higher SDS scores and that greater 
SDS scores are associated with more physical (e.g. insomnia) and psychological health problems 
(e.g. anxiety, agitation, restlessness) after using khat (Elmi, 1983; Kalix & Braenden, 1985; 
Nakajima et al., 2014)Elmi, 1983; Kalix & Braenden, 1985; Nakajima, Dokam, Alsameai, et al., 
201. Such findings support the potential utility of the SDS in relation to khat for healthcare 
providers to efficiently identify those experiencing khat related harms (Young, Butt, Hersi, Tohow, 
& Mohamed, 2016) .Recent studies have provided initial support for the use of SDS-khat as a valid 
research tool for assessing psychological aspects of khat dependence (Elmi, 1983; Kalix & 
Braenden, 1985; Nakajima et al., 2014). To date, however, no work has sought to determine a cut-
off point for screening against khat diagnoses of use disorder/dependence, nor to examine whether 
scores on the SDS for khat are also associated with physical and psychological health and other 
behaviours known to be correlated with dependence. This is particularly important as previous 
studies have revealed low rates of treatment-seeking among those experiencing problems with khat 
use (e.g. Duresso et al., 2016).  
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The goal of the current study was to examine whether the SDS can be applied as a valid screening 
tool to efficiently identify potential cases of khat dependence. The SDS is particularly beneficial 
as a screening tool for use disorder as it is in the public domain, brief, suitable for a range of 
substances, and easily administered. The measure has been demonstrated to be reliable, valid and 
culturally adaptable in measuring problems related to drug use in the past 12 months (Ferri, 
Marsden, M, Laranjeira, & Gossop, 2000; Gossop, Best, Marsden, & Strang, 1997; Topp & 
Mattick, 1997a). The SDS has been demonstrated to sensitively identify - within a short time frame 
and without specific clinical training - individuals with substance dependence in relation to a range 
of drug types including amphetamines, cannabis and opioids (Gossop, Griffiths, et al., 1997; Topp 
& Mattick, 1997b) Although the scale has been used in similar ways for khat research (Kassim et 
al., 2010), the cut-off values applied for identification of ‘cases’ have been estimates derived from 
prior work with stimulant drugs. As such, empirical evaluation of cut-off points for their sensitivity 
in identifying individuals experiencing khat use disorder is important, as is validating these 
thresholds against multiple measures of problems associated with use of the drug.  
 
In order to address this question, a large sample of frequent khat consumers were assessed with the 
SDS and the modified version of the Alcohol Use Disorder and Associated Disabilities Interview 
Schedule-IV (AUDADIS-IV) to determine Diagnostic and Statistical Manual of Mental Disorders 
-IV and -5 cases of khat dependence and khat use disorder, respectively. The AUDADIS is a 
validated standardized instrument against which the cut-off values were determined. Using a 
representative sample of the general population, the test-retest reliability of AUDADIS has shown 
good to excellent reliability and validity for the identification of range of illicit drug dependence 
and use disorders (Grant, Harford, Dawson, Chou, & Pickering, 1995; Hasin, Carpenter, McCloud, 
Smith, & Grant, 1997; Ruan et al., 2008) Moreover, a recent study (Duresso et al., 2016)  which 
examined khat use disorder (KUD) symptoms among frequent khat users using AUDADIS-IV, 
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demonstrated that the scale performed validly, with the psychometric properties of the scale 
consistent with that identified for other substances, and that those categorised as experiencing khat 
use disorder using at greater quantity, frequency and experiencing more associated problems than 
non-disordered participants. 
    
The core aim of the current study was to evaluate the use of the SDS as it relates to screening for 
cases of khat use disorder under the DSM-5 system. Specifically, the study aims at answering two 
core research questions:  
 
1. Does the SDS for khat use perform in a similar way to existing diagnostic measures of 
khat use disorders? If so, what is an adequate cut-off score for case identification for screening 
purposes? To address this, scores on SDS and AUDADIS-IV were used to identify DSM-IV cases 
of khat dependence and DSM-5 cases of khat use disorder. 
 
2. Are these cut-off scores valid in terms of identifying a group of individuals using khat at 
greater frequency and quantity, and experiencing functional problems? To address this, the 
validity of the SDS cut-off scores were evaluated against the frequency and quantity of khat use, 
levels of psychological distress as measured by Kessler Psychological Distress Scale (K-10), 
quality of life as measured by Personal Wellbeing Index (PWI –Australian Normative Data) and 
level of impairments in academic functioning. 
 
MATERIALS AND METHODS 
Participants 
Participants were recruited through a purposive sampling strategy in Adama, Ethiopia in 2013 and 
2014. Inclusion criteria required that participants be at least 16 years old and had used khat at least 
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once in the preceding year (Duresso et al., 2016). Initially, 454 participants were recruited however 
after excluding 76 cases missing dependence data, 388 participants were retained for the analyses. 
 
Measures 
Khat use disorder (KUD) and khat dependence were assessed using a modified version of the 
Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV) (Ruan 
et al., 2008; Saunders, Aasland, Babor, de la Fuente, & Grant, 1993), with item content expanded 
to include craving and withdrawal items (Duresso et al., 2016). This was used to derive past 12-
month DSM-IV dependence and DSM-5 use disorder diagnoses in relation to khat use. The 
AUDADIS is a fully structured diagnostic interview designed to assess alcohol and drug 
use/disorders in clinical samples and the general population (Grant et al., 1995). Reliability was 
good to excellent. The observed reliability of the DSM-IV diagnosis and dimensional scales for the 
substance use psychiatric disorders indicates that the AUDADIS-IV can be usefully applied in 
various research settings, particularly in studies of the general population and community samples 
with alcohol and drug diagnosis.  
 
Severity of Dependence Scale (SDS) 
The SDS is a commonly used 5-item screening tool, with demonstrated sensitivity for the 
identification of dependence in relation to amphetamines, cannabis and other drugs (Gossop, Best, 
et al., 1997). The scale assesses psychological components of dependence over the past year, 
namely, compulsion to use a drug (the impaired loss of control over drug use), and preoccupation 
and anxiety about drug use (Gossop et al., 1995). While the SDS has been found to be a valid and 
reliable single factor uni-dimensional scale for measuring alcohol dependence (Lawrinson, 
Copeland, Gerber, & Gilmour, 2007) cocaine dependence (Kaye & Darke, 2002) and for 
amphetamine dependence (Topp & Mattick, 1997a), uni-dimensionality has not been universally 
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identified using exploratory factor analysis (Ferri et al., 2000; Tsai et al., 2012). In relation to khat 
specifically, a bilingual adaptation of the scale (Arabic and English) identified two factors 
(Nakajima et al., 2014). These provide some demonstrations that the scale should work in the 
context of khat use. However, there is no clear information as to where to place a cut-off on the 
scores to practically identify individuals that may be experiencing such a level of problems, so they 
can benefit from further assessment or an intervention. The SDS items are (all in relation to the 
past year): 
(1) Did you ever think your use of khat was out of control? 
(2) Did the prospect of missing khat make you very anxious or worried? 
(3) Did you worry about your khat use?  
(4) Did you wish you could stop using khat?  
(5) How difficult would you find it to stop or go without? 
Items are scored on a 4-item Likert scale (items 1-4: 0=never; 1=sometimes; 2=often; 3=always; 
item 5: 0=not difficult; 1=quite difficult; 2=very difficult; 3=impossible), with a possible total 
score of 15. 
 
Construct validity of the SDS was assessed through relationships between cut-off points and 
measures of quantity and frequency of consumption. To test the predictive validity of the SDS cut-
off points, health (mental health) and socio economic (quality of life and financial) factors were 
assessed. Non-specific psychological distress was assessed using Kessler Psychological Distress 
Scale (K-10) (Kessler et al., 2002), using a cut-off score of 30 to indicate ‘very high’ levels of 
psychological distress. A subjective multi-domain quality of life measure, with Australian 
normative data was used to assess quality of life (Group, 2013). Frequency of cognitive and 
academic impairment in the past six months was assessed using a 12-item academic functioning 
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scale that was refined by the current researchers from cognitive and executive function 
questionnaires used in similar studies (Schwartz, 2007). 
 
Statistical Analysis 
Receiver operating characteristic (ROC) analyses were conducted to identify the point that best 
strikes a balance between the sensitivity (proportion of true-positives) and specificity (proportion 
of true-negatives) of the SDS as a screening tool for DSM-IV khat dependence or DSM-5 Khat 
Use Disorder. While application-agnostic procedures, such as the Youden Index (Youden, 1950) 
were reported (the SDS value that maximises sensitivity and specificity), because the aim of the 
study was to identify a screening cut-off, these were selected as the lowest SDS score that was a) 
within the 95%CI of the maximum Youden Index value that also b) maximised specificity above 
90% and maintained sensitivity at approximately 80% or greater. Other diagnostic efficiency 
measures were calculated using Diagnostic and Agreement Statistics (DAGstat) (Mackinnon, 
2000). 
 
The structure of SDS khat items were assessed using unifactorial confirmatory factor analysis with 
additional item-response theory (IRT) measures, in Mplus v7.0, using robust estimators to account 
for skewed data. Model fit indices were examined to assess structural fit, including root mean 
squared error of approximation (RMSEA); Tucker-Lewis Index (TLI) and comparative fit index 
(CFI); RMSEA <0.06, TLI >0.95 and CFI >0.95 are considered to indicate good fit (Hu & Bentler, 
1999; Mulaik, 2007; Steiger, 2007). Recent simulation studies suggest that N>200 is sufficient for 
robust estimation of such a structure (Myers, Ahn, & Jin, 2011).To provide some construct and 
predictive validation of these cut-off points on the SDS, using IBM SPSS Statistics v22, odds ratios 
with 95% confidence intervals (95%CI) derived from independent logistic regression models were 
used to examine if having an SDS score above the identified cut-point relates to increased rates of 
Chapter 3: Using the Severity of Dependence Scale to Screen for DSM-5 Khat Use Disorder.  80  
 
 
harms in terms of variables such as patterns of consumption, mental health, and financial and 
occupational problems. In other words, if the cut-off points are valid then they should discriminate 
between people that are and are not experiencing problems associated with khat use. These were 
conducted for the identified cut-points for DSM-IV dependence and for DSM-5 khat use disorder. 
 
RESULTS 
The mean participant age was 30 years (SD=7, range 17-49); and approximately three-quarters 
(76.5%) were male. The majority were currently employed (80%) with nearly one-quarter (22%) 
having a diploma or higher university qualifications. One third (35%) had used khat on a daily 
basis; the remainder (60%) typically used three or more times a week (Table 1). 
 
SDS for Khat 
Table 2 shows the distribution of responses of the SDS items. Thirty percent of the sample (95% 
CI = 26–35) did not endorse any of the SDS items (total score = 0), a further 5% (95% CI = 3.2–
7.5) only nominated the lowest level of concern (‘sometimes’) for one of the five SDS items (total 
score = 1).  
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Structure of the SDS for Khat  
Table 3 presents CFA results for a unifactorial model of SDS for khat items.  Fit indices were 
satisfactory (both CFI and TLI > 0.95 (Hu & Bentler, 1999) although the RMSEA value suggested 
that there remained notable model misfit. The correlation between scores on the SDS and the DSM-
5 symptom count were highly correlated (r=0.81, p<0.001). 
 
 
 
 
 
Table 1: Demographic characteristics of the sample (N=388) 
  
 n % (95%CI) 
Gender 
Male 297 76.5 [72.1,80.5] 
Age Age Age 
≤24 112 28.9 [24.6, 33.6] 
25-34 171 44.1 [39.2, 48.0] 
35-44 93 24.0 [20.0, 28.5] 
≥45 12 3.1 [1.8, 5.3] 
Frequency of khat use (n=385) 
Daily 136 35.1 (30.5-40.0) 
3 times or more a week 233 60.5 (55.6-65.3) 
Ethnicity (n=386) 
Amhara 109 28.2 (23.9-32.9) 
Harari 12 3.1 (1.8-5.4) 
Oromo 143 37.0 (32.4-41.9) 
SNNP 68 17.6 (14.1-21.7) 
Tigrie 30 7.8 (5.5-10.9) 
Others ᶺ 24 6. 2(4.2-9.1) 
Educational Level 
Completed Grade 11 or less 213 54.9 (50.0-59.8) 
Completed Grade 12 (secondary education) 55 14.2 (11.1-18.0) 
Diploma 66 17.0 (13.6-21.1) 
Bachelor’s degree or higher 7 1.8 (0.9-4.7) 
No formal school 47 12.1 (9.2-15.7) 
Employment Status(n=258) 
Current Student 133 34.3 (29.7-39.1) 
Unemployed 15 5.83 (3.6-9.4) 
Self-employed 141 54.7 (48.6-60.6) 
Employed for wages 65 25.2 (20.3-30.8) 
Looking for work 32 12.4 (8.9-17.0) 
Others ∞ 5 1.9 (0.8-4.5) 
   
Notes: CI = confidence interval; SNNP = Southern Nations and Nationalities People 
∞Unable to work, retired, home duty ᶺ other Ethnic groups  
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Table 2: Distribution of responses to items of the SDS for Khat (N=388) 
 
SDS Items Never or 
almost never 
(^Not 
difficult) 
Sometimes 
(^Quite 
difficult) 
Often 
(^Very 
difficult) 
Always or nearly 
always 
(^Impossible) 
 % n % n % n % n 
Did you ever think your use of khat 
was out of control? 
43.8 170 35.1 136 16.0 62 5.2 20 
Did the prospect of missing khat 
make you very anxious or worried? 
48.2 187 28.1 109 17.0 66 6.7 26 
Did you worry about your khat use? 43.8 170 34.0 132 16.5 64 5.7 22 
Did you wish you could stop using 
khat?  
39.9 155 29.6 115 18.0 70 12.4 48 
How difficult would you find it to 
stop or go without khat? 
53.1 206 28.9 112 14.9 58 3.1 12 
Note: SDS = Severity of Dependence Scale. 
 
ROC analysis was applied to examine the performance of the SDS khat in identifying the presence 
of DSM-5 khat use disorder (KUD) and DSM-IV khat dependence. Figure 1 presents the graphical 
plot that illustrates the diagnostic ability of SDS-Khat for DSM-5 KUD with its varying 
discrimination thresholds. For both criterion, area under the curve (AUC) values were >0.92, 
suggesting that the scale has an excellent ability to discriminate between those with and without 
KUD (Table 4). Given the distribution of scale total scores (Table 4), cut points were determined 
emphasising specificity; selected on the basis of the dual criteria of a) identifying the cut-point 
within the 95% of the scale score that maximised the Youden Index and b) maintained specificity 
above 90% and maintained sensitivity approximately at 80% or greater. This identified that SDS 
scores of 4 or above were appropriate for identification of cases of likely DSM-IV khat 
dependence; and SDS scores of 3 or greater were appropriate for cases of likely DSM-5 khat use 
disorder (with values of SDS ≥ 4 for moderate and ≥ 5 for severe use disorder respectively).  
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Table 3: Unifactorial confirmatory factor analysis and Item Response Theory parameter 
estimates for SDS for khat items (N=388) 
 
Note. CFA = confirmatory factor analysis; CFI = Comparative Fit Index; RMSEA = root mean square error of approximation; 
SDS = Severity of Dependence Scale; TLI = Tucker–Lewis Index; WLSMV = weighted least squares estimator with degrees of 
freedom adjusted for means and variances estimator; WRMR = weighted root mean residual. 
 
 
FIGURE 1 Receiver operating characteristic (ROC) for the Severity of Dependence Scale using 
Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition khat use disorder diagnosis 
as criterion 
 
   
 
 
SDS Items  
CFA Item-Response Theory parameters 
Loadings 
α (SE) 
(discrimination) 
Β1 (SE) 
(difficulty) 
Β2 (SE) 
(difficulty) 
Β3 (SE) 
(difficulty) 
How difficult would you find it to 
stop or go without khat? 
0.724 
1.368 (0.096) -0.585 (0.101) 1.007 (0.106) 2.725 (0.208) 
Did you ever think your use of 
khat was out of control? 
0.908 
2.514 (0.178) -1.007 (0.078) 0.561 (0.071) 1.785 (0.116) 
Did the prospect of missing khat 
make you very anxious or 
worried? 
0.844 
1.890 (0.130) -0.825 (0.085) 0.525 (0.079) 1.791 (0.125) 
Do you worry about your khat 
use? 
0.914 
2.153 (0.148) -1.031 (0.085) 0.510 (0.075) 1.811 (0.122) 
Do you wish you could stop 
using khat? 
0.815 
1.537 (0.104) -1.245 (0.107) 0.287 (0.084) 1.395 (0.110) 
CFA model fit indices       
CFI1 0.989     
TLI1 0.978     
RMSEA1 0.161     
WRMR1 0.938     
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Variables Associated with Khat Use Disorder 
In Table 5, groups above and below these two cut-off values were compared using independent 
logistic regression models. These demonstrate that both of these cut-off points (SDS ≥ 3 for likely 
khat use disorder and SDS ≥ 5 for likely severe khat use disorder) are valid as they identify groups 
with substantially greater rates of behaviours suggesting heavier khat use (more frequent and 
greater volumes of use) as well as higher rates of experience of harms associated with their use 
(more financial problems, more cognitive problems, poorer quality of life, higher rates of mental 
health problems) and greater rates of help-seeking for khat use. While those classified above these 
cut-off points for likely caseness also had significantly higher rates of other substance use, this was 
typically still only a minority of the group (e.g. 10% reporting past six-month cannabis use) or of 
more common substances typically co-consumed in places where khat is also consumed (e.g. 
shisha). As such, as has been demonstrated previously (Duresso et al., 2016), it is not likely that 
this greater rate of polysubstance use has been the driving factor in group membership.  
 
DISCUSSION 
The purpose of the current study was to determine the efficacy of the SDS as a screening tool for 
khat use disorder. The Severity of Dependence Scale is a short, easily administered instrument for 
measuring psychological components of dependence, and is recognised as a robust screening tool 
across a variety of substances in diverse populations (Gossop, Best, et al., 1997; Gossop et al., 
1995). In keeping with studies of similar substances (Ferri et al., 2000; Gonzalez-Saiz et al., 2008; 
Gossop et al., 1995; Kaye & Darke, 2002; Lawrinson et al., 2007), this study clearly supports the 
use of the SDS to screen for problems related to khat use. 
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Confirmatory factor analyses supported a unifactorial structure for the scale. This supports the use 
of a total scale score for the SDS, and is consistent with findings for the SDS in relation to 
methamphetamine (Topp & Mattick, 1997a) and khat (Kassim et al., 2010). There has been one 
recent study that identified two factors within the SDS items for khat, with two items (3 and 4 – 
worry about use and wish to stop) separating from the remainder (Nakajima et al., 2014). However, 
this was identified via exploratory techniques, and the fit indices identified here provide no good 
empirical rationale for the more complex model. Similarly, the DSM dependence/use disorder 
syndrome symptoms for both methamphetamine (Topp & Mattick, 1997a) and khat (Duresso et 
al., 2016) are unifactorial.  
 
The ROC analysis suggests that a score on the SDS of 3 or more provides good sensitivity and 
specificity for possible cases of khat use disorder; this cut-off has demonstrated construct validity 
identifying a group with behaviours indicative of use disorder and greater rates of adverse 
consequences associated with use. While this value appears on the surface to be low, requiring 
only the most moderate of responses to three items, or a strong response to a single item, it is 
consistent with scores identified using the SDS to screen for cases of DSM-IV ecstasy dependence 
(Bruno, Gomez, & Matthews, 2011). Moreover, the optimal cut-off values for DSM-IV khat 
dependence are consistent with those identified for cannabis in adolescents (Martin, Copeland, 
Gates, & Gilmour, 2006). 
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Table 4: Diagnostic Efficiency of the SDS scores for DSM-IV and DSM-5 Khat use disorders. (Using DSM-IV and DSM-5 diagnosis as 
criteria) 
 
SDS 
Score 
Sample DSM-IV Dependence DSM-5 any KUD DSM-5 Moderate KUD DSM-5 Severe KUD 
Proportion  
Scoring (%) 
AUC=0.946 
(95% CI=0.918 to 
0.966) 
AUC=0.924 
(95% CI= 0.894 to 
0.949) 
AUC= 0.958 
(95% CI=0.934 to 
0.976) 
AUC= 0.942 
(95% CI=0.915 to 
0.964) 
 Sensitivity Specificity Sensitivity Specificity Sensitivity Specificity Sensitivity Specificity 
≥0 100.0 100.00 0.00 100.00 0.00 100.00 0.00 100.00 0.00 
≥1 69.6 97.85 72.90 90.49 87.50 97.54 77.78 99.05 65.17 
≥2 64.4 94.85 81.29 85.56 93.27 ˆ 95.08 87.50 96.67 73.60 
≥3 60.3 92.27 87.74ˆ 80.99 96.15 91.80 93.06 ˆ 94.76 80.34 
≥4 55.9 87.55 91.61 75.35 97.12 86.07 95.14 91.43 85.96 ˆ 
≥5 47.2 74.68 94.19 63.38 97.12 72.95 96.53 79.52 91.01 
≥6 35.6 57.51 97.42 47.89 98.08 55.33 97.92 62.38 96.07 
≥7 28.6 45.92 97.42 38.38 98.08 44.26 97.92 50.48 97.19 
≥8 20.1 32.19 98.06 26.76 98.08 31.15 98.61 35.71 98.31 
≥9 15.7 24.89 98.06 20.77 98.08 24.18 98.61 27.62 98.31 
≥10 10.1 16.74 100.00 13.73 100.00 15.98 100.00 18.57 100.00 
≥11 5.7 9.44 100.00 7.75 100.00 9.02 100.00 10.48 100.00 
≥12 3.1 5.15 100.00 4.23 100.00 4.92 100.00 5.71 100.00 
≥13 1.8 3.00 100.00 2.46 100.00 2.87 100.00 3.33 100.00 
≥14 1.0 1.72 100.00 1.41 100.00 1.64 100.00 1.90 100.00 
≥15 0.5 0.86 100.00 0.70 100.00 0.82 100.00 0.95 100.00 
 
 
 
Note. Sensitivity = % true positive; specificity = % true negative. The cut‐off values in bold are for clinical screening and represent the lowest score 
within the 95% CI of maximum Youden that maximised specificity above 90% while maintaining sensitivity at approximately 80% or greater. Area 
under the ROC curve reflects the ability of the scale to discriminate between case and non‐case; all values >0.8 = excellent discrimination. AUC = area 
under the curve; CI = confidence interval; DSM‐5 = Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition; DSM‐IV = Diagnostic and 
Statistical Manual of Mental Disorders, Fourth Edition; KUD = khat use disorder; ROC = receiver operating characteristic; SDS = Severity of 
Dependence Scale.  ˆ Point at which Youden Index [(sensitivity + specificity) − 1] is maximised. 
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Consistent with the strong linear relationship between SDS items and DSM-5 symptom count, 
optimal cut-offs on the SDS increased steadily at each of the defined DSM severity levels (3 
or more for any khat use disorder; 4 of more for moderate; 5 or more for severe). This SDS 
value for likely cases of severe DSM khat use disorder is consistent with that validated for 
screening for DSM(-III-R) amphetamine dependence (Topp & Mattick, 1997a). This spread 
of cut points on the scale may be useful for stepped level assessments and interventions, with, 
for example, individuals scoring 3 possibly optimally serviced by brief motivational 
interviewing interventions (Kaye & Darke, 2002); and those scoring 5 or above referred to 
more formal assessment and support interventions (Kassim et al., 2010).  
 
Table 5: Correlates of DSM-5 khat use disorder according to SDS groupings (N=388) 
 
 
 
Items 
DSM-5 khat use disorder1 DSM-5 Severe khat use disorder1 
Screened 
negative 
(SDS<3) 
n=154 
Screened positive  
(SDS≥3) 
n=234 
Screened 
negative 
(SDS<5) 
n=205 
Screened positive  
(SDS≥5) 
n=183 
 
% % OR (95%CI) % % OR (95%CI) 
Demographics 
Male 63.0 85.5 3.46 (2.12-5.63) *** 65.9 88.5 4.00 (2.34-6.85) *** 
Age (≤24) a 36.4 23.9 0.55 (0.35-0.86) ** 35.1 21.9 0.52 (0.33-0.81) ** 
Full time student 42.2 29.1 0.56 (0.37-0.86) ** 42.4 25.1 0.46 (0.30-0.70) *** 
Unemployed  10.4 12.8 1.27 (0.67-2.42) 10.7 13.1 1.26 (0.68-2.33) 
Patterns of khat use 
First used khat ≤16 years 10.4 16.7 1.73 (0.93-3.21) 11.2 17.5 1.68 (0.94-2.99) 
Used khat for ≥5 years 77.3 83.8 1.52 (0.91-2.53) 78.5 84.2 1.45 (0.86-2.43) 
Used khat daily in past 12 months 
(n=385) 
7.2 53.6 14.84 (7.63-28.86) *** 14.9 57.9 7.89 (4.85-12.84) *** 
Amount chewed per session 
Used ≥1.5 bundles of khat per 
session in past 12months 
14.3 31.6 2.78 (1.64-4.71) *** 15.6 35.0 2.91 (1.79-4.72) *** 
Chewing session duration 
5 hours or more (n=382) 70.4 61.3 0.67 (0.43-1.03) 65.0 64.8 0.99 (0.65-1.51) 
Other drug use in last six months 
Daily alcohol (n=384) 0.7 12.4 21.32 (2.87-158.29) ** 3.5 12.6 4.03 (1.69-9.63) ** 
Daily tobacco (n=383) 5.9 35.2 8.70 (4.21-17.97) *** 10.8 37.8 5.00 (2.92-8.53) *** 
High FTND b (n=385) 0.0 8.2 - 1.0 9.4 10.47 (2.38-45.97) ** 
Any cannabis use (n=378) 2.6 10.2 4.19 (1.42-12.38) ** 4.5 10.2 2.42 (1.06-5.52) * 
Any benzodiazepine use (n=382) 1.3 7.4 5.99 (1.36-26.30) * 3.0 7.2 2.52 (0.94-6.76) 
Any shisha use (n=386) 21.4 51.7 3.93 (2.47-6.24) *** 25.5 55.5 3.65 (2.37-5.60) *** 
Financial problems in last twelve months  
Spent money on khat meant for 
other things 
59.1 85.9 4.22 (2.59-6.87) *** 61.5 90.7 6.12 (3.45-10.86) *** 
Sold belongings to buy khat 13.6 58.1 8.79 (5.18-14.91) *** 18.5 65.0 8.17 (5.13-13.01) *** 
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Note. CI = confidence interval; DSM‐5 = Diagnostic and Statistical Manual of Mental Disorders, Fifth 
Edition; FTND = Fagerström Test for Nicotine Dependence; K‐10 = Kessler Psychological Distress Scale; OR 
= odds ratio; PWI = Personal Wellbeing Index; SDS = Severity of Dependence Scale. a Based on median split 
for the sample. b A score of ≥6 on FTND scale. c Scores on K‐10 30–50 indicating very high psychological 
distress derived from the K‐10 cut‐offs that were used in the Australian National Mental Health and 
Wellbeing Survey (Australian Bureau of Statistics, 2008). d PWI cut‐off is mean − 2SD (73.83) based on the 
generic normal ranges calculated by using the survey mean scores as data from 30 surveys conducted between 
April 2001 and August 2013. e Satisfaction with life cut‐off is mean − 2SD (76.01) based on the generic 
normal ranges calculated by using the survey mean scores as data from 30 
surveys conducted April 2001 and August 2013. 
*p < .05. **p < .01. ***p < .001. 
 
Table 5: continued 
 
 
 
Items 
DSM-5 khat use disorder1 DSM-5 Severe khat use disorder1 
Screened 
negative 
(SDS<3) 
n=154 
Screened positive  
(SDS≥3) 
n=234 
Screened 
negative 
(SDS<5) 
n=205 
Screened positive  
(SDS≥5) 
n=183 
 
% % OR (95%CI) % % OR (95%CI) 
Worried about the amount of 
money spent on khat 
20.1 67.9 8.41 (5.20-13.60) *** 26.3 74.3 8.09 (5.14-12.75) *** 
Had khat related debts 14.3 60.7 9.26 (5.50-15.61) *** 21.5 65.6 6.97 (4.44-10.95) *** 
Made excuses about money spent 
on khat 
16.9 75.6 15.29 (9.12-25.63) *** 27.8 79.8 10.25 (6.39-16.44) *** 
Treatment 
Accessed treatment for khat 9.7 35.5 5.09 (2.81-9.25) *** 16.1 35.5 2.87 (1.78-4.64) *** 
Mental health 
K-10 ≥ 30c  0.0 42.3 - 2.9 50.8 34.27 (14.47-81.18)*** 
Self-reported mental health 
problem 
2.6 48.7 35.63 (12.78-99.34) *** 10.2 53.0 9.88 (5.78-16.90) *** 
Quality of life 
Personal wellbeing (PWI 2SD 
below mean) d (n=386) 
20.9 72.1 9.77 (6.03-15.85) *** 30.5 75.4 6.97 (4.45-10.94) *** 
Satisfaction with life (PWI 2SD 
below mean) e (n=386) 
30.7 77.3 7.66 (4.84-12.14) *** 40.4 79.2 5.63 (3.58-8.87) *** 
Academic function  
Trouble keeping attention on 
activity for too long (n=384) 
29.6 88.8 18.84 (11.02-32.21) *** 43.1 90.1 12.04 (6.87-21.10) *** 
Difficulty in organizing/scheduling 
routine tasks (n=384) 
48.0 88.8 8.57 (5.11-14.38) *** 56.9 90.1 6.89 (3.93-12.08) *** 
Trouble listening in lectures 
(n=384) 
15.8 60.8 8.26 (4.97-13.75) *** 22.3 65.9 6.75 (4.30-10.61) *** 
Trouble making study plans 
(n=384) 
49.3 80.6 4.27 (2.71-6.72) *** 52.5 85.7 5.43 (3.30-8.95) *** 
Spent lot of time doing nothing 
(n=384) 
44.1 87.5 8.88 (5.37-14.70) *** 51.0 91.8 10.70 (5.90-19.42) *** 
Unable to do two or three tasks in a 
row (n=384) 
57.2 87.1 5.03 (3.05-8.30) *** 63.4 88.5 4.43 (2.59-7.59) *** 
Trouble remembering things to do 
(n=384) 
17.1 82.8 23.26 (13.52-40.02) *** 31.2 85.2 12.67 (7.64-21.00) *** 
Don’t stick to tasks to completion 
(n=384) 
33.6 86.2 12.38 (7.49-20.46) *** 45.5 87.4 8.27 (4.93-13.87) *** 
Lack of attention (n=384) 23.0 86.6 21.68 (12.70-36.99) *** 39.1 86.3 9.78 (5.88-16.25) *** 
Trouble with short term memory 
(n=384) 
18.4 77.2 14.96 (8.96-24.96) *** 31.7 78.6 7.91 (4.98-12.55) *** 
Difficulty sustaining concentration 
(n=384) 
27.6 85.3 15.25 (9.17-25.37) *** 41.1 86.3 9.00 (5.42-14.94) *** 
Lack of concentration on studies 
(n=384) 
19.1 81.5 18.64 (11.05-31.45) *** 33.2 83.0 9.82 (6.04-15.94) *** 
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We consider the following as limitations of the present study. Firstly, participants were 
recruited using purposive sampling which necessarily increased the probability of involvement 
of frequent khat chewers with higher risk of khat use disorders. However, given that the 
purpose of the study was to determine the utility of the SDS in screening for khat use disorder, 
this bias away from representativeness to a more heavily consuming sample actually facilitated 
achieving the aims of this work. Secondly, as the results were completely based on self-
reported data, there may be some degree of recall bias and susceptibility to social desirability 
of responses. However, since we maintained anonymity through the use of self-administered 
questionnaire, we believe that response bias was significantly minimized. Finally, AUDADIS-
IV used in this study might have not validly identified cases of khat use disorders. However, 
recent results of a related study have revealed that the modified AUDADIS-IV does validly 
identify cases of Khat Use Disorders and individuals experiencing problems (e. g. Duresso et 
al., 2016). 
 
CONCLUSION 
Considering the findings for the SDS in relation to similar drugs, it is apparent that, while the 
scale appears universally applicable as a brief screening tool, cut-off values differ across 
substance types and require independent identification. A cut-off value of 3 or greater on the 
SDS provides high sensitivity and specificity for the presence of DSM-5 khat use disorder and 
identifies a group of consumers with higher quantity and frequency of use and experiencing 
substantially greater harms in association with their use of khat. Hence, consistent with earlier 
studies (Kassim, Islam, & Croucher, 2011), the simple, one minute screen provided by the 
SDS can provide a useful tool in research for identifying individuals with probable use 
disorders; and in primary care as a means of identification of most appropriate interventions 
in a stepped care context and that such services still need to be developed and delivered. 
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Abstract 
Introduction and Aims. Despite the adverse effects of khat use and chewers interest in 
cessation, there are few studies that have reported on the outcome of khat cessation attempts, 
and limited resources available for potential quitters. We used electronic diaries to monitor the 
outcomes of an unassisted quit attempt among daily and near daily khat consumers and 
examine predictors of success.  
 
Design and Methods. Sixty participants between the ages of 18 and 35 years who regularly 
chewed khat and who were attempting to quit were purposively recruited from an Ethiopian 
University campus. Real-time prospective daily recording of khat use was obtained for an 
average of 10 days prior to quit day (range 6–13) and 28 post-quit days (range 9–31), using an 
electronic diary.  
 
Results. Almost all (95%) achieved initial abstinence. Of these, 80% reached at least seven 
continuous days of abstinence; 7% maintained continuous abstinence for 28 days post-quit. 
While 93% lapsed (average 11 days post-quit, SD = 7), only a smaller proportion relapsed 
(41%: chewed for at least three consecutive days after at least 5 days of abstinence). Among 
the three variables considered, only quantity of khat use predicted continuous abstinence. 
 
Discussion and Conclusions. Regular khat chewers have difficulties in maintaining 
abstinence despite having motivation and desire to quit. This implies that treatment aids may 
be needed to assist chewers’ in their quit attempts. Controlled experimental trial through the 
use of available low cost quit aids and behavioural resources is crucial in order to increase 
success rates for those seeking to desist from khat use. 
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INTRODUCTION: 
Khat (Catha edulis) is a plant whose leaves contain cathinone and cathine, which produces 
stimulant effects analogous to amphetamine (Nencini & Ahmed, 1989). In Ethiopia, the 
chewing of khat for religious and recreational purposes is a deep rooted socio-cultural tradition 
(Kalix & Braenden, 1985).  It is valued for stimulant effects and usually chewed in company 
to facilitate social interaction (Kalix & Khan, 1984) and to enhance work performance (Elmi, 
1983). A 2011 population prevalence study estimated use at 15.3% across Ethiopia (Males: 
22.6%; Females: 9.1%).  
 
Khat use is associated with a variety of psychological and behavioural changes. The most 
common subjective effects of the initial stage of khat chewing include increased motor 
stimulation, euphoria, and a sense of excitement and energy (Nencini, Fraioli, Pascucci, & 
Nucerito, 1998; Widler, Mathys, Brenneisen, Kalix, & Fisch, 1994). Chewers also report 
improvement in the ability to communicate and subjective excellence in work performance 
(Cox & Rampes, 2003). Conversely, later after chewing ceases, unpleasant after-effects such 
as insomnia, numbness, poor concentration and low mood tend to dominate the experience. 
Higher potency khat consumption may also induce unpleasant acute effects, such as anxiety, 
tension, and restlessness (Cox & Rampes, 2003).  
 
Importantly, khat users experience symptoms of dependence (Duresso, Matthews, Ferguson, 
& Bruno, 2016). Ingestion of khat is self-limiting, but chronic use seems to be associated with 
poorer mental health (Kalix & Braenden, 1985). Chewers may experience a range of symptoms 
from minor unpleasant after-effects such as low mood and poor concentration to more 
significant problems like insomnia, anxiety, irritability, depression, aggression, and 
restlessness (Duresso et al., 2016; Odenwald et al., 2007; Pantelis, Hindler, & Taylor, 1989). 
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It is not surprising, therefore, that many users express a desire to quit, or at least reduce, their 
khat consumption (Alsanusy & El-Setouhy, 2013).    
 
Despite the negative consequences of khat use and consumer interest in cessation, there are a 
dearth of studies reporting on the outcome of khat cessation attempts, and few cessation 
resources available for potential quitters (Alsanusy & El-Setouhy, 2013). Most consumers 
describe easy access to khat and social pressure as major factors for continued khat use, and 
others acknowledged long leisure times with little to do as an interfering issue in their attempts 
to remain abstinent (Alsanusy & El-Setouhy, 2013). While there is a small literature examining 
pharmacological aids for ceasing khat use (Giannini, Miller, & Turner, 1992; Giannini & 
Nakoneczie, 1995), there are reports of successful quitting without medical interventions. As 
little is known about the nature of khat dependence, here we describe the outcomes of 
unassisted khat cessation among 60 khat users who were motivated to quit.  
 
METHODS 
Participants 
Sixty participants (3 recent graduates and 57 under graduate students) who were attempting to 
quit khat were recruited through advertisement and fliers in and around Adama Science and 
Technology University campus (Ethiopia).  While the inclusion criteria included regular habit 
of khat chewing, at minimum of 3 days per week, for 2 years by self-report and high motivation 
and overall interest to quit chewing during the study quite periods, the exclusion criteria, on 
the other hand, included current significant medical condition, current diagnosis of a 
significant psychiatric disorder, as indicated on the MINI International Neuropsychiatric 
Interview, history of alcohol or drug abuse or dependence disorder or use of alcohol at 
hazardous or harmful levels, evident via a score of 16 or higher on the AUDIT, current regular 
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tobacco use (self-reported), and current use of a contraindicated prescription or psychotropic 
medications (self-reported). The Tasmania Human Research Ethics Network granted approval 
for the study (#HO013347), with additional local ethical clearance obtained from Ministry of 
Education via Adama Science and Technology University in Ethiopia.  
 
Procedure 
After obtaining informed consent, participants were trained on the use of the Electronic Dairy 
(ED). The EDs were 10 Android-based smartphones (LG© P500) running customisable 
software (HBART; http://www.utas.edu.au/health/research/groups/behavioural-and-
situational-research-group-bsrg/hbart), which were provided by University of Tasmania. 
These devices were provided to participants for the duration of the study. At the completion 
of the study, participants returned their device, the participant data removed, and the device 
was then used for subsequent participants; in this way, the 10 individual units were used across 
the entire cohort of participants. This software was specifically developed for real-time data 
capture and has been used in numerous previous studies across a range of behaviours (Peacock, 
Cash, Bruno, & Ferguson, 2015; B. Schuz, Schuz, & Ferguson, 2015; N. Schuz, Walters, 
Frandsen, Bower, & Ferguson, 2014). Subjects were trained to use the ED to report every 
instance of khat chewing during the monitoring period. Similar to previous smoking studies 
using the methods of ecological momentary assessment (EMA) (Shiffman et al., 1997; 
Shiffman & Ferguson, 2008; Shiffman et al., 2006), the ED was designed to issue random 
prompts for assessments 4-7 times a day. During both chewing and random assessments, 
participants reported their current mood and social context. Participants monitored their 
chewing on the ED for 10 (M=10.8; SD=1.2) days prior to cessation and met with the 
researcher in three study visits, scheduled on the second, fifth and tenth days after the initial 
screening visit. During study visit 1, the information sheet was read, consent forms were 
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signed, participants were enrolled in database, baseline surveys were conducted, EMA 
booklets were handed out, the phones (EMA devices) were set up, phones chargers were 
provided, and the next appointments were booked. During visit 2, EMA data was downloaded, 
compliance was checked, additional training if needed was provided, participants were 
instructed to monitor chewing for 10 consecutive days and the next appointment was booked. 
During the third visit, the day before quit day, subjects were instructed to quit chewing the 
next day (target quit day, TQD). The first actual full day of abstinence (i.e. no chewing for 24 
hours) was labelled the quit day. 
 
Total monitoring ranged from 20 to 44 days, with an average of 34.7 (SD=6.7) days, close to 
the intended 38 days. Post-quit monitoring continued for up to 4 weeks after cessation 
(M=24.0, SD=6.5) with an additional four visits scheduled approximately weekly. During 
visits 4 - 6, EMA data was downloaded, compliance was checked, participants were instructed 
to quit chewing for the next four weeks and the next appointment was booked. During the last 
visit, EMA data was downloaded, phone and charger were collected, participants were 
debriefed, and experiences were shared. All participants were reimbursed AUD 63.00 which 
is equivalent to ETB 950.00 for seven study visits. 
 
Outcome measures 
The focus of this study was primarily descriptive, examining the outcomes of an unassisted 
quit attempt by regular users with a desire to discontinue use. Correlates of success were solely 
a secondary aim and the numbers of variables examined were constrained given the substantial 
burden of participation already placed on participants through use of the prospective data 
collection approach. 
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Regardless, the three predictors of success (gender, amount of khat and psychological distress) 
examined as secondary aims were based from an examination of what little is known about 
dependent khat use. In Ethiopia, the use of Khat (current and lifetime) is significantly higher 
among males than female and males are more likely to continue chewing in their life time than 
females (Wedegaertner et al., 2010; Zein, 1988).  It has been indicated that chewers who either 
use a larger amount of khat per chewing session or consume additional stimulants like caffeine 
and nicotine might find it difficult to minimize use or succeed in quit attempts (Mihretu, 
Teferra, & Fekadu, 2017).  Some findings have also suggested that some individuals engage 
in khat chewing in order to get relief from symptoms of mental distress such as depression and 
anxiety which may indicate an association between mental distress and continued khat 
chewing (Wedegaertner et al, 2010). 
 
Outcome analyses were based on participants’ reports of khat chewing on the ED and the Time 
Line Follow Back (TLFB) survey. All participants had calendar like note books for the full 
period of assessment to record their daily khat chewing activity in addition to the ED. All 
interviews and surveys, including the EMA surveys, were conducted in English.  Three 
different outcome milestones as adapted from previous studies on cigarette use were used in 
the analysis (Shiffman et al., 2006). Since no definitions of abstinence currently exist for khat 
use, we adapted established outcomes from the smoking cessation literature.  Initial abstinence 
was defined as 24 hours without khat chewing based on ED diary entries. Khat abstinence was 
defined as no use of khat in the last 7 days and continuous abstinence was defined as no 
chewing since TQD.  Individual monitoring days were considered abstinence days only if both 
EMA and TLFB data both indicated no chewing. This occurred for 34 out of 59 cases. When 
dates of no chewing varied between EMA and TLFB data (for 25 out of 59 cases), we selected 
the EMA quit date if EMA compliance was acceptable (15 of 25 cases). Conversely, if 
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compliance was poor, we selected the TLFB quit date (10 of 25 cases). The same procedure 
was used for deciding the lapse and the relapse dates. Initial lapse was the first episode of any 
amount of khat chewing after initial cessation or during post quit period. Relapse was a 
resumption of regular chewing at least for three consecutive days after five days without khat. 
Lapse date variations between TLFB and EMA data, with 4 (7%) participants not lapsing was 
5/55 (8%). For 3 participants compliance was acceptable and the EMA date was considered as 
actual lapse date. For the remaining 2 participants the lapse date was based on TLFB data. With 
regard to dates of relapse, there were 10 variations out of 25 (17%) instances of relapse, with 
34 (57%) participants not relapsing. Four out of ten had acceptable compliance; hence EMA 
data was set as actual relapse date. For the remaining 6 participants, EMA data compliance was 
poor and TLFB data was taken as actual relapse date. 
 
RESULTS 
Demographic Characteristics: 
At baseline, participants reported a variety of demographic measures, including gender, age, 
years of education completed, typical khat consumption quantity and frequency, prior quit 
attempts, and psychological distress (K-10) (Andrews & Slade, 2001). Out of 59 eligible 
participants, 5% (n=2) were recent University graduates and the remaining 95% (n=57) were 
all university under graduate student (year I – Year III).  Participant mean age was 24.8 years 
(range 20-32; SD=2.8), and predominantly male (n=45, 75%). One-quarter were chewing daily 
and 38% were chewing near daily (six days per week); when participants used khat, the 
majority consumed 1 bundle (approximately 100-200gm of leaves; n=44, 73.3%), with the 
remainder using 1.5 bundles (n=16, 27%). The majority had made prior quit attempts (n=42, 
70%), maintaining abstinence on average for 10 weeks (SD=4.0). None of the chewers had 
current significant medical disorders or history of severe mental illnesses. Scores on the 
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Alcohol Use Disorders Identification Test (AUDIT) (Babor, 2001) suggested the absence of 
significant alcohol-related problems (mean=13.3, SD=1.2, range 11-15). All participants 
reported episodic tobacco smoking, but scores on the Fagestrom Test for Nicotine Dependence 
(FTND) (T. F. Heatherton, L. T. Kozlowski, R. C. Frecker, & K. O. Fagerstrom, 1991) 
suggested low dependence (mean=0.90; SD=0.72, range 0-2). No participants screened 
positively for high psychological distress (≥ 30) on the Kessler Psychological Distress Scale 
(K-10), with the majority in the well (35%) or mild (58%) range.  
 
Outcomes 
Table 1 presents the proportion of participants reaching each endpoint. Nearly all reached the 
target quit date and achieved initial abstinence. Only one participant did not achieve abstinence 
and dropped out after 6 days of monitoring. One half of chewers quit on the Target Quit Date 
(TQD) (33, 56%), and the remainder achieved abstinence after (20%) or prior (24%) to TQD. 
By implication those who failed to achieve abstinence on the TQD were assumed to have 
chewed on that day. Seven-day abstinence was achieved by 80% of participants.  
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Table 1: Proportion of participant reaching each endpoint (N=60) a. 
 % (n) 95% CI 
Endpoint   
Reached Target Quit Day 98.3% (59)  91.1-99.7 
Achieved Initial Abstinence 96.6 % (57)  88.4-99.0 
Lapsed 93.2% (55)  83.8-97.3 
28-day outcomes (n=59)   
7-day PP Abstinence 79.7% (47) 67.7-88.0 
Continuous Abstinence  6.8% (4) 2.7-16.2 
Relapsed 40.7% (24)  29.1-53.4 
a Initial abstinence, 24 h time without chewing; lapse, chewed after initial abstinence based on the denominator 
of subjects who quit (n = 59); 7-day abstinence, abstinence for the preceding 7 days based on the denominator of 
subjects who quit (n = 59); continuous abstinence, no chewing since TQD based on the denominator of subjects 
who quit (n = 59); relapse, resumption of regular chewing at least for three consecutive days after 5 days 
without khat based on the denominator of subjects who quit (n = 59). CI, confidence interval. 
 
 
Among the 59 participants who achieved initial Abstinence 93% lapsed. Days to lapse ranged 
from 2 to 25 days (M=11.0, SD=6.9). With regard to relapsing, 41% of those who quit chewing 
relapsed and only 7% of the participants maintained continuous abstinence throughout the 
study period. We examined sex, quantity of use and psychological distress (K-10) as predictors 
of successful quit attempts. As age did not vary substantially it was not considered as a 
predictor variable. Among the three variables considered, only quantity of khat use predicted 
continuous abstinence (Table 2).    
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Table 2: Demographic correlates of khat abstinence 
 Initial Abstinence a 
No (n=2; 3.4%) Yes (n=57; 96.7%) 
% % OR (95%CI) 
Male b 50.0 75.4 3.26 (0.19-5.55) 
Khat in bundle (1.5) c 25.0 28.1 0.82 (0.08-8.48) 
K10d 75.0 63.2 1.74 (0.17-17.73) 
 Seven Days Abstinence 
No (n=12; 20.3%) Yes (n=47; 79.7%) 
% % OR (95%CI) 
Male b 58.3 78.7 0.39 (0.10-1.45) 
Khat in bundle (1.5) c 7.1 34.7 0.14 (0.02-1.20) 
K-10 d 75.0 61.7 0.54 (0.13-2.25) 
 Continuous Abstinence a 
No (n=55; 93.2%) Yes (n=4; 6.8%) 
% % OR (95%CI) 
Male b 72.0 83.3 1.95 (0.21-18.03) 
Khat in bundle (1.5) c 22.8 83.3 0.06* (0.01-0.55) 
K10d 63.6 75.0 1.71 (0.17-17.6) 
 
*P < 0.05. None of these are statistically significant other than those for the continuous abstinence – and that 
analysis should be interpreted with caution given the relatively small n. a Neither the initial or continuous 
columns have enough power to be able to identify relationships. b Males in each outcome. c Rate of people 
that used large amounts of khat (1.5 bundles or greater per session). d People with psychological distress (K-
10 scores > = 30). CI, confidence interval; OR, odds ratio. 
 
DISCUSSION 
In our study, we describe unassisted chewing cessation outcome data in terms of three outcome 
endpoints. Although a majority of the participants maintained initial and 7-day abstinence, 
most relapsed within 11 days post quit and very few were able to maintain abstinence 
throughout the study period. Those who maintained continuous abstinence were not assessed 
after the study period and could have resumed chewing. In addition, with the exception of 
quantity of khat consumed, none of the demographic variables examined predicted successful 
abstinence. Quantity of khat consumed in bundles was statistically significant only for the 
continuous abstinence group (participants who did not chew throughout the study post-quit 
period), indicating that those in the continuous abstinence group, who usually consumed one 
and half bundle or more of khat per session, were likely to maintain abstinence (compared to 
those who are in the continuous abstinence group but consumed one bundle or less of khat 
leaves). This finding is somewhat puzzling, as the direction of the association is opposite to 
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what we would expect based on work in other substances of addiction. It is possible that the 
heavier users in our study were more committed to quitting, or that other factors explain this 
discrepancy. However, given the small sample size, we feel that is important to replicate this 
finding before speculating on the cause of the association; it is entirely possible that this pattern 
will not be observed in a larger study. Although this may partially reflect low power that 
potentially limits the ability to identify particular predictors of quit success, this may imply 
that irrespective of their demographic and situational backgrounds, chewers may need 
assistance in their attempt to quit chewing, through the provision of behavioural resources and 
drug treatment. A 12-step self-help group approach has demonstrated a reduced substance use 
and improved outcomes among stimulant consumers (Donovan & Wells, 2007). Considering 
this approach as a treatment process for khat abuse could be effective since it may provide 
low-cost options and may be easy to organize as khat chewing is social by its nature. 
 
This study has some limitations. First, due to the pilot nature of the study this was conducted 
on only a small sample of university students who used khat regularly, and results may not be 
generalizable to a larger population. Secondly, the lack of urine screening for verification of 
abstinence and relying merely on self-reported abstinence was also a limitation; but given that 
this is the very first study of quit attempts, it is a strength that this was done using prospective 
recording with ED. Thirdly, outcome variables selected from related smoking cessation 
literature—especially the criteria of 24 h of cessation for initial abstinence—may not be 
perfect fit for this specific drug. Similarly, while short-term cessation has been found to predict 
long-term success (Heatherton, Kozlowski, Frecker, & Fagerstrom, 1991), our follow-up 
duration was relatively brief; further studies are required to determine whether the observed 
outcomes are maintained over time. And finally, although it is very unlikely that the act of 
having the study participants set their quit provided assistance in terms of aiding their quit 
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attempts, we cannot absolutely rule out the possibility that our EMA monitoring procedures 
could have influenced the outcomes observed. However, considering the scarcity of research 
findings in this area the current findings undeniably shed light on this matter of substantial 
concern.  
 
CONCLUSION 
Despite khat being a culturally acceptable and legal substance in the country,  it is noted that 
some people do develop problems from use (Duresso et al., 2016) and that even motivated 
individuals have difficulties maintaining abstinence. It is vital therefore that there is clinical 
attention made to identifying applicable supports for people to quit chewing. The findings of 
the present study examining unaided quit attempts may also inform the design of controlled 
experimental trials to examine the effectiveness of low cost quit aids and behavioural resources 
for khat that would work in the Ethiopian context in helping quitters successfully maintain 
abstinence.   
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Abstract 
Research reports show increased prevalence of habitual khat chewing among various parts of the 
community in Ethiopia. Some users experience problems controlling their use; withdrawal 
symptoms may be adding to difficulties with reducing or ceasing use. We aimed to describe the 
nature and the time course of any withdrawal syndrome in relation to the cessation of khat use 
over the first 2 weeks of a quit attempt. 
 
Fifty-nine participants between the ages of 18 and 35 and who have already chewed ≥1 bundle of 
khat in their life with a chewing frequency of ≥3 days per week were recruited from Adama 
Science and Technology University campus. Participants were predominantly male (n = 45, 75%) 
and had the mean age of 24.8 years (range = 20–32; SD = 2.8).  
 
Participants used smart phones to monitor withdrawal symptoms and cravings. The total 
assessments were divided in to 3 pre-quit and 14 post-quit days. The development of withdrawal 
symptoms was evident, and all withdrawal symptoms followed similar overall patterns, with 
salient elevations after the quit day and curvatures around the first week of post-quit period.  
 
Depression, craving, nervousness, tiredness, restlessness, poor motivation, irritability, and 
negative affect substantially increased and reached peak on the first week around Day 7 and 
remained higher compared with the level at baseline indicating the persistence and severity of 
these symptoms over time. In addition, craving, irritability, and restlessness had significantly 
reverted to their baseline level during the second week of the post quit duration. We have 
demonstrated low rates of success during unaided quite attempts from khat and that the withdrawal 
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syndrome is not trivial. Interventions are necessary to support individuals during the period of 
increased symptoms of dysphoria and to reduce the risk of relapse. 
 
Keywords: khat withdrawal, khat abstinence, negative affect, craving, positive affect 
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Introduction  
Research indicated that world-wide, tens of millions of people are estimated to consume khat on 
daily basis (Stefan & Mathew, 2005). Global spread of khat use is largely attributed to easy air 
transportation for khat export and migration of people from East African countries (such as 
Somalia, Ethiopia, Kenya, etc.) and Yemen to the UK and other Western countries (Griffiths et 
al., 2010; Stevenson, Fitzgerald, & Banwell, 1996). In Ethiopia, Khat is habitually consumed by 
craftsmen, farmers, and laborers, and also academics and students (Adugna, Jira, & Molla, 1994; 
Alem, Kebede, & Kullgren, 1999; Ayana & Mekonen, 2004; Ayenew, Tadesse, & Azale, 2012; 
Cox & Rampes, 2003; Ihunwo, Kayanja, & Amadi-Ihunwo, 2004). A 2011 population prevalence 
study estimated past month use at 15.3% across Ethiopia (22.6% among males; 9.1% among 
females). Among Ethiopian university students, lifetime prevalence was estimated at 24.0%, while 
7.7% reported past month khat use (Gebrehanna, Berhane, & Worku, 2014). 
 
Khat (Catha edulis) is a plant with psychostimulant effects from its most active constituents, 
cathinone and cathine, which are structurally similar to amphetamine (Nencini, Ahmed, Amiconi, 
& Elmi, 1984). While cathinone is the most active ingredient of khat, cathine has a milder and 
short-lasting psychostimulant action and plays only a minor role in the effects of khat. It is 
believed that cathine is responsible for unwanted adverse effects of the drug, such as feelings of 
low mood and sluggishness (Cox & Rampes, 2003). Symptoms of increased alertness, dependence 
and adverse psychiatric events can arise due to the effects of khat on the central nervous system 
(Kalix & Braenden, 1985). 
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Consumers report that khat is chewed to increase mental alertness; to prevent sleepiness and 
overcome physical fatigue (Alem et al., 1999; Ayana & Mekonen, 2004). Reports show increased 
prevalence of khat chewing among various parts of the community in Ethiopia (Alem et al., 1999; 
Ayenew et al., 2012). Khat is used habitually by craftsmen, farmers and laborers during physical 
work. University instructors (Ihunwo et al., 2004) and large proportions (64.9% current 
prevalence) of secondary and higher education students also regularly chew khat (Adugna et al., 
1994; Cox & Rampes, 2003; Ihunwo et al., 2004). Students report chewing khat with the aim of 
gaining concentration and focus and to reduce fatigue (Ayana & Mekonen, 2004).  
 
One of the major issues with regard to chronic drug use is the occurrence of withdrawal symptoms 
and craving related to the discontinuation of use after long time exposure or habitual and 
prolonged consumption. In Ethiopia, while few khat chewers (0.6%) reported having continued 
to chew to prevent withdrawal symptoms (Alem & Shibre, 1997), most chewers (46%) wanted to 
stop khat chewing and have tried to give up chewing, with nearly half of them (21%) resuming 
chewing because of dependence and the social interaction associated with khat chewing (Yussuf, 
Asquith & Ali, 2007). Diagnostic and Statistical Manual (DSM) criteria suggest that the 
withdrawal syndrome for psychostimulant drugs encompasses dysphoric mood and symptoms 
such as fatigue, vivid or unpleasant dreams, insomnia or hypersomnia, increased appetite and 
psychomotor retardation or agitation (American Psychiatric Association, 2000).  
 
Despite conflicting opinions regarding the existence of dependence in relation to khat use, there 
is accumulating evidence indicating the presence of a withdrawal syndrome, craving, and a degree 
of tolerance related to chronic khat chewing (Cox & Rampes, 2003). Physical withdrawal 
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symptoms and craving have been documented, including lethargy, anergia, and nightmares, which 
appear several days after ceasing to chew (Giannini & Castellani, 1982). Depressive moods, 
psychotic symptoms, drowsiness and hypotension are sometimes seen after discontinuation of 
khat, and khat chewers often continue to use the drug in order to avoid the withdrawal symptoms 
(Alem et al., 1999; Widmann et al., 2017). In support of this, a recent finding (Duresso, Matthews, 
Ferguson, & Bruno, 2016) indicates the presence of withdrawal symptoms and craving and 
suggests that many regular khat chewers experience at least one clinically significant withdrawal 
symptom and 28% meet core requirements for stimulant withdrawal (concurrent dysphoria plus 
two other symptoms, severe enough to cause distress). Among the common symptoms were 
dysphoria, insomnia/hypersomnia and psychomotor agitation/retardation.  
 
In summary, chronic khat chewers often experience problems controlling their use and report 
withdrawal symptoms during periods of abstinence, and the experience and severity of withdrawal 
symptoms may be a significant barrier to cessation/reduction of problem drug use (Shoptaw, Kao, 
Heinzerling, & Ling, 2009). Most theories of dependence have posited that continued drug use is, 
at least in part, driven by withdrawal symptom avoidance and addressing withdrawal is a key 
component of many treatments (Shoptaw et al., 2009). There is substantial evidence that negative 
affect interacts with arousal in predicting craving and potential relapse (Dunbar, Scharf, Kirchner, 
& Shiffman, 2010). While the presence of symptoms of withdrawal has been identified in relation 
to khat in retrospective surveys, there have been no studies to date identifying the time course of 
their severity prospectively. The present study aimed to examine the time course of development 
and reduction of withdrawal symptoms (craving, negative affect, arousal, depression, 
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nervousness, irritability, restlessness, tiredness/fatigue, and poor motivation) over the first 2 
weeks of a quit attempt. 
Methods 
Participants 
Sixty participants were recruited mostly through online advertisements on social media and 
leaflets distributed at Adama Science and Technology University campus. To be eligible, 
interested applicants were required to demonstrate high motivation and overall interest to quit 
chewing during the study quit periods and to have a chewing frequency of at least one bundle of 
khat leaves for ≥ 3 days per week over the past 12-month duration. All participants had 
demonstrated khat dependence by self-report and Mini International Neuropsychiatric Interview 
(MINI) screen and reported high motivation to quit chewing. Participants were reimbursed ETB 
950.00 (approximately USD $47) for a total of seven study visits. 
 
Materials 
Affective factors and energy level were assessed by using 17 items: focus, alert, angry/frustrated, 
loss of interest, excited, tired, passive, poor concentration, poor memory, happy, irritable, poor 
motivation, nervous/anxious, drowsy/sleepy, restless, depressed, and arousal (visual analog scales 
[VAS] anchors: 0 _ “No!!,” 100 _ “Yes!!”) derived from the circumplex model of affect (Shiffman, 
Ferguson, Gwaltney, Balabanis, & Shadel, 2006). Individual adjectives (e.g., “depressed”, 
“restless”) were presented on the screen one at a time. Ten items were used to form two factor 
scores: specifically, negative affect and arousal. The 10 items that were used to form the two 
factors were focus, alert, excited, passive, drowsy/sleepy, poor concentration, and poor memory, 
which formed arousal factor scores and angry/frustrated; loss of interest and happy (reverse) 
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formed negative affect factor scores. In addition, we reported the results from seven individual 
items (in addition to arousal and negative affect). These 7 items were selected as relating to the 
DSM stimulant withdrawal symptoms, as this was the topic of the paper. Craving was assessed 
on a single VAS item with anchors of 0 = “No!!” 100 = “Yes!!”. 
 
Procedures: 
The current study was the first to use Ecological Momentary Assessment (EMA) Techniques in a 
naturalistic context (Ferguson & Shiffman, 2011) to examine khat cravings and withdrawal 
syndrome among chronic khat users. Informed consent was obtained from each participant before 
providing training on the use of an electronic diary (ED) and on how to report every instance of 
khat chewing, withdrawal symptoms, and cravings during the monitoring period. Assessments 
were completed in English as there was no need to translate the survey into Amharic (native 
language), given the participants in our study were university graduates and students. Moreover, 
all participants were given enough training during enrolment sessions on the nature of the survey 
items, the psychological constructs and on how to use the EMA devices and complete the survey 
electronically. 
 
Similar to previous smoking studies using ecological momentary assessment (Shiffman et al., 
1997; Shiffman & Ferguson, 2008; Shiffman et al., 2006; Shiffman, Scharf, et al., 2006), in 
addition to participant-initiated data collection when khat was consumed, the ED was also 
designed to issue random prompts for assessments 4–7 times a day during waking hours. Both 
event and time sampling strategies were used in this study. Withdrawal scores collected on the 
three days prior to the quit date were averaged to form the baseline data. Data collected 24hr after 
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the actual quit day (Day 1) was used as 24-hr. point in time. Data collected on the seventh day 
post-quit was used as Day 7 time point whereas the data collected on the fourteenth day was 
considered as Day 14 time point. The points in time were chosen based on the evidence from 
previous research that withdrawal symptoms, including cravings, are likely to manifest within 24 
hr, to reach peak at about the first week and decline around the second week and thereafter, which 
could provide sufficient evidence to quantify severity of withdrawal and compare the measures 
accordingly (e.g., nicotine withdrawal; Van Zundert, Boogerd, Vermulst, & Engels, 2009).  
 
During both chewing   random assessments, participants recorded their chewing status and current 
mood and social context. Participants monitored their chewing and related feelings on the ED for 
10 (M = 10.8; SD = 1.2) days prior to cessation and met with the researcher in three study visits, 
scheduled on the second, fifth and tenth days after the initial screening visit. Each of the seven 
visits lasted on average 30 min. During study visit 1, the information sheet was read, consent 
forms were signed, participants were enrolled in database, and baseline surveys were conducted, 
EMA booklets were handed out, the phones (EMA devices) were set up, phones and chargers 
were provided, and the next appointments were booked. During visit 2, EMA data was 
downloaded, compliance was checked, additional training if needed was provided, participants 
were instructed to monitor chewing for 10 consecutive days and the next appointment was booked. 
During the third visit EMA data was downloaded, compliance was checked, and participants were 
instructed to quit chewing the following day (target quit day, TQD). Post-quit monitoring 
continued for up to 4 weeks after cessation (M =24.0, SD = 6.5) with an additional four visits 
scheduled approximately weekly. During visits 4 – 6, EMA data was downloaded, compliance 
was checked, and participants were instructed to quit chewing for the next four weeks and the 
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next appointment was booked. The first actual full day of abstinence (i.e., no chewing for 24 hr) 
was labeled as actual quit day. The Tasmania Human Research Ethics Network granted approval 
for the study (#H 0013347), with additional local ethical clearance obtained from Adama Science 
and Technology University. 
 
Data reduction and analytic plan 
Eligible subjects for analyses must have provided baseline data; reported khat abstention on the 
scheduled quit date and abstained from chewing for the first 24 hr. of their quit attempt. 
Additionally, while eligible participants were encouraged to maintain khat abstinence over the 
course of the study, this was not possible for many, and to obtain clean withdrawal measurements 
uncontaminated by days with any use of khat, we abandoned days of monitoring where any 
participant used khat during post-quit days. While 80% of participants achieved 7-day abstinence, 
less than a third (32%) maintained 14-day abstinence. We also plotted withdrawal symptoms 
separately for those who lapsed (68%) and those who did not (non-lapsers; 32%) and the results 
demonstrated that there were no substantial differences in the trends of withdrawal syndromes 
between the non-lapser and lapser groups (Supplemental material Figure S1). 
 
Baseline ad libitum chewing data were collected from random prompts and khat use reports. 
Participants were instructed to chew ad libitum during the first 10 days of pre-quit monitoring. 
However, while 56% of participants reached 24-hr abstinence on the target quit day, 20% quit 
between Day 11 and Day 12. The remaining participants (24%) reached 24-hr abstinence a day 
before the target quit day. Only one participant dropped out 4 days prior to the target quit day and 
was hence not included in any analyses. Data was centered on actual quit day. EMA data were 
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collected from a total of 3,913 random prompts during both periods of abstinence and use (M = 3 
random prompts per day, SD = 1.5). 
 
While monitoring was conducted for approximately 28 days post-quit, 40 (68%) had lapsed or 
relapsed after 14 days post-quit day. As such, for the description of withdrawal symptom severity 
over time, only 14 days post-quit was included in analyses and for any day in which a participant 
reported chewing khat, all symptoms were removed from analysis for (only) that day. To 
determine the presence of specific changes in symptom severity between baseline, acute 
withdrawal (24-hr post-quit) and changes over time (7 and 14 days), we employed mixed models 
for repeated measures analyses using AR (1) covariance matrix to compare symptom endorsement 
from each of these time points. This procedure allowed us to include cases where we have 
incomplete data for this series of analysis (Table 2). The figures were constructed using least 
squared (LS) means generated from mixed models for repeated measures. 
 
Results 
Substance Use Profile of Participants  
Of the 59 participants contributing data during periods of both use and abstinence, mean age was 
24.8 years (range 20–32; SD = 2.8), and were predominantly male (n = 45, 75%). One-quarter 
were chewing daily and 38% were chewing near daily (M = 5.7; SD = 1.1; range = 4 – 7) when 
participants used khat, the majority consumed 1 bundle (approximately 100–200g of leaves; n = 
44, 73.3%), with the remainder using 1.5 bundles (n = 16, 27%). Mean khat consumption was 1.3 
(SD = 0.4) bundle of khat leaves per session. The majority had made prior quit attempts (n = 42, 
70%), maintaining abstinence on average for 7.2 weeks (SD = 5.9). 
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None of the chewers had current significant medical disorders or history of severe mental 
illnesses. Scores on the Alcohol Use Disorders Identification Test (AUDIT; Babor, Higgins-
Biddle, Saunders, & Monteiro, 2001) suggested the absence of significant alcohol-related 
problems (M = 13.3, SD = 1.2, range = 11–15). All participants reported episodic tobacco smoking 
and scores on the Fagestrom Test for Nicotine Dependence (FTND; Heatherton, Kozlowski, 
Frecker, & Fagerström, 1991) suggested low dependence (M = 0.90; SD = 0.7, range = 0–2). The 
mean score on the Kessler Psychological Distress Scale (K10 (Andrews & Slade, 2001) was 20.4 
(SD = 3.1; range = 14–27). No participants screened positively for high psychological distress 
(≥30), with the majority (35%) in the well (<20) or 58% in mild (20 – 24) range. 
 
Table 1: Polynomial regression models describing changes in withdrawal symptoms from 3 
days prior to, and 14 days following, khat cessation  
 
Variable Intercept Linear term Quadratic term 
Coefficient (95%CI) t(p) Coefficient t(p) 
Craving 54.24 1.54 (1.02 – 2.07) 5.82*** -0.14 (-0.18 – -0.09) 5.71*** 
Negative affect^ -0.13 0.16 (0.14 – 0.18) 14.47*** -0.01 (-0.01 – -0.01) 11.58*** 
Arousal^ 0.34 -0.18 (-0.20 – -0.16) 16.45*** 0.01 (0.01 – 0.01) 10.61*** 
Tired 36.97 3.63 (3.15 – 4.12) 14.75*** -0.25 (-.29 – -0.20) 11.21*** 
Poor Motivation 36.73 3.03 (2.56 – 3.50) 12.70*** -0.21 (-.26 – -0.17) 9.97*** 
Nervous 37.80 2.87 (2.40 – 3.35) 11.89*** -0.21 (-0.26 – -0.17) 9.77*** 
Depressed 34.36 3.63 (3.15 – 4.11) 14.96*** -0.27 (-0.31 – -0.23) 12.45*** 
Irritable 41.02 1.98 (1.49 – 2.47) 7.91*** -0.15 (-0.20 – -0.11) 6.86*** 
Restless 39.64 2.18 (1.71 – 2.65) 9.14*** -0.18 (-0.22 – -0.13) 8.18*** 
 
Note. ^ Analyses involving arousal and negative affect performed on their factor scores, values ranging from – 1 to 
+ 1; all other variables on scales 0–100. 
***p < .001. 
Withdrawal symptoms, trend and characteristics 
The best-fitting model with quadratic terms for the average subjective scores of nine withdrawal 
symptoms over 3 days pre-quit chewing and 14 days of abstinence (n = 59) is summarized in 
Table 1 and portrayed graphically in Figure 1. For the sake of uniformity and clarity of the figures, 
the factor scores of Negative affect and Arousal (originally on a scale –1 to +1) were transformed 
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to a 0–100 scale consistent with other measures. Depression, craving, nervousness, tiredness, 
restlessness, poor motivation, irritability, and negative affect seem to increase substantially and 
reach peak in the first week around Day 7 and decline thereafter in some cases (craving, irritable, 
and restless) returning to near baseline values (Table 2). Arousal showed a sharp decrease in 
symptoms during the first week following the quit day and decreased slightly throughout the 
second week (Figure 1d). As can be seen from the plots, all withdrawal symptoms followed similar 
overall patterns with salient changes after the quit day and curvatures around the first week post-
quit day. 
 
 Figure 1 (a-i): Trends of average withdrawal scores of the participants over 3 pre-quit and 14 
post quit days (N=59). 
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study significantly change over the course of a quit attempt. There was an acute withdrawal effect 
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arousal, fatigue, poor motivation, nervousness, and depression) remained significantly elevated 
from baseline at Day 14. Craving, irritability, and restlessness, however, had returned to levels 
comparable to baseline during the second week of the post-quit period. 
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Table 2:  Mean withdrawal symptom scores at baseline, on quit day, 1st week post quit and at 2nd week post quit. 
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Craving 49.5 (10.8) 57.0 (15.4) 56.4 (15.9) 51.9 (15.7) 5.7** <0.01 <0.05 1.000 1.000 1.000 
Negative affect^ -0.6 (0.4) 0.2 (0.6) 0.3 (0.6) 0.1 (0.7) 32.5*** <0.001 <0.001 1.000 0.659 <0.001 
Arousal^ 0.9 (0.3) 0.01(0.7) -0.2 (0.6) -0.3 (0.6) 73.6*** <0.001 <0.001 0.077 1.000 <0.001 
Tired 25.6 (8.1) 43.5 (14.8) 50.0 (14.6) 45.8 (16.1) 39.7*** <0.001 <0.001 0.100 0.949 <0.001 
Poor motivation 27.1 (8.2) 44.3 (14.1) 45.5 (13.2) 41.2 (14.2) 27.2*** <0.001 <0.001 1.000 1.000 <0.001 
Nervous 28.2 (10.0) 42.4 (13.1) 45.6 (12.5) 39.1 (14.1) 19.0*** <0.001 <0.001 0.965 0.378 <0.01 
Depressed 22.6 (7.6) 44.2 (13.3) 44.4 (14.6) 37.2 (16.3) 35.1*** <0.001 <0.001 1.000 0.206 <0.001 
Irritable 34.8 (13.0) 46.3 (13.0) 46.3 (13.7) 41.0 (13.2) 7.0** <0.01 <0.01 1.000 0.431 0.431 
Restless 33.0 (12.3) 43.8 (14.1) 43.4 (12.4) 39.6 (14.3) 8.2*** <0.001 <0.001 1.000 1.000 0.303 
Note. ^Analyses involving arousal and negative affect performed on their factor scores, values ranging from +1 to –1; all other variables on scales 0–100. 
** p <.01. *** p <.001. 
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Discussion 
The main objective of the present study was to determine whether there were any meaningful 
and sustainable withdrawal symptoms present in a sample of frequent khat chewers who 
engaged on a motivated quit attempt. Withdrawal symptoms (craving, negative affect, 
tiredness, poor motivation, nervousness, depression, irritability, and restlessness) 
significantly changed on the designated quit day and continued at higher levels throughout 
the first week. During the second week, only some of the symptoms (craving, irritability, and 
restlessness) had reverted to the baseline levels. 
 
Craving showed significant growth on the designated quit day (24 hr) and remained high 
throughout the first week of the post quit monitoring period with the smallest magnitude of 
changes overtime returning to baseline rates around Day 14. This trend was also true for 
irritability and restlessness which continued at high levels after the quit day until roughly 
Day 8 and reverted back to baseline levels in the second week. These results partially 
support earlier studies which reported significant craving after cutting down or reducing khat 
chewing by 82% of chewers (Al-Motarreb, Baker, & Broadley, 2002) and significant 
increase in irritability, enhanced distress, emotional reactivity and nervousness among 53% 
of chewers (Bongard, al’Absi, Khalil, & Al Habori, 2011). 
 
For most of withdrawal items, particularly negative affect, patterns of steady increase in 
elevation of withdrawal symptoms during pre-quit days and noticeable change around the quit 
day heading for greatest severity during the first week were observed. In addition, as revealed 
in the time course analysis (Table 2), for most withdrawal items maximum severity of 
symptoms was observed starting from the 24-hr. initial quit day throughout the first week of 
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the 4-week quitting process. Taking this into account, it may be crucial to target withdrawal 
symptoms before the attempt is started as well as once 24-hr. abstinence is achieved. 
 
The change in arousal/energy level was significant and the observed results were similar in 
terms of trend and elevation to all other symptoms. Pre-quit level was generally higher at 
baseline and was in a slightly decreasing trend toward the designated quit day. Eventually, 
there was nonsignificant trend for symptoms to continue to decline from Day 7 to Day 14. In 
this regard, although longer duration of follow up is necessary to clearly examine this, it may 
be reasonable to say that a prolonged reduction of arousal/energy level after the quit day might 
be a likely change that could be attributed at least in part from lack of access to the stimulant 
agent (khat) during the post-quit days. 
 
The present study has some limitations given that it is the first study of withdrawal symptoms 
in relation to khat chewing and quit attempts using the method of EMA. First, because of lack 
of availability of the necessary equipment for urinalysis, we relied on participants’ self-reports 
of both khat chewing and cessation and were unable to conduct ongoing urine analysis to 
objectively verify these conditions during pre- and post-quit periods. So, it is possible that 
chewing participants might have reported false abstinence during post quit periods or vice 
versa. Second, because of the large difference in sample size between those who maintained 
continuous abstinence (n = 4) and those who lapsed (n = 55) we were unable to compare the 
difference in course of withdrawal symptoms and clearly examine its contribution to 
abstinence. 
 
Despite these limitations, however, the present study has yielded new insights about the natural 
course of khat withdrawal symptoms over time in the process of a chewing cessation attempt. 
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Our results have demonstrated that the intensity of withdrawal symptoms associated with khat 
abstinence were significantly high, long lasting and meaningfully changed following a quit 
attempt. Given that many of the participants lapsed/relapsed after maintaining 7-day 
abstinence, the present finding has important implications, demonstrating that khat withdrawal 
symptoms may not indeed be mild as inferred by other authors (Kalix, 1988) and that chewers 
may experience significant discomfort following discontinuation, which may increase the risk 
of lapse and relapse. Although comparisons of the withdrawal symptoms between the groups 
to help justify that higher withdrawal leads to lapsing, were not made because of time 
limitations and very small cell size, taking the aforementioned idea into account, our findings 
provide an indication of the influence of withdrawal symptoms in the quitting process. Hence, 
supporting the need for interventions to reduce the presence of withdrawal symptoms or to 
enhance coping with withdrawal symptoms is indispensable to support individuals during the 
period of increased symptoms of dysphoria and to reduce the risk of relapse. 
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SUPLIMENTAL MATERIAL 
Figure S1: Trends of average withdrawal scores over 3 pre-quit and 14 post quit days for 
lapser and non-lapser groups. 
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General Discussion  
In this chapter, the main findings with regard to the research questions are summarized and the 
general conclusions based on the findings of the studies presented in this thesis are described. 
Furthermore, the strengths and limitations of this thesis are considered and suggestions for further 
research in relation to khat use and its multiple consequences are provided. This chapter concludes 
with practical recommendations for concerned stakeholders in Ethiopia: policy makers, 
community members, teachers and students.  
 
Khat (Catha edulis Forsk)  is a natural stimulant plant and has become a public health concern 
due to adverse health risks and increased negative risks for social, financial, and mental health 
problems associated with chronic frequent chewing (Aden, Dimba, Ndolo, & Chindia, 2006; Al-
Motarreb, Al-Habori, & Broadley, 2010; El-Wajeh & Thornhill, 2009; Tulloch, Frayn, Craig, & 
Nicholson, 2012). The population prevalence of past month use has been estimated to be 15.3% 
across the Ethiopian general population, and 7.7% among Ethiopian university students (n=3268) 
(Gebrehanna, Berhane, & Worku, 2014c). Although there are conflicting opinions with regard to 
the existence of dependence in relation to khat use, higher frequency of khat chewing has been 
associated with psychological dependence (Kassim, Islam, & Croucher, 2010).  There is also 
accumulating evidence suggesting the presence of lack of control over use, withdrawal, craving 
and a degree of tolerance related to chronic khat chewing (Cox & Rampes, 2003), which might 
become significant barriers to cessation/reduction of problem drug use (Shoptaw, Kao, 
Heinzerling, & Ling, 2009). However, there has been inadequate systematic study of the nature 
of symptoms of substance use disorder relating to khat use. Likewise, very little has been done 
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with regard to the nature and time course of withdrawal symptoms during motivated quit attempts 
among frequent khat users.  
 
The major aims of the studies in this thesis, therefore, were to examine the presence, structure, 
and external validity of a khat use disorder (KUD) syndrome using current Diagnostic and 
Statistical Manual (DSM-5) criteria, as well as the more clinically familiar DSM-IV dependence 
syndrome; to evaluate the use of the SDS as a potential screening tool for identifying people 
experiencing KUD; to  describe the outcomes of unassisted khat cessation among frequent khat 
users who had motivation to quit and  to examine the time course of development and reduction 
of withdrawal symptoms over the first two weeks of a quit attempt.  Thus, this thesis contributes 
vital insight into the nature of khat use disorder, severity of use dependence and the nature of khat 
withdrawal symptoms, which ultimately would help in designing intervention strategies to handle 
consequences associated with problematic use.  
 
The thesis has four cohesive chapters with distinct but unified objectives that focus on addressing 
potential psychological and health consequences in relation to khat use by examining the nature 
of khat dependence, the outcome of khat cessation attempts and the characteristics of withdrawal 
symptoms and craving during khat abstinence.  The central aim of the studies reported in Chapters 
2 and 3 was to examine the validity of khat use disorder and to determine if a brief screening tool 
could be validly identified to identify people experiencing problems with use. The principal aim 
of the studies presented in Chapters 4 and 5 was to explore how successful are frequent khat users 
in their khat cessation attempts and to examine the trends and characteristics of withdrawal 
symptoms in the quitting process.  The data for Study 1 and 2 were collected by using a survey 
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questionnaire comprised a modified version of AUDADIS-IV for assessment of past year khat 
use disorder and items taken from the Composite International Diagnostic Interview (CIDI) for 
the assessment of withdrawal symptoms. Four hundred current khat chewers (aged 16 and above) 
recruited from khat markets and cafes provided valid answers either to the online version or the 
pencil and paper version of the khat survey. 
 
The first study investigated the presence of khat use disorder syndrome using DSM-5 criteria and 
identified its relationship with increased experience of harms. Khat use disorder was evident 
among the majority (74%) of the participants; 10.5% were categorized as experiencing mild, 
8.8%, moderate and 54.5% severe khat use disorder. Those identified as having khat use disorder 
experienced multiple harms associated with their use. More specifically, use of khat was 
associated with self-reported mental health problems and psychological distress. About a third of 
users reported life-time access to help-seeking largely from friends and relatives. The findings of 
this study support the existence of the substance use disorder syndrome for khat and clearly show 
that people experience problems and the syndrome structure matches with the findings of other 
drugs of dependence such as amphetamine. These provided unique contributions to substance use 
research by using DSM 5 criterion to validate khat use disorder.  
 
The second study assessed the efficacy of the Severity of Dependence Scale (SDS) as a screening 
tool for Khat Use Disorder. The key finding of this study showed that nearly three quarters (73%) 
of the sample experienced some symptoms related to Khat Use Disorder. The SDS for khat had 
excellent discrimination for identifying cases of DSM-5 khat use disorder with an optimal cut-off 
score of 3 or above. Those individuals screening at 3 or greater had substantially higher rates of 
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adverse consequences associated with khat use than those with lower scores. Those that were 
screened positive reported greater frequency and quantity of khat use.  
 
Study 3 and study 4 were quitting studies using Ecological Momentary Assessment (EMA) 
methodologies. Both studies involved the use of electronic diary (ED smart phones) to assess 
withdrawal symptoms, mood, and khat consumption at multiple random occasions of 10 days 
prior to, and 28 days following an attempt to discontinue regular khat chewing (a quit attempt). 
Study 3 involved data collection in a naturalistic setting from 59 daily and near daily khat 
consumers who were motivated and interested in khat abstinence. While 80% reached at least 
seven continuous days of abstinence, 93% lapsed after 11 post-quit days and only 7% maintained 
continuous abstinence for 28 post-quit days. These findings revealed that chewers who have the 
motivation to quit have difficulties maintaining abstinence. This is strongly suggestive that it is 
important to provide clinical attention and relevant support for interested quitters.   
 
Study 4 using the same participants and research devices (Electronic Diary) as the previous study 
collected real time data of khat withdrawal symptoms and cravings. The data was used to evaluate 
the time course of the major withdrawal symptoms and craving during 3 pre-quit and 14 post-quit 
days. All withdrawal symptoms followed similar overall patterns with salient elevations after the 
quit day and curvatures around the first week of post quit period. Most symptoms reached peak 
level around day 7 and many remained elevated at 14 days from quitting. This finding indicates 
that withdrawal symptoms may be heavier than previously suggested (Kalix, 1988) and that 
frequent users may experience significant discomfort following discontinuation, which may 
increase the risk of lapse and relapse.  
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Table 1: A Summary of Major Findings of this Thesis 
Central Aim Findings Conclusions 
Chapter 2 (Study 1) Aim 1: 
To identify cases of khat use 
disorder using DSM criteria.   
Khat use disorder was identified in 
almost three-quarters of this 
general community sample of 
frequent chewers. 
Khat-chewing is legal and culturally acceptable habit in 
Ethiopia. However, there is a clear evidence of the presence 
of khat use disorder among frequent khat chewers. Those 
with KUD were more likely to have issues with increase 
debts due to khat, poor access to treatment and poor 
cognition. 
 
Chapter 2 (Study 1) Aim 2: 
To determine if khat use 
disorder symptoms produce a 
syndrome that performs in 
the same manner as other 
stimulants. 
Confirmatory factor analysis 
demonstrated a good ﬁt of a 
unifactorial model to both DSM-IV 
dependence and DSM-5 substance 
use disorder items 
The khat use disorder symptoms fell into a unifactorial 
structure and the presence of three latent symptom classes 
were consistent with a dimensional process, consistent with 
ﬁndings for amphetamines and other drugs of dependence 
such as cannabis. This provides further support for khat use 
disorder as a valid entity.  
 
Chapter 2 (Study 1) Aim 3: 
To examine if khat use 
disorder performs as a valid 
syndrome, relating to an 
increased experience of 
harms. 
Those with khat use disorder 
experienced significantly higher 
rates of psychological, social and 
cognitive problems than those 
without khat use disorder. 
While khat chewing is a deep-rooted culturally acceptable 
habit and khat itself plays a substantial role in Ethiopia’s 
economy, it is associated with health and public safety 
problems which are not well addressed by legislative 
responses. Help-seeking was uncommon and mainly from 
untrained family/friends rather than from professional 
counseling centers.  
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Chapter 3 (Study 2) Aim 1: 
to determine the 
psychometric properties of 
the Severity of Dependence 
Scale in relation to khat 
Confirmatory factor analysis 
supported a unifactorial structure 
for the scale, and a wide spread of 
scores. 
 
 
The total score on the Severity of Dependence scale can be 
used as a measure of increasing problems associated with 
khat 
 
Chapter 3 (Study 2) Aim 2: 
To determine a useful cutoff 
score on SDS-khat to 
identify people likely to be 
experiencing Khat Use 
Disorder 
 
Cutoff scores of ≥3 and ≥4 were 
determined for identification of 
mild and moderate KUD (Khat Use 
Disorder/dependence), respectively.  
While SDS scores of 3 or above were appropriate for 
screening of cases of likely mild Khat disorder/dependence, 
SDS scores of 4 or greater were appropriate for cases of 
likely moderate Khat use disorder/dependence. SDS score of 
5 or above was appropriate for screening severe KUD. 
Chapter 3 (Study 2) Aim 3: 
To examine if the SDS cut-
off scores validly identify 
group of individuals using 
khat at greater frequency and 
quantity and experiencing 
functional problems.  
Overall the cut-off Scores have 
demonstrated construct validity 
identifying a group with behaviors 
indicative of use dependence with 
higher quantity and frequency of 
use, greater rates of adverse 
consequences and harms associated 
with use. 
The SDS is a 1-minute tool and scores are associated with 
an increased experience of problems associated with khat 
use. The scale should be applied in routine screening 
processes in primary health care. 
Chapter 4 (Study 3) Aim 1: 
To describe the outcomes of 
unassisted khat cessation 
among 60 khat users who 
were motivated to quit 
All except one participant (n=59) 
reached initial abstinence. 
However, the majority (93%) 
lapsed. Very few (7%) could 
maintain continuous abstinence 
throughout the study period.  
Some chewers have problems arising from their use of khat 
and even motivated individuals have difficulties maintaining 
abstinence. Hence, psycho-educational and peer/group 
support approaches might be helpful in reducing substance 
use and improving outcomes of quit attempts among khat 
consumers (Donovan & Wells, 2007)  
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Chapter 4 (Study 3) Aim 2: 
To identify the predictors of 
success during a khat 
cessation attempt 
Only quantity of khat consumed 
was a statistically significant 
predictor of successful abstinence 
for the continuous abstinence 
group. However, there was low 
power for these analyses. 
None of the demographic variables examined but quantity of 
khat consumed predicted successful abstinence for the 
continuous abstinence group, counter-intuitively indicating 
that those in the continuous abstinence group, who usually 
consumed one and half bundle or more of khat per session, 
were more likely to maintain abstinence than those 
consumed one bundle or less of khat in the same group. 
However, due to the small number of individuals 
maintaining abstinence, these findings were preliminary and 
tentative. 
Chapter 5 (Study 4) Aim 1: 
To examine the time course 
of development and 
reduction of withdrawal 
symptoms over a 14-day 
period spent without khat. 
Significant withdrawal symptoms 
were apparent. There were salient 
elevations after the quit day, and 
symptoms peaked around the first 
week after quitting. Craving, 
irritability and restlessness returned 
to baseline ratings after 14 days. 
However, dysphoric symptoms 
(negative affect, depression and 
nervousness), fatigue and 
motivation did not return to return 
to baseline ratings after 14 days.  
 
While craving, restlessness and irritability resolved in 14 
days, dysphoria, fatigue and motivation did not resolve in 14 
days. The influence of withdrawal symptoms is an important 
issue in the quitting process. To help quitting individuals 
during the period of increased symptoms of dysphoria and to 
reduce the risk of relapse, intervention strategies that aim to 
reduce withdrawal symptoms or to enhance coping with 
withdrawal symptoms are vital.  
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Findings with regards to the research questions 
Chapter 2 (Study 1) 
Research question (Aim) 1 Are use disorder symptoms experienced in relation to khat? One 
of the main aims of study 1 was to identify cases of khat use disorder (KUD) syndrome 
using current Diagnostic and Statistical Manual (DSM-5) criteria. Almost three-quarters of 
the sample of frequent chewers had diagnosable khat use disorder. Half of the participants 
surveyed were identified as having severe khat use disorder (KUD) symptoms. Most 
chewers continued using khat despite having knowledge of physical and psychological 
harms from use. As khat chewing is a long process, usually lasting about 5-6 hours (Kalix, 
1988) and mainly being conducted in special places intended for this purpose (khat café), 
most chewers failed to fulﬁl major role obligations in workplaces, schools, within the family 
and in the wider community, which resulted in interpersonal problems. The reported 
experience of prioritization of purchasing khat over basic personal and family needs may 
suggest loss of control over khat chewing (Griffiths et al., 1997; Kalix, 1990; Kassim & 
Croucher, 2006; Luqman & Danowski, 1976; Nencini, Grassi, Botan, Asseyr, & Paroli, 
1989). Most chewers reported continuing to use khat despite interpersonal consequences. 
Previous studies of university and hospital staff in Ethiopia have revealed that half the khat 
consumers surveyed reported leaving work early or missing work entirely to chew khat 
(Gelaw & HaileAmlak, 2004).  
 
In the present study, physical withdrawal symptoms and craving that were severe enough 
to interfere with functioning were apparent in half the participants and almost all had 
experienced at least one clinically signiﬁcant withdrawal symptom. However, in regard to 
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the core requirements for stimulant withdrawal (concurrent dysphoria plus two other 
symptoms, severe enough to cause distress), only 28% of the participants met this criterion.  
Overall, in this sample of the current study, the presence of KUD was evident and khat use 
disorder was substantially linked to a number of behavioural problems.  
 
Research question (Aim) 2: Do these symptoms produce a syndrome that performs in the 
same manner as other stimulants?  
A conﬁrmatory factor analysis was performed to determine if all symptoms relate to a 
shared latent process. Results established a good ﬁt of a unifactorial model to both DSM-
IV dependence and DSM-5 substance use disorder items. This is consistent with the 
syndrome structure for other drugs of dependence. A latent class analyses of DSM-5 khat 
use disorder symptoms determined a 3-class model, identifying three distinctive categories 
of participants in this sample:  A “low-dependent consumers” with low probability of any 
use disorder symptoms (35% of this sample); a second group with khat abuse, physiological 
dependence, use in larger or longer amounts than planned, and continuing use despite 
experiencing physical/psychological harm (33%); and a third group (32%) with high 
probability of endorsement of all DSM-5 symptoms. The identified latent symptom classes 
were consistent with a dimensional process (i.e. severity of dependence), consistent with 
ﬁndings for amphetamines (Saha et al., 2012) and other drugs such as cannabis (Compton, 
Saha, Conway, & Grant, 2009).  
 
Research question (Aim) 3: Does the presence of a khat use disorder syndrome perform 
validly, relating to an increased experience of harms?  
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To address this aim, differences between individuals identified with and without khat use 
disorder (KUD) in terms of variables such as patterns of consumption, mental health and 
ﬁnancial and occupational problems were examined. Those classiﬁed with KUD were 
signiﬁcantly more likely to use khat in larger amounts and more frequently compared to 
non-classified participants, with nearly half of them chewing khat on daily basis. One third 
of those categorized as KUD reported participating in life time ‘help-seeking’ for khat use 
from family members, teachers and friends.  
 
Those identified as having KUD were signiﬁcantly more likely to be male, daily alcohol 
consumers and dependent or daily tobacco smokers. Khat is typically chewed by groups of 
men in culturally sanctioned gatherings (Hoffman & Al'Absi, 2010). Traditionally, khat 
consumption by women is less likely as it is mostly considered socially unacceptable and 
discouraged by family and the community (Beckerleg, 2010). In support of this, recent 
epidemiological work in Ethiopia has demonstrated substantially greater prevalence of past-
month khat-chewing among males than females (Haile & Lakew, 2015). This might have 
put males than females at a higher risk of developing khat dependence (Baer, Kivlahan, 
Blume, McKnight, & Marlatt, 2001).  
 
Recent use of shisha was also more common among the group with KUD, as reported by 
half of individuals in this group. Although the use of other drugs (alcohol, cannabis and 
benzodiazepines) was uncommon, rates were elevated in the group with KUD.  During khat 
chewing, other substances, mainly cigarettes, alcohol and, more recently, shisha are 
commonly consumed. The stimulating effects of cigarettes and shisha may enhance the 
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effect obtained during khat chewing and to reduce its bitter taste, while alcohol is widely 
used to ease the stimulatory effects of khat.  
 
The group with KUD had increased rates of self-reported mental health problems, ﬁnancial 
problems, psychological distress and poorer quality of life. Problems related to academic 
functioning were significantly more common among the group with KUD. This result is 
contrary to the widely reported expectation that khat enhances cognitive ability and 
concentration in academic activity. However, multiple studies of cognition (inhibition of 
response conflicts, monitoring of working memory, mental flexibility) in regular khat 
consumers have demonstrated impaired cognitive function when not actively intoxicated 
(Colzato, Ruiz, van den Wildenberg, & Hommel, 2011; Colzato, Sellaro, Ruiz, Sikora, & 
Hommel, 2013a; Hoffman & Al'absi, 2013a).  Similarly, research results showed that khat 
chewing students have lower mean Cumulative Grade Point Average (CGPA) compared to 
non-chewers.  Comparable negative effects on learning ability have also been found with 
regard to the use of amphetamine among individuals. Therefore, the current study clearly 
indicates that khat use disorder is substantially associated with multilevel adverse health 
and psychological effects and may be related to negative behavioural changes and 
significant impairments of mental health and cognitive functioning such as poor 
concentration and short-term memory.  
  
Regarding financial problems, those in the KUD group were more likely to have made 
excuses about money spent on khat, to have sold their belongings to buy khat, to have 
worried about the amount of money they spent on khat, to have drug related debts and to 
have spent money that meant for other things on khat. In several surveys of khat using 
communities it was reported that time spent chewing as well as amount of money dedicated 
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to khat use were major factors for family breakdowns and conflict between spouses, 
contributing significantly to socioeconomic problems in the community (Omar et al., 2015).  
 
Chapter 3 (Study 2) 
Research question (Aim) 1: Does the Severity of Dependence Scale (SDS) for khat use 
perform in a similar way to existing diagnostic measures of khat use disorders?  
The SDS is a short, easily administered instrument for measuring subjective concerns in 
relation to particular substance use. It is recognized as a robust and adaptable measure of 
screening for dependence across variety of substances of abuse in diverse populations and 
samples. Consistent with findings for the SDS in relation to amphetamine (Topp & Mattick, 
1997) the findings from this study clearly support the use of SDS scale as a screening 
instrument for psychological dependence. Fit indices from confirmatory factor analyses 
were satisfactory indicating good fit of a unifactorial structure of the scale. This means that 
a total sum score on this scale is valid and also that the scale performs in a manner consistent 
with the nature of the dependence syndrome itself in relation to khat. The SDS has 
performed similarly in relation to other stimulant drugs such as methamphetamine (Topp 
& Mattick, 1997)  
 
Research question (Aim) 2: What is an adequate cut-off score for case identification for 
screening purposes?  
ROC analysis demonstrated that the SDS has high diagnostic utility in identifying the 
presence of DSM-5 Khat Use Disorder (KUD) and DSM-IV Khat Dependence. Cut off 
scores of 3 and 4 were identified as the most appropriate for the identification of likely 
cases of DSM-5 mild khat use disorder and DSM-5 moderate khat use disorder, 
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respectively, with good sensitivity and specificity. Moreover, a value of 5 was appropriate 
for screening severe khat use disorder. These cut-off values are similar to those identified 
for screening for ecstasy dependence (Bruno, Gomez, & Matthews, 2011), for amphetamine 
dependence (Topp & Mattick, 1997) and for cannabis dependence in adolescents (Martin, 
Copeland, Gates, & Gilmour, 2006). This spread of cut points on the scale may be useful 
for designing and providing the appropriate and stepped level assessments and 
interventions. While individuals scoring 3 may require brief motivational interviewing and 
interventions (Kaye & Darke, 2002), those scoring 5 or above may be referred to more 
formal assessment and support interventions (Kassim et al., 2010).  
 
Research question (Aim) 3: Are identified SDS cut-off scores valid in terms of identifying 
a group of individuals using khat at greater frequency and quantity, and experiencing 
functional problems?  
Independent logistic regression models using the groups above and below the two SDS cut-
off scores (SDS ≥ 3 for likely Khat Use Disorder and SDS ≥ 5 for likely severe Khat Use 
Disorder) were used to examine the validity of these cut-off values in distinguishing groups 
with greater psychological and related harms. Previous studies indicated that frequent khat 
chewing was associated with anxiety and depression among users and suggested that 
heavier and frequent use was predominantly related to the severity of khat dependency 
(Kassim, Croucher, & al'Absi, 2013a). The current study has demonstrated that that the 
group above these cut-off scores were more commonly male, were using khat frequently 
and in larger volume and were experiencing a significantly greater amount of mental health 
problems, financial problems, cognitive problems and had poorer quality of life than those 
scoring below the cut-off. Male and female chewers had different patterns of khat use as 
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well as symptoms related to dependence. The finding of gender differences in correlates 
and patterns of khat use and dependence is consistent with previous studies (Nakajima & 
al'Absi, 2013). The group with SDS score above the cut-off scores had also engaged in 
greater rates of help-seeking for khat use. These findings are consistent with studies of 
similar substances (Ferri CP, 2000; Gonzalez-Saiz et al., 2008; Gossop et al., 1995; Kaye 
& Darke, 2002; Lawrinson, Copeland, Gerber, & Gilmour, 2007), and support the use of 
the SDS as a brief screening tool for identifying individuals potentially experiencing 
problems related to khat use.  
 
Chapter 4 (Study 3) 
Research question (Aim) 1: What is the outcome/success rate of unassisted quit attempts 
of frequent khat users who were motivated to quit?   
The main aim of this study was to describe the outcome of unassisted khat quitting attempts 
in terms of the proportion of participants reaching four different end points – a proposed 
target quit date (TQD), initial 24-hr abstinence, 7-day abstinence and continuous abstinence 
over 28 days.  The results of this study showed that all except one participant (n=59) reached 
the TQD and achieved 24-hr abstinence around the designated quit day. While 80% of the 
participants achieved, very few (7%) maintained continuous abstinence over 28 days of 
study. Among those who achieved initial abstinence, 93 % lapsed.  
 
The findings suggest that without support for quitting khat, successful abstinence was very 
low, and lapse and relapse rates were high. The study implies that motivation to quit in the 
process of quit attempts may need to be supported with additional interventions to help the 
quitting process succeed.  
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Research question (Aim) 2: What are the demographic variables which are associated with 
success of abstinence?   
In this study three demographic variables (gender, amount of khat used in bundle per session 
and the level of psychological distress as measured by the Kessler Psychological Distress 
Scale (K-10)) were examined as potential factors which might have association with rates 
of successful khat abstinence.  Surprisingly, none of the demographic variables examined 
but quantity of khat consumed, predicted successful abstinence for the continuous 
abstinence group, counter-intuitively indicating that those in the continuous abstinence 
group, who usually consumed one and half bundle or more of khat per session, were likely 
to maintain abstinence than those consumed one bundle or less of khat in the same group. 
Although, this finding is somewhat puzzling, as the direction of the association is opposite 
to what we would expect based on work in other substances of addiction, it may be possible 
that the heavier users in our study were more committed to quitting, or that other factors 
might have explained this discrepancy. However, given the small number of ‘successful’ 
quitters in this study, there was poor power to identify correlates, and as such these findings 
merit replication in larger studies before speculating on the cause of the association. 
 
Chapter 5 (Study 4) 
Research question (Aim) 1: What are the trends and characteristics of the rate of 
withdrawal symptoms over the course of the first two weeks of a quit attempt?  
There were overall significant changes in withdrawal symptoms following khat cessation. 
Most withdrawal symptoms followed overall similar trends, with moderate elevations that 
continued to be greater than baseline even 14 days following quitting. However, craving, 
Chapter 6: General Discussion    160  
 
irritability and restlessness reverted to the levels recorded at baseline. Dysphoric symptoms 
(negative affect, depression and nervousness), fatigue and poor motivation did not return to 
baseline ratings. Peak severity of symptoms was observed between 24hr post-quit and day 
7 indicating the importance of targeting withdrawal symptoms prior and after the designated 
quit days for successful khat cessation.  Understanding the trend, nature and influence of 
withdrawal symptoms over the course of a quitting process is an important issue.  
Intervention strategies that aim at reducing and copping with withdrawal (mainly the 
dysphoric symptoms) are vital in order to help individuals successfully quit and to reduce 
the risk of relapse. 
 
Limitations 
The four studies in this thesis have used effective and well-designed sampling and research 
methods and employed a number of standard and validated measures to gather the necessary 
data from a relatively ‘hard-to-access’ population in which recruiting frequently consuming 
individuals for inclusion in the studies were challenging tasks.  However, there were a 
number of limitations which might have potentially affected the results to some extent: The 
first study which attempted to examine khat use disorder as a valid diagnostic entity has the 
following important imitations: Firstly, a self-report survey (e. g. AUDADIS-IV) was used 
to collect diagnostic data rather than the gold standard of clinical diagnosis. In addition, 
survey responses may also be susceptible to social desirability and recall bias. However, we 
believe that the influence might be low since in multiple studies the AUDADIS-IV has 
demonstrated good to excellent reliability and validity (Chatterji et al., 1997; Grant, 
Harford, Dawson, Chou, & Pickering, 1995; Hasin, Carpenter, McCloud, Smith, & Grant, 
1997) for the identification of illicit drug use disorders in similar applications to the current 
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study. Moreover, we used anonymous self-administered surveys which provided full 
anonymity to all participants. As such, we believe that the response biases have been kept 
to minimum.  
 
Secondly, since participants were all drawn from a defined geographical region (Adama, 
Ethiopia) and recruited using convenience sampling, primarily through khat cafes, it is clear 
that this has definitely increased the likelihood of the participation of frequent chewers who 
were at elevated risk of khat use disorder with greater base rates of symptoms identified.  
As such, the patterns of dependence identified here are clearly not reflective of rates in the 
general population, however, for the aims of the current study, where the presence and 
relationships between dependence symptoms was critical, a sample with elevated rates of 
problems was clearly appropriate for the aims of the study.  
 
Thirdly, given the social context of khat use, polysubstance use, especially of cigarettes and 
shisha, is probably unavoidable. As a result, as polysubstance use often has the potential to 
contribute to the symptoms identified, there could be some potential interpretive problems 
arising from the presence of polysubstance use. However, the occurrence of a substantial 
inflating effect is unlikely, given the low proportion of frequent polysubstance use reported, 
the low levels of dependence and the finding that increased rates of adverse effects 
remained the same after controlling for polysubstance use. 
 
The use of purposive sampling which increased the probability of recruiting frequent khat 
chewers could be considered as a limitation of study 2. However, as the ultimate objective 
of this work was to determine the efficacy of the severity of dependence scale (SDS) in 
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screening for khat use disorder, the use of this sampling method was appropriate in order 
to successfully achieve the intended goal.  
 
Study 3 which aimed at describing the outcomes of an unassisted quit attempts made by 
motivated frequent khat users has also some limitations. First, due to the pilot nature of the 
study this was conducted on only a small sample of university students who used khat 
regularly, and results may not be generalizable to a larger population.  Secondly, the lack 
of urine screening for verification of abstinence and relying merely on self-reported 
abstinence was also a limitation. However, the application of prospective recording of 
participants’ responses using electronic diaries, we believe, has substantially increased the 
reliability of the responses obtained. Thirdly, we used outcome variables selected from 
related smoking cessation literature. Theses variables might not be perfect fit for khat, given 
the marked difference between the process of khat chewing and tobacco smoking. Finally, 
the study procedure had required the study participants set their quit dates, which might 
have acted as assistance in terms of aiding their quit attempts. We cannot absolutely rule 
out the chance that our EMA monitoring procedures could have influenced the outcomes 
observed. However, considering the scarcity of research findings in this area the current 
findings undeniably shed light on this matter of substantial concern.  
 
General conclusion and future studies 
The global estimate of khat use is reported to be 20 million or higher, making it a public 
health concern nationally and internationally (Feyissa & Kelly, 2008). In Ethiopia, khat is 
consumed largely for recreational purposes and chewing of khat is a deep rooted socio-
cultural tradition (Kalix & Braenden, 1985). The prevalence of past month khat use is 
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estimated to be 15 % (Gebrehanna et al., 2014c). Khat chewing brings about a number of 
adverse health impacts that may include behavioral and mental health problems (Kassim, 
Croucher, & al'Absi, 2013b). Despite the health-related consequences identified in some 
studies, khat chewing is still a common practice among youths and adults in Ethiopia.  
While society’s knowledge, in general and chewers’ awareness, in particular, of the 
problems and adverse psychological effects associated with khat use have been increasing, 
it seems that there is still a need to further people’s understanding of clinically defined khat 
use disorders and ways of screening for khat use problems, which can help design effective 
strategies to minimize the potential harms and multifaceted consequences.  Public health 
interventions need to aim at the increasing trend of khat use among the general population 
(primary prevention), and in particular to address the issue of problematic khat use (tertiary 
prevention) among youth and adult community members in Ethiopia 
 
The research reports presented in this thesis have enhanced the current understanding of the 
existence and nature of khat use disorders and the withdrawal profile of khat. The research 
has also answered key questions about khat chewing practices and potential adverse effects. 
The popularity of khat chewing and the escalation of the frequency of use among students 
and adults in Ethiopia were the important factors underlying the development of these 
studies. Although the survey studies were not restricted to university students, the relatively 
high prevalence of student chewers (Gebrehanna et al., 2014c) and the concentrations of 
khat supplies around university campus (Gebrehanna, Berhane, & Worku, 2014a), suggest 
that adopting comprehensive prevention strategies for substance use in colleges and 
universities may be warranted. This must extend beyond the simple prevention of use on 
campus grounds to use in the wider associated community. Khat supplies and khat chewing 
Chapter 6: General Discussion    164  
 
facilities in the community around university campuses have been identified as liability 
factors for the spread of khat chewing, and increasing the potential for dependence among 
students (Gebrehanna, Berhane, & Worku, 2014b) 
 
According to the findings of this research study, most of the withdrawal symptoms reach 
their peak at around day 7 after quitting and the majority of them, specifically dysphoria and 
fatigue, do not resolve or persist well after the first week of use discontinuation. Hence, the 
time frame for experience of withdrawal symptoms following discontinuation of khat 
chewing should be communicated to those considering quitting, and effective treatment 
options (e.g. behavioural resources and social support) should be developed in order to better 
support sustained cessation.  
 
In the current study more than 50% of khat chewers endorsed’ interference with role 
obligations’ as one of khat use disorder symptoms.  This supports the reports of other studies 
which suggested that khat chewing is not only interfering with full engagement of workers 
in work places but also is a barrier to gaining employment, due to considerable amount of 
time is spent in chewing and recovering from its after-effects (Nabuzoka and Badhadhe, 
2000). Hence, it would be reasonable to suggest that the Ministry of Labour and Social 
Affairs should take appropriate measures to alleviate these. 
 
It seems obvious that khat is socially, culturally and financially important crop in Ethiopia. 
It is one of the major cash crops well known for generating substantial income to the farmers 
and foreign currency earnings to the government (Amare Getahun & Krikorian, 1973; 
Lemessa, 2001). Therefore, considering the potential negative impact that chewing exerts 
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directly on the end users and on productivity of the work force, from policy perspectives, it 
may be reasonable to levy sales and use this for education and support through establishing 
primary care services and providing sspecific training to drug and alcohol service 
practitioners. This would increase the capacity of practitioners to deliver effective services 
that help increase community awareness of khat chewing and its multiple harms. 
 
Future directions  
The potential for further studies in this area remains very high, as research involving khat 
consumption involves human subjects and as it is relatively new area of research. One of 
the most important findings of the present study is that it has provided new understandings 
about the natural history of the course of khat withdrawal symptoms following cessation of 
regular khat use. The results suggest that understanding how withdrawal symptoms/craving 
develop and change over time and developing interventions to reduce these may help 
support successful khat cessation. However, the contributions of khat related environments 
in the development of withdrawal and risk of relapse were not studied. There is substantial 
evidence for the association of cue-induced cravings with the success of attempts to 
discontinue drug use (Ferguson & Shiffman, 2009). Attentional bias for drug-related stimuli 
in drug using individuals is likely to induce craving, exacerbate withdrawal and ultimately 
to relapse (Field & Cox, 2008; Field, Munafo, & Franken, 2009; Franken, 2003; Franken, 
Kroon, Wiers, & Jansen, 2000; Sayette et al., 2003; Waters et al., 2003). Therefore, future 
study may need to focus on investigating these potential factors using the methods of EMA 
amongst other diverse samples. 
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The current study has also identified a few self-reported cognitive problems such as trouble 
with short term memory and difficulty sustaining concentration among individuals 
classified as having khat use disorder. Previous findings suggested that impairments in the 
inhibition of response conﬂicts, monitoring of working memory and mental ﬂexibility have 
been evident in abstinent khat consumers (Colzato et al., 2011; Colzato, Sellaro, Ruiz, 
Sikora, & Hommel, 2013b). Hence, future research work may need to focus on a well-
designed human experimental study using psychological and neuropsychological measures 
for investigating the acute dose-related effects of khat use on a variety of cognitive 
functions (Hoffman & al'Absi, 2013b). This will assist in determining any causation in the 
cognitive problems associated with khat use identified in these studies. Similarly, a better 
understanding of the scope and range of residual cognitive impairments, and the time course 
of their reversibility, following use of khat is important. These may require large scale 
prospective longitudinal studies.  
 
In conclusion, Khat brings great financial benefit and many people may chew without 
adverse problems. The socio-cultural aspect of khat chewing in terms of enhancing 
relationships with friends and peers is something to appreciate. However, some people do 
clearly experience significant problems in association with their khat use. Despite the 
prevailing view of khat as a mild stimulant, regular khat use is associated with significant 
negative impacts on mental health, emotional, relational and vocational roles. Hence, 
clearly there needs to be greater awareness of the risks and benefits in association to khat 
use, and it is a public health imperative for governments of countries where khat use is legal 
to implement demand reduction programs in addition to increasing supports for existing 
consumers by educating, training, and developing health and community services 
responsible for assisting those experiencing adverse consequences of khat use.  
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Appendices: A - T 
Following is a copy of the study advertisements, information sheet, consent form 
and survey questionnaires presented to participants in Ethiopia in 2013 - 2014 
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Appendix A: Khat use and experience Survey Questionnaire. 
 
General information 
How old are you? 
Please write your answer here: _______________ 
  
Do you live in Ethiopia? 
Please choose only one of the followings 
• Yes  
• No  
Have you chewed any khat over the last twelve months? * 
Please choose only one of the followings: 
• Yes  
• No  
 
Thank you for your interest in this research. This study is being conducted in partial fulfilment of a PhD 
degree for Samson Duresso under the supervision of Dr. Raimondo Bruno at the University of Tasmania. 
Demographic information 
What is your gender? * 
Please choose only one of the followings: 
• Female  
• Male  
Are you a University student? 
Please choose only one of the followings: 
• Yes  
• No  
If yes, what is your year of higher education? 
Please choose only one of the followings: 
• Year I  
• Year II  
• Year III  
• Year IV  
• Year V  
• Year VI  
• Other  
 If you are not a student, which one best describes your employment status?  
Please choose only one of the followings: 
• Unemployed  
• Self-employed  
• Employed for wages or payments  
• Looking for work  
• Solely engaged in home duties  
• Retired or a pension  
• Volunteer or charity work  
• Unable to work  
• Other  
What is the highest year of education you have completed?  
Please choose only one of the followings: 
• I did not go to school  
• Grade 6 or below  
• Grade 7 or equivalent  
• Grade 8 or equivalent  
• Grade 9 or equivalent  
• Grade 10 or equivalent  
• Grade 11 or equivalent  
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• Grade 12 or equivalent  
• Diploma  
• 1st Degree  
• 2nd degree and above  
• Other  
 What is the highest qualification that you have achieved?  
Please choose only one of the followings: 
• Certificate  
• TVET certificate (Level I& II)  
• New answer option  
• Diploma  
• Advanced Diploma  
• Bachelor’s degree  
• Higher than a bachelor’s degree  
• Other  
 The next questions ask about your ETHINICITY. The Ethnic groups are listed in Alphabetical order. 
Please, select and mark the ethnic group that you belong to 
Which one is your Ethnic group?  
* 
Please choose only one of the followings: 
• Afar  
• Agew  
• Amhara  
• Benshangul  
• Harari  
• Oromo  
• Gambella  
• Somali  
• SSPN  
• Tigrai  
• Other  
 The next questions ask about your PARENTS. If you were raised mostly by foster parents, step-parents or 
others, answer for them. For example, if you have both a stepfather and a natural father, answer for the 
one who was the most important in raising you. What is the highest level of schooling your father 
attained? * 
Please choose only one of the followings: 
• Completed primary school or less  
• Some secondary school  
• Completed secondary school  
• Some college or university  
• Completed college or university  
• Don't know or does not apply  
• Other  
 What is the highest level of schooling your mother attained? 
Please choose only one of the followings: 
• Completed primary school or less  
• Some secondary school  
• Completed secondary school  
• Some college or university  
• Completed college or university  
• Don't know or does not apply  
• Other  
 Which of the following people live in the same household with you? 
Please choose only one of the followings: 
• I live alone  
• Father  
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• Stepfather  
• Mother  
• Stepmother  
• Brother(s) and/or sister(s)  
• Grandparent(s)  
• Other relative(s)  
• Non-relative(s)  
• Other  
 Khat Use and Dependency 
The following questions ask about your khat use 
In the last 12 months, how often did you chew khat? * 
Please choose only one of the followings: 
• Every day  
• 3 times or more a week  
• Twice a week  
• Once a week  
• Every few months  
• Once or twice a year  
• Other  
 On a typical day of khat chewing how much of the day do you feel excited or stoned? * 
Please choose only one of the followings: 
• 0 hours  
• 1 to 2 hours  
• 3 to 4 hours  
• 5 to 6 hours  
• 7 to 8 hours  
• 9 or more hours  
• Other  
 Which variety of khat have you often chewed during the past twelve months? 
Please choose the appropriate response from: 
(1 = Not at all; 2 = rarely; 3 = sometimes; 4 = often; 5 = most often) * 
Please choose the appropriate response for each item: 
  1     2     3     4     5 
Wondo/Beleche  
     
Gemeto  
     
Bahirdar  
     
Gelemso  
     
Meticho 
     
Awoday  
     
Hirna  
     
Metakesha 
     
 
It is assumed that the strength and stimulating effects of khat vary among the different varieties. Based on 
your experience and subjective evaluation, please, rate the strength of the khat variety you have ever used 
in the past twelve months: 
Please choose the appropriate response from: 
(1 = the least strong; 2 = fairly strong; 3 = strong; 4 = very strong; 5 = extremely strong) * 
Please choose the appropriate response for each item: 
  1     2     3     4     5 
Wondo/Beleche 
     
Gemeto 
     
Gelemso 
     
Bahirdar 
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  1     2     3     4     5 
Meticho 
     
Hirna 
     
Awoday 
     
Metakesha 
     
How often in the past 12 months …………? 
Please choose the appropriate response from: 
(1 = Never, 2= less than a month, 3 = monthly, 4 = weekly, 5 = daily or almost daily) * 
  1     2     3     4     5 
………. have you had a problem with your memory or concentration after using 
khat?      
………. did you fail to do what was normally expected from you because of using 
khat?      
………. did you find yourself unable to stop using khat once you had started? 
     
………. how often have you used khat in situations that could physically 
hazardous, such as driving, operating machinery, or caring for children?      
………. have you devoted a great deal of your time to getting, using, or recovering 
from khat?      
Have you ever thought about cutting down, or stopping, your use of khat? * 
Please choose only one of the followings: 
• Never  
• Yes, but not in the past 12 months  
• Other  
  
Frequency of Khat Use 
The following questions are based on the frequency of your khat use 
How old where you the first time you used khat? 
Please, enter your age in Years* 
Please write your answer here: ____________ 
  
How did you typically access khat over last 12 months? 
* 
Please choose only one of the followings: 
• Purchased from khat shop  
• Purchased from open air khat market  
• Purchased from khat shop near the school  
• Have been given it by friends  
• Have my own supply  
• Other  
How much did you spend for khat over the last four weeks? * 
Please choose only one of the followings: 
• Less than 50 Birr  
• 50 - 100 Birr  
• 100 - 150 Birr  
• 150 - 200 Birr  
• 200 - 300 Birr  
• Over 300 Birr 
• Other  
  
On a typical day when you chew khat, on average, how much (in grams or Bundles) of khat leaves do you 
normally have? * 
Please choose only one of the followings: 
• 50gms /half a bundle or less  
• 50gms - 100gms/half a bundle - quarter to a bundle  
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• 100gms - 150gms/ quarter to a bundle - a bundle  
• 150gms - 200gms / one bundle - a bundle and half  
• 250gms or more/ 2 bundles or more  
• Other  
  
Over the past 12 months, have you tended to chew more on your own than you use to? 
Please choose the appropriate response* 
Please choose only one of the followings: 
• Yes  
• No  
How khat affected your finances in the last 12 months? 
Please choose the appropriate response (Yes or No) for the following items. * 
Please choose the appropriate response for each item: 
  Yes No 
Have you spent money on khat that was meant for other things (e.g., rent, 
photocopying, food etc.) on khat?    
Have you sold any of your belonging to buy khat? 
  
Have you found yourself worried about the amount of money you have 
been spending on khat?   
Have you had any drug related debts? 
  
Did you find yourself making excuses about money? 
  
 
Have you ever accessed services for your khat use (e.g. counselling)? 
Please choose the appropriate response* 
Please choose only one of the followings: 
• Yes  
• No  
 
If Yes, what is the main type of drug treatment you have accessed? * 
Please choose only one of the followings: 
• Not in treatment  
• Family treatment  
• Rehabilitation Centre  
• Community support center  
• University counselling/psychiatric Centre  
• public psychiatric centre  
• Other  
DSM - V 
The following questions about your khat use over the last 12 months. 
Please, choose the appropriate response for each item: 
In the last 12 months did you………* 
Please choose the appropriate response for each item: 
  Yes No 
………. Have job or school troubles as a result of your khat use - like missing too 
much work, not doing your work well, being demoted or losing a job, or being 
suspended, expelled, or dropping out of school? 
  
………. Have a period when your khat use (or recovering from your khat use) often 
interfered with taking care of your study or home or family?   
………. Accidently injured yourself while under the influence of khat, for example, 
have a bad fall or cut yourself badly, get hurt in a traffic accident, or anything like 
that? 
  
………. More than once driven a car, motorcycle, truck, boat or other vehicle when 
you were under the influence of khat?   
………. Find yourself under the influence of khat or feeling its after-effects in 
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  Yes No 
situations that increased your chances of getting hurt “like swimming, using 
machinery, or walking in a dangerous area or around heavy traffic? 
………. Get arrested, get held at a police station, or have any other legal problems 
because of your khat use?   
………. Have arguments with your spouse, boyfriend/girlfriend, family, friends or 
teachers as a result of your khat use?   
………. Get into physical fights while under the influence of khat? 
  
In the last 12 months did you………. 
Continue to use khat even though you knew it was causing you trouble with your family or friends? * 
Please choose only one of the followings: 
• Yes  
• No  
 
Now I’m going to ask you about some OTHER experiences you may have had with khat. 
 
In the last 12 months did you………... 
………. More than once want to stop or cut down on using khat? * 
Please choose only one of the followings: 
• Yes  
• No  
 
In the last 12 months did you………... 
………. More than once try to stop or cut down using khat but found you couldn’t do it? * 
Please choose only one of the followings: 
• Yes  
• No  
 
DSM-V4 
OTHER experiences you may have had with khat.  
Now I’m going to ask you about some OTHER experiences you may have had with khat.  
In the last 12 months did you………...* 
Please choose the appropriate response for each item: 
  Yes No 
….. Often use khat in larger amounts or for a much longer period than you meant to? 
  
….. Often use khat in large amounts or for a much longer period than you meant to? 
  
….. Have a period of a month or more when you spent a lot of time using khat or getting 
over its bad after-effects?   
….. Have a period of a month or more when you spent a lot of time making sure you 
always had enough khat available?   
….. Find that your usual amount of khat had much less effect on you than it once did? 
  
….. Find that you had to use much more khat than you once did to get the effect you 
wanted?  
  
….. Give up or cut down on activities that were important to you in order to use khat like 
work, school, or associating with friends or relatives?   
….. Give up or cut down on activities that you were interested in or that gave you 
pleasure in order to use khat?   
(Now I’m going to ask you about some OTHER experiences you may have had with khat. In the last 12 
months did you…....  
……give up or cut down on activities that you were interested in or that gave you pleasure in order to use 
khat?) 
Please choose only one of the followings: 
• Yes  
• No  
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Now I’m going to ask you about some OTHER experiences you may have had with khat. 
In the last 12 months did you……* 
Please choose the appropriate response for each item: 
  Yes No 
….. Continue to use khat even though it was making you feel depressed, uninterested in 
things, or suspicious and distrustful of other people?   
….Continue to use khat even though you knew it was causing you a health problem or 
making a health problem worse?  
  
In the last 12 months, did you have any of the following bad aftereffects when the effects of khat were 
wearing off? This includes the morning after using it or in the first few days after stopping or cutting 
down on it. For example, did you.... 
* 
Please choose the appropriate response for each item: 
  No 
Yes, within 
24 hours of 
the (desired) 
effects of 
khat wearing 
off 
Yes, more 
than 1 day 
after the 
(desired) 
effects of 
khat wearing 
off 
No, was not 
uncomfortable, 
upsetting or 
cause problems, 
like at work or 
school or with 
family or 
friends 
Yes, was 
uncomfortable, 
upsetting or 
cause problems, 
like at work or 
school or with 
family or 
friends 
….. Sleep more than usual? 
     
….. Feel weak or tired? (not due to 
insufficient sleep or rest)      
….. Feel depressed? 
     
….. Eat more than usual or gain 
weight? (increase in appetite)      
….. Feel anxious or nervous? 
     
….. Become so restless you fidgeted 
paced or couldn’t sit still?      
….. Move or talk much more slowly 
than usual?       
….. Have unpleasant dreams that 
often seemed real?       
….. See, feel or hear things that 
weren’t really there?      
….. Have trouble falling sleep or 
staying asleep?      
….. Have very bad headaches? 
     
….. Become irritated more easily 
than usual?      
….. Eat less than usual or lose 
weight? (appetite decrease)      
….. Have trouble concentrating? 
     
….. have a strong desire or craving 
for more khat       
 
….. was there ever a time where two or more of these problems occurred together for two days or more 
because of stopping, cutting down on, or going without khat? * 
Please choose only one of the followings: 
• Yes  
• No  
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In the last 12 months did you…... 
….. did you take more khat or a similar drug to get over or avoid any of these bad aftereffects? * 
Please choose only one of the followings: 
• Yes  
• No  
 
Khat Expectancy and Reason 
The following questions ask about what impact Khat has on you. Please indicate how true each statement 
is of you  
Please, choose the appropriate response for each item from: 
(1 = strongly disagree, 2 = disagree, 3 =Â neutral, 4 = agree, 5 = strongly agree) * 
 
  1     2     3     4     5 
I have better ideas when I am chewing khat 
     
I have better concentrations when I am chewing khat 
     
Little things annoy me less when I am chewing khat 
     
I have more self-confidence when chewing khat 
     
I chew khat to get full enjoyment out of life 
     
Chewing khat makes me passive 
     
When I chew khat I withdraw from others  
     
When I chew khat it is easier to express my feelings 
     
Chewing khat makes me more easily irritated 
     
When I chew khat my mood feels flat 
     
Chewing khat makes me happy 
     
Chewing khat makes me feel insecure 
     
When I chew khat I feel panicky 
     
When I chew khat I feel excited  
     
When I chew khat I feel jumpier and more agitated  
     
Chewing khat makes me lose sexual interest 
     
When I chew khat I have more energy 
     
When I chew khat I do things that I do not really mean to do  
     
Chewing khat makes me feel insecure 
     
I become clumsier when I chew khat 
     
When I chew khat I tend to avoid sex 
     
When I chew khat I can speak my mind 
     
Chewing khat makes me talk more 
     
When I chew khat I tend to avoid people for fear of embarrassment 
     
Chewing khat helps me feel normal again 
     
When I chew khat I become less shy 
     
When I chew khat I will be more easily irritated 
     
I tend to adopt who cares attitude when I chew khat 
     
When I chew khat I become less motivated 
     
Chewing khat makes me serious 
     
Chewing khat increases my tension 
     
I feel restless when I chew khat 
     
When I chew khat I become more aware of what I say and what I do 
     
Chewing khat ultimately makes me confused 
     
When I chew khat I become more sexually responsive 
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  1     2     3     4     5 
Chewing khat makes me outgoing and friendly 
     
I become more worried about what others say about me when I chew khat 
     
 
The following questions ask about the reasons why you smoke khat. Please mark from 1(not true of me) to 
10 (very true of me) how true each statement is for you* 
Please choose the appropriate response for each item: 
  1 2 3 4 5 6 7 8 9 10 
I use khat because I believe that I am addicted  
          
I use khat as it reduces the anxiety and/or the depression I experience  
          
I use khat because I am bored and want to feel excited alert and 
euphoric            
I use khat to enhance my cognitive skills 
          
I use khat to help me cope 
          
I use khat for entertainment 
          
I use khat as it is a habit 
          
I use khat as it helps me to interact with others 
          
I use khat as it helps me to increase my thinking and reasoning  
          
I use khat as I enjoy how it changes my perception 
          
I use khat as it enhances my concentration on my study  
          
I use khat as I prefer it to everything else 
          
I use khat to avoid experiencing psychotic symptoms  
          
I use khat as it makes me more alert or energetic 
          
I use khat as it helps me escape from my problems and worries 
          
I use khat, so I do not have to interact with others 
          
I use khat because I want to use other drugs and alcohol 
          
I use khat because I want to achieve better  
          
I use khat because I want to feel more confident and enthusiastic 
          
I use khat because I want to stay awake or alert 
          
I use khat because I want to stay motivated for my work or study 
          
 
Severity of Dependence (SDS - Khat)  
In the last 12 months…. 
Please, choose the appropriate response for each item from: 
(1 = Never or almost never, 2 = Sometimes, 3 = rarely, 4 = Often 5 = 
Always or nearly always) * 
 
          
 
  1     2     3     4     5 
Did you ever think your use of khat was out of control? 
     
Did the prospect of missing khat make you very anxious or worried? 
     
Do you worry about your khat use? 
     
Do you wish you could stop using khat? 
     
 
How difficult would you find it to stop or go without? * 
Please choose only one of the followings: 
• Not difficult  
• Quite difficult  
• Very difficult  
• Impossible  
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• Other  
  
K - 10 
Please indicate what best represents how you have been over the past four weeks. 
During the last four weeks about how often did you………. 
Please, choose the appropriate response for each item from: 
(1 = none of the time, 2 = A little of the time, 3 = some of the time, 4 = Most of the time, 5 = All of the 
time) * 
  1     2     3     4     5 
……feel fatigued out for no good reason? 
     
……feel nervous? 
     
……feel so anxious that nothing could calm you down? 
     
……feel hopeless? 
     
……feel restless or fidgety? 
     
……feel so restless you could not sit still? 
     
……feel depressed? 
     
……feel that everything was an effort? 
     
……feel so sad that nothing could cheer you up? 
     
……feel worthless? 
     
 
 
The following questions ask about things in the last 12 months. 
In the last 12 months …… 
Please, choose the appropriate response (Yes or No) for each item: * 
  Yes No 
……have you ever had any mental health problems, such as depression, anxiety, or 
psychosis? This could include any issues you haven’t spoken to a health professional 
about. 
  
……have you attended an appointment with a health professional for mental health 
problems?   
……have you been prescribed any medication for a mental health problem? 
  
 
What was the mental health problem(s)? * 
Please choose all that apply: 
• Depression  
• Phobia  
• Posttraumatic stress disorder  
• Other psychosis  
• Other:  
  
SF - 12 
The following questions ask about your health. In general, would you say your health is: * 
Please choose only one of the followings: 
• Excellent  
• Very good  
• Good  
• Fair  
• Poor  
 
The following questions ask about your activities you might do during a typical day. 
Does your health limit you in these activities? * 
Please choose the appropriate response for each item: 
  Yes No 
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  Yes No 
Moderate activities such as moving a table, cleaning a house, playing football 
  
Climbing several stairs 
  
 
During the past 4 weeks, have you had any of the following problems with your work, study or other 
regular activities as a result of your physical health? * 
Please choose the appropriate response for each item: 
  Yes No 
Accomplished less than you would like 
  
Were limited in the kind of work or other regular daily activities 
  
 
 
 
During the past 4 weeks, have you had any of the following problems with your work, study or other 
regular activities as a result of your emotional problems (such as feeling depressed or anxious)? 
 
Please, choose the appropriate response (Yes or No) for each item: * 
 
  Yes No 
Accomplished less than you would like? 
  
Did work or other regular daily activities less carefully than usual? 
  
 
 
During the past 4 weeks.......... 
Please, choose the appropriate response for each item from: 
(1 = Not at all, 2 = A little bit, 3 = moderately, 4 = Quite a bit, 5 = extremely) * 
 
  1     2     3     4     5 
How much did pain interfere with your normal work (including both work outside 
the home and housework)?      
 
The next questions are about how you feel and how things have been with you during the past 12 months. 
As you read each question, please indicate one answer that comes closest to the way you have been 
feeling. 
How much of the time during the past 4 weeks ………? 
Please, choose the appropriate response for each item from: 
(1 = none of the time, 2 = A little bit of the time, 3 = some of the time, 4 = A good bit of the time, 5 = All 
the time) * 
  1     2     3     4     5 
……have you felt calm and peaceful? 
     
……did you have a lot of energy? 
     
……have you felt downhearted and blue? 
     
 
During the past 4 weeks, how much of the time has your physical health or emotional problems interfered 
with your social activities (like visiting friends, relatives, etc.)? 
(1 = none of the time, 2 = A little bit of the time, 3 = some of the time, 4 = Most of the time, 5 = All of the 
time) * 
Please choose only one of the followings: 
• 1  
• 2  
• 3  
• 4  
• 5  
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OTHER DRUGS 
The following questions are interested in your experience with drugs other than khat. 
Of the drugs listed below, which (if any) was the FIRST one you ever tried in in the past twelve months? * 
Please choose only one of the followings: 
• I've never tried any of the substances listed below  
• Tranquillizers or sedatives (without a doctor or medical worker telling you to do so)  
• Marijuana or hashish  
• Khat  
• Shisha  
• tobacco  
• I don't know what it was  
• Other  
  
In the past 12 months, of the drugs listed below, which (if any) was the FIRST one you tried? * 
Please choose only one of the followings: 
• I've never tried any of the substances listed below  
• Tranquillizers or sedatives (without a doctor or medical worker telling you to do so Phobia)  
• New answer option  
• Marijuana or hashish  
• Khat  
• Shisha  
• tobacco  
• I don't know what it was  
• Other  
  
How often do you have a drink containing alcohol? * 
Please choose only one of the followings: 
• Never  
• Monthly or less  
• 2 to 4 times a month  
• 2 to 3 times a week  
• 4 or more times a week  
• Daily or nearly daily  
• Other  
  
How many drinks (in Bottles/glasses of drinks) containing alcohol do you have on a typical day when you 
are drinking? * 
Please choose only one of the followings: 
• 1 to 2  
• 3 to 4  
• 5 to 6  
• 7 to 9  
• 10 or more  
• Other  
 
How often do you have six or more drinks (in Bottles/glasses) containing alcohol on one occasion? * 
Please choose only one of the followings: 
• Never  
• Monthly or less  
• 2 to 4 times a month  
• 2 to 3 times a week  
• 4 or more times a week  
• Daily or nearly daily  
• Other  
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Do you smoke tobacco? * 
Please choose only one of the followings: 
• Yes  
• Yes, only when I chew khat  
• No  
• Other  
 How often do you smoke tobacco? * 
Please choose only one of the followings: 
• Never  
• Monthly or less  
• 2 to 4 times a month  
• 2 to 3 times a week  
• 4 or more times a week  
• Daily or nearly daily  
• Other  
 Do you smoke shisha? * 
Please choose only one of the followings: 
• Yes  
• Yes, when I chew khat  
• No  
• Other  
 How often do you smoke shisha? * 
Please choose only one of the followings: 
• Never  
• Monthly or less  
• 2 to 4 times a month  
• 2 to 3 times a week  
• 4 or more times a week  
• Daily or nearly daily  
• Other  
 Have you used tranquillizers and/or sleeping pills (e.g. benzos, valium, alprazolam, temazepam) for non-
medical purposes in the last 12 months? * 
Please choose only one of the followings: 
• Yes  
• Yes, when I chew Khat  
• No  
• Other  
 In the last 12 months, how often did you use tranquillisers and/or sleeping pills for non-medical 
purposes? * 
Please choose only one of the followings: 
• Never  
• Monthly or les  
• 2 to 4 times a month  
• 2 to 3 times a week  
• 4 or more times a wee  
• Daily or nearly daily  
• Other  
 Have you used inhalants (e.g. glue) in the last 12 months? * 
Please choose only one of the followings: 
• Yes  
• No  
In the last 12 months, how often did you use inhalants? * 
Please choose only one of the followings: 
• Never  
• Monthly or less  
• 2 to 4 times a month  
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• 2 to 3 times a week  
• 4 or more times a week  
• Daily or nearly daily  
• Other  
 Fagerstrom Nicotine Dependence Scale (FTND) 
How soon after you wake up do you smoke your first cigarette? * 
Please choose only one of the followings: 
• Within 5 minutes  
• 6-30 minutes  
• 31-60 minutes  
• After 60 minutes  
Do you find it difficult to refrain from smoking in places where it is forbidden for example at church, at 
the library, in the cinema, and so on? * 
Please choose only one of the followings: 
• Yes  
• No  
Which cigarette would you hate to give up? * 
Please choose only one of the followings: 
• The first one in the morning  
• All others  
How many cigarettes do you smoke a day? * 
Please choose only one of the followings: 
• 10 or less  
• 11-20  
• 21-30  
• 31 or more  
Do you smoke more during the first two hours than during the rest of the day? * 
Please choose only one of the followings: 
• Yes  
• No  
Do you smoke if you are so ill that you are in bed most of the day? * 
Please choose only one of the followings: 
• Yes  
• No  
Personal Wellbeing Index (PWI) 
The following questions ask how satisfied you feel, on a scale from zero to 10. Zero means you feel 
completely dissatisfied and 10 means you feel completely satisfied. The middle of the scale is 5, which 
means you feel neutral, neither satisfied nor dissatisfied  
Thinking about your own life and personal circumstances, how satisfied are you…… 
Please, choose the appropriate response for each item from: 
Â (1 = completely dissatisfied, 2 ... 3...... 4.... 5 = Neutral, 6.... 7 ....8....9.... 10 = completely 
satisfied) * 
  1 2 3 4 5 6 7 8 9 10 
……with your personal relationships? 
          
……with your standard of living?  
          
……with your life as a whole?  
          
……with your personal relationships?  
          
……with your health?  
          
……with what you are achieving in life?  
          
……with how safe you feel?  
          
……with feeling part of your community?  
          
……with your future security?  
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Cognitive and Academic experiences (CGAC) 
The following questions ask about your learning and academic experiences, on a scale from zero to 3. 
Zero means that experience happens to you none of the times and 4 means that experience happens all of 
the times describes you very well  
During the last 12 months……Please, choose the appropriate response for each item from: 
(0 - doesn't describe me at all, 1 - describes me somewhat, 2 - describes me pretty well, 3 - describes me 
very well) * 
Please choose the appropriate response for each item: 
  0 1 2 3 
......I have Trouble listening in lectures  
    
......I trouble making study plans  
    
......I spent lot of time doing nothing  
    
......I unable to do two or three tasks in a row  
    
.......I have trouble remembering things to do  
    
.... I don’t stick to tasks to completion  
    
.... I often have lack of attention  
    
.... I have trouble with short term memory  
    
.... I don't stick to tasks that are optional 
    
.... I have difficulty sustaining concentration  
    
.... I often have lack of concentration on studies  
   
 
 
The following questions ask about your overall academic achievement. Please indicate your response by 
selecting one number from: 
1(extremely lower) 2....3....4 (a bit lower), 5 (same)  6 (a bit higher) 7.... 8....9...to 10 (Extremely higher) 
*If you are a College student............. 
Please choose the appropriate response for each item: 
  1 2 3 4 5 6 7 8 9 10 
compared to your high school GPA, your current college GPA is  
          
 
What was your high school GPA? 
 
Please, enter your GPA in figures* 
Please write your answer here: 
  
What is your current college GPA? 
 
Please, enter your GPA in figures* 
Please write your answer here: _______________ 
Social approval 
The following questions ask about your attitudes concerning drug use. Individuals differ in whether or not 
they disapprove of people doing certain things.  
DO YOU DISAPPROVE of people doing any of the following? 
Please, choose the appropriate response for each item from 
(Don't disapprove/Disapprove/Strongly disapprove/Don’t Know) * 
Please choose the appropriate response for each item: 
  
Don't 
disapprove 
Disapprove 
Strongly 
disapprove 
Don't know 
Chewing Khat every day 
    
Chewing khat more than 100gms (a bundle) per 
session     
Smoking 10 or more cigarettes a day 
    
Having five or more drinks* in a row each 
weekend     
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Don't 
disapprove 
Disapprove 
Strongly 
disapprove 
Don't know 
having drinks every day 
    
Trying marijuana or hashish (cannabis, pot, grass) 
once or twice     
Smoking marijuana or hashish occasionally 
    
Smoking marijuana or hashish regularly 
    
Smoking shisha regularly 
    
Smoking shisha occasionally 
    
 
Drug risk 
The following questions ask about your thoughts of risks associated with different drug related activities.  
How much do you think people risk harming themselves (physically or in other ways), if they do the 
following? 
Please, choose the appropriate response for each item from 
(No Risk, Slight Risk, Moderate Risk, Great Risk, and Don’t Know) * 
  No Risk Slight Risk Moderate Risk 
Great 
Risk 
Don’t 
Know 
Chewing khat occasionally 
     
Chewing khat frequently 
     
Chewing chat on daily basis 
     
Chewing one or more bundle of khat per session 
     
Smoke cigarettes occasionally  
     
Smoke one or more packs of cigarettes per day 
     
Have one or two drinks nearly every day 
     
Have four or five drinks in a row nearly every day 
     
Have five or more drinks in a row each weekend  
     
Try marijuana or hashish (cannabis, pot, grass) 
once or twice      
Smoke marijuana or hashish occasionally  
     
Smoke marijuana or hashish regularly 
     
Smoking shisha everyday  
     
Smoking shisha occasionally 
     
 
 
 
 
 
 
 
THE END 
 
 
 
 
 
 
 
 
 
 
Thank you for your time and effort in completing this survey! 
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If you would like to contact someone if you are feeling at all worried, anxious, or distressed, you 
can contact: 
Adama Science & Technology University Counselling Health Services Centres at 
http://www.astu.edu.et/index.php/services/medical-and-clinical-services/health-center 
Further participation 
Research is only possible due to the generous nature of those who volunteer to participate. As 
researchers, we are constantly indebted to those who give up their time and resources to 
participate. 
If you are interested in participating in further research on Khat Chewing and Cognitive 
Functioning, and you are a university student between the ages of 18 and 35, and frequently chew 
khat (at least 3 times a week over the last 12 months) please: 
✓ If you are completing the survey by hand using the pencil and paper version of the survey, 
complete the attached Further Research Participation and seal it in the white envelope 
titled Further Research Participation and post it back to us separately from your survey 
✓ If you are completing the survey electronically, click here 
While we do appreciate any expressions of interest, please do not feel obliged to complete this 
form, your current contribution has already added to this research project significantly. 
 
Submit your survey. 
Thank you for completing this survey. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
https://surveys.psychol.utas.edu.au 
© University of Tasmania, Australia ABN 30 764 374 782 CRICOS Provider Code 00586B 
Info line 1300 363 864 
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Appendix B – Information Sheet and Consent Form/electronic version 
 
 
 
 
 
Khat Use and Experience 
 
Thank you for your interest in this research. This study is being conducted in partial fulfillment 
of a PhD degree for Samson Duresso under the supervision of Dr. Raimondo Bruno at the 
University of Tasmania. Before you decide to participate, it is important for you to understand 
why the research is being done and what it will involve. Please take time to read the following 
information carefully. Please contact the researchers by email at Samson.Duresso@utas.edu.au if 
you would like more information. 
1. What is this study about? 
This study aims to better understand the ways people consume khat, and how any problems may 
develop. In particular, we aim to better understand the possible positive and negative 
psychological, emotional, health, cognitive and social implications that may arise from different 
degrees of khat use. This study will help with the development of ways of identifying khat 
problems and the interventions needed to manage khat dependency. You are invited to participate 
if you are over the age of 16 years old, live in Ethiopia, and have chewed khat in the past 12 
months. 
2. What will I be asked to do? 
As a participant in this survey, you would be asked to complete on anonymous online or paper-
pencil survey on the positive and negative effects of chewing khat, including questions regarding 
your health, lifestyle, other drug use, physical health, mental health, cognitive/academic 
influences and social interaction. This will take about 30-40 minutes to complete. It is important 
that you understand that your involvement in this study is voluntary. If you decide to discontinue 
participation at any time, you can do so by simply closing your web browser or withholding the 
questionnaire. No information will be submitted to the researchers until you have completed the 
survey. 
3. Where will the data be kept? 
All of the survey information/data we obtain from participants will be kept on a password 
protected computer in the School of Psychology, University of Tasmania, for a period of five 
years. 
4. How will the data be kept secure? 
All survey data will be stored on a password-protected computer. 
5. How and when will the data be destroyed? 
All data relating to the study will be electronically stored for five years. After this period, all 
survey data will be deleted, following secure data destruction processes. 
6. Are there any possible benefits from participation in this study? 
Participating in this study may result in individuals having a greater understanding of their khat 
use and the possible effects that this may have on their wellbeing. By participating in this study, 
you are providing important and valuable information in an area of research that is relevant to 
you. Your participation will help us gain important information that will assist us to better 
understand the positive and negative effects that Ethiopians experience from their khat use and 
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how this relates to different levels of dependence and withdrawal problems. This information will 
be valuable in the development of community intervention programs aimed at reducing the harms 
some people may experience with khat. 
Additionally, to thank you for your time, upon completion you may choose to enter a draw to win 
an Apple iPad. 
7. Are there any possible risks involved in participating in this study? 
There are no specific risks anticipated with taking part in this study. However, should you 
become uncomfortable or upset whilst completing the survey, or feel you’d like to talk to 
someone about your khat use, below are some contact details of services that are available during 
office hours 5 days a week: 
Adama Science & Technology University Counseling & Health Services at 
http://www.astu.edu.et/index.php/services/medical-and-clinical-services/health-center 
8. How will your confidentiality and privacy be protected? 
Our server uses a 128bit encryption, which is backed by Verisign, the world largest security 
certificate provider. This is the same level of encryption used by banks and the Australian Tax 
Office. Therefore, the responses you provide will remain completely anonymous and 
confidential, as the risk of identification is negligible. However, you may also choose to use an 
anonymiser, which will mask your IP address. This will mean that both the computer you are 
using, as well as the responses you provide will be completely unidentifiable. Anonymisers work 
by inserting a fake computer between your computer and our server, therefore, masking your IP 
address. For more information, see: http://www.livinginternet.com/i/is_anon.htm 
On completion of the survey, you will be asked if you would like to take part in the prize draw. If 
you wish to take part, you will be redirected to a different website, where you will be asked to 
provide an email address. In order to protect your confidentiality, we would recommend using an 
email address that is not associated with your name in any way, such as bowwow@google.com 
rather than your.name@myworkplace.com. Free email addresses are available at 
mail.google.com or mail.yahoo.com, and many other sites. No connection is made between 
completed questionnaires and submitted email addresses, as these are stored on independent 
servers and no timestamps are taken. 
9. What if I have questions or concerns about this research? 
If you would like to discuss any aspect of this study please feel free to contact either of the 
researchers by email at Raimondo.Bruno@utas.edu.au or Samson.Duresso@utas.edu.au. If you 
would like to view the results of this research, this can occur at the conclusion of this research 
and the results will be published online at the survey website. Additionally, if the participants 
require further information or want to discuss the results they are encouraged to call or email the 
researchers. 
This study has been approved by the Tasmanian Social Science Human Research Ethics 
Committee. If you have concerns or complaints about the conduct of this study, you should 
contact the Executive Officer of the HREC (Tasmania) Network on +61(0)36226 7479 or email 
human.ethics@utas.edu.au. The Executive Officer is the person nominated to receive complaints 
from research participants. You will need to quote [HREC project number: H0013036]. 
10. How do I participate? 
By clicking the "Next" button below, you indicate that you have read the information on this 
page and you are agreeing to participate in this survey. If you do not wish to participate, we thank 
you for your time and you can close this browser window to end this session. 
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Consent 
1. I have read and understood the 'Information Sheet' for this study. 
2. I have understood the nature and possible effects of this study. 
3. I have understood that this study involves answering questions about khat and other drug 
use, physical health, mental health, and social interactions. 
4. I am 16 years of age or older. 
5. I have understood that all questions are optional and that I may choose to not answer any 
questions that I am uncomfortable with. 
6. I have understood that all research data will be securely stored on a password protected 
server at the University of Tasmania. 
7. I have understood that my participation is voluntary and that I cannot be identified in any 
way.   
I agree with the above statements and wish to participate in the survey by clicking “Next”  
Thank you for taking the time to consider this study and we hope you are interested in 
participating. 
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Appendix C– Information Sheet and Consent Form/Pencil paper version 
 
 
 
 
 
Khat Use and Experience 
 
Thank you for your interest in this research. This study is being conducted in partial fulfillment 
of a PhD degree for Samson Duresso under the supervision of Dr. Raimondo Bruno at the 
University of Tasmania. Before you decide to participate, it is important for you to understand 
why the research is being done and what it will involve. Please take time to read the following 
information carefully. Please contact the researchers by email at Samson.Duresso@utas.edu.au if 
you would like more information. 
1. What is this study about? 
This study aims to better understand the ways people consume khat, and how any problems may 
develop. In particular, we aim to better understand the possible positive and negative 
psychological, emotional, health, cognitive and social implications that may arise from different 
degrees of khat use. This study will help with the development of ways of identifying khat 
problems and the interventions needed to manage khat dependency. You are invited to participate 
if you are over the age of 16 years old, live in Ethiopia, and have chewed khat in the past 12 
months. 
2. What will I be asked to do? 
As a participant in this survey, you would be asked to complete on anonymous online or paper-
pencil survey on the positive and negative effects of chewing khat, including questions regarding 
your health, lifestyle, other drug use, physical health, mental health, cognitive/academic 
influences and social interaction. This will take about 30-40 minutes to complete. It is important 
that you understand that your involvement in this study is voluntary. If you decide to discontinue 
participation at any time, you can do so by simply closing your web browser or withholding the 
questionnaire. No information will be submitted to the researchers until you have completed the 
survey. 
3. Where will the data be kept? 
All of the survey information/data we obtain from participants will be kept on a password 
protected computer in the School of Psychology, University of Tasmania, for a period of five 
years. 
4. How will the data be kept secure? 
All survey data will be stored on a password-protected computer. 
5. How and when will the data be destroyed? 
All data relating to the study will be electronically stored for five years. After this period, all 
survey data will be deleted, following secure data destruction processes. 
6. Are there any possible benefits from participation in this study? 
Participating in this study may result in individuals having a greater understanding of their khat 
use and the possible effects that this may have on their wellbeing. By participating in this study, 
you are providing important and valuable information in an area of research that is relevant to 
you. Your participation will help us gain important information that will assist us to better 
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understand the positive and negative effects that Ethiopians experience from their khat use and 
how this relates to different levels of dependence and withdrawal problems. This information will 
be valuable in the development of community intervention programs aimed at reducing the harms 
some people may experience with khat. 
Additionally, to thank you for your time, upon completion you may choose to enter a draw to win 
an Apple iPad. 
7. Are there any possible risks involved in participating in this study? 
There are no specific risks anticipated with taking part in this study. However, should you 
become uncomfortable or upset whilst completing the survey, or feel you’d like to talk to 
someone about your khat use, below are some contact details of services that are available during 
office hours 5 days a week: 
Adama Science & Technology University Counseling &Health Services at 
http://www.astu.edu.et/index.php/services/medical-and-clinical-services/health-center 
8. How will your confidentiality and privacy be protected? 
Our server uses a 128bit encryption, which is backed by Verisign, the world largest security 
certificate provider. This is the same level of encryption used by banks and the Australian Tax 
Office. Therefore, the responses you provide will remain completely anonymous and 
confidential, as the risk of identification is negligible. However, you may also choose to use an 
anonymiser, which will mask your IP address. This will mean that both the computer you are 
using, as well as the responses you provide will be completely unidentifiable. Anonymisers work 
by inserting a fake computer between your computer and our server, therefore, masking your IP 
address. For more information, see: http://www.livinginternet.com/i/is_anon.htm 
On completion of the survey, you will be asked if you would like to take part in the prize draw. If 
you wish to take part, you will be redirected to a different website, where you will be asked to 
provide an email address. In order to protect your confidentiality, we would recommend using an 
email address that is not associated with your name in any way, such as bowwow@google.com 
rather than your.name@myworkplace.com. Free email addresses are available at 
mail.google.com or mail.yahoo.com, and many other sites. No connection is made between 
completed questionnaires and submitted email addresses, as these are stored on independent 
servers and no timestamps are taken. 
9. What if I have questions or concerns about this research? 
If you would like to discuss any aspect of this study please feel free to contact either of the 
researchers by email at Raimondo.Bruno@utas.edu.au or Samson.Duresso@utas.edu.au. If you 
would like to view the results of this research, this can occur at the conclusion of this research 
and the results will be published online at the survey website. Additionally, if the participants 
require further information or want to discuss the results they are encouraged to call or email the 
researchers. 
This study has been approved by the Tasmanian Social Science Human Research Ethics 
Committee. If you have concerns or complaints about the conduct of this study, you should 
contact the Executive Officer of the HREC (Tasmania) Network on +61(0)36226 7479 or email 
human.ethics@utas.edu.au. The Executive Officer is the person nominated to receive complaints 
from research participants. You will need to quote [HREC project number: H0013036]. 
10. How do I participate? 
By clicking the "Next" button below, you indicate that you have read the information on this 
page and you are agreeing to participate in this survey. If you do not wish to participate, we thank 
you for your time and you can close this browser window to end this session. 
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Consent 
1. I have read and understood the 'Information Sheet' for this study. 
2. I have understood the nature and possible effects of this study. 
3. I have understood that this study involves answering questions about khat and other drug 
use, physical health, mental health, and social interactions. 
4. I am 16 years of age or older. 
5. I have understood that all questions are optional and that I may choose to not answer any 
questions that I am uncomfortable with. 
6. I have understood that all research data will be securely stored on a password protected 
server at the University of Tasmania. 
7. I have understood that my participation is voluntary and that I cannot be identified in any 
way.   
 
Thank you for taking the time to consider this study and we are hope you are interested in 
participating. 
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Appendix D: Further Research Participation Form/ Electronic version 
 
Further participation 
 
Research is only possible due to the generous nature of those who volunteer to participate. As 
researchers, we are constantly indebted to those who give up their time and resources to 
participate. 
 
If you are interested in participating in further research on Khat Chewing and Cognitive 
Functioning, and you are a university student between the ages of 18 and 35, and frequently chew 
khat (at least 3 times a week over the last 12 months) please: 
If you are completing the survey by hand, complete the attached “Further Research Participation” 
and seal it in the white envelope titled “Further Research Participation” and post it back to us. 
If you are completing the survey electronically, click here  
 
While we do appreciate any expressions of interest, please do not feel obliged to complete this 
form, your current contribution has already added to this research project significantly. 
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Appendix E: Further Research Participation Form/ Envelop version 
 
 
PARTICIPATION IN FURTHER RESEARCH 
 
Survey of Khat use and experiences 
 
Thank you for participating in our survey. 
 
If you are a University student between the ages of 18 and 35consume khat frequently (3 or more 
days per week) and are interested in volunteering to participate in further research on khat 
chewing and impacts on cognitive control functions, please provide a contact number and/or 
email address below: 
 
Your phone number: ............................................ 
Confirm phone number: ............................................ 
 
Email address: ............................................ 
Confirm email address: ............................................ 
 
We will contact you in early January 2014 to determine your continued interest and eligibility for 
subsequent studies. 
 
Thank you! 
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Appendix F: General Survey Email Preamble 
Survey Khat Use & experience 
Dear,  
At the University of Tasmania, we are conducting research examining the effect of chronic khat 
consumption on emotional and cognitive functioning. We are currently seeking volunteers to 
participate and would be most appreciative if you would consider distributing the attached flyer to 
members of your business/organisation/society. 
Participants are asked to fill in a 30-40-minute survey which examines history, rate of khat use, 
current consumption patterns, motivations for, and perceived emotional and cognitive 
consequences of use. 
Volunteers must have at least some history and exposure of khat use to participate.  
Participants will have the opportunity to go into a prize draw to win an Apple IPad. Data 
collection will be complete by January 2014. So please feel free to remove the flyer at this point. 
The survey is available online at www.khatuse.utas.edu.au or a paper version can be requested by 
emailing Samson.Duresso@utas.edu.au or calling +251           . 
Please feel free to contact me further with any queries. Thank you in advance for your assistance. 
Kind regards 
Samson Duresso 
School of Psychology 
University of Tasmania 
Temporary Psychology Research office (Adama Science & Technology University) 
P. O. Box 456 
Oromia, Ethiopia 
Ph: +251        . 
Email: Samson.Duresso@utas.edu.au 
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Appendix G: General Survey Noticeboard Advertisement 
Khat use & experience 
Are you interested in the effects of khat chewing? 
Researchers at the University of Tasmania (Australia) are seeking volunteers over the age of 16 to 
take part in a study examining khat chewing and experiences in Ethiopia. 
Participation involves completing a 30-40 minute anonymous online or pencil and paper survey 
which examines consumption rate, antecedents and consequences of use, perceived positive and 
negative effects of khat chewing, including questions about health and life styles. People with at 
least moderate history of khat use are welcome to participate. 
Participants have the opportunity to enter a prize draw to win an Apple iPad. 
The survey can be completed online at: www.khatsurvey.utas.edu.au or you can request a postal 
paper version by phoning +25          or  
emailing: Samson Duresso@utas.edu.au 
 
 
 
 
 
 
 
 
 
Appendix I: General Survey Noticeboard Advertisement (Amharic Version) 
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Appendix H: General Survey Noticeboard Advertisement (Amharic version) 
 
 
 
 
 
 
 
 
 
 
University of Tasmania (Australia) 
School of Psychology 
ታስማኒያ ዩኒቨርሲቲ (አውስትራሊያ)  
የሳይኮሎጂ ት/ቤት 
ጫት መጠቀምና ልምዱ 
በአውስትራሊያ የሚገኙ የታስማኒያ ዩኒቨርሲቲ ተመራማሪዎች በጫት አጠቃቀም ልምድና ተዛማጅ አሉታዊና 
አዎንታዊ ተፅዕኖዎቹ ላይ በሚያካሂዱት ጥናት ላይ ለመሳተፍ ፍቃደኛ የሆኑ ከዚህ በፊት ጫት ተጠቅመው የሚያውቁና 
እድሜያቸው ከ 16 ዓመት በላይ የሆኑ ግለሰቦችን ይፈልጋሉ፡፡ 
 
ተሣትፎው ከ30 – 40 ደቂቃ የሚወስድ ማንነትን የማይገልፅ የኢንተርኔት ላይ መጠይቅ ወይንም የወረቀት ላይ 
መጠይቅን መሙላት ሲሆን መጠይቁ ስለ ጫት አጠቃቀም፤ መጠን፤ ምክንያቶች፤ ሊያሰከትል የሚችለውን አሉታዊ እና 
አዎንታዊ ተፅዕኖዎችንና አጠቃላይ የጤንነት እና የኑሮን ሁኔታን የሚዳስሱ ጥያቄዎችን ያካተተ ነው፡፡ ጫትን የመጠቀም 
የተለያየ ልምድ ያላቸው ወይንም ጫትን በተለያየ ደረጃና መጠን የሚጠቀሙ ሁሉ በዚህ ሰርቬይ/መጠይቅ ላይ እንዲሳተፉ 
ተጋብዘዋል፡፡  
 
በእነግሊዝኛ ቐንቐ የተዘጋጀው ሰርቬይ (መጠይቅ) በሚከተለው ሊንክ በኢንተርኔት ይገኛል ፤ 
www.khatsurvey.utas.edu.au  በአማርኛ ቐንቐ በወረቀት ላይ የተዘጋጀው ሰርቬይ (መጠይቅ) ደግሞ በሚከተለው 
የአጥኚው አድራሻ ይገኛል፤ ስ. ቁ. 093605535 ኢ ሜይል፤ Samson Duresso@utas.edu.au 
 
ተሳታፊዎች በተዘጋጀው የአፕል አይፓድ ዕጣ ላይ የመሳተፍ ዕድል አላቸው፡፡ 
 
 
 
 
 
 
 
 
 
Text messaging questionnaire                Code: _______________  
  
Age: _____ years and _____ months           Sex:    Male    Female  
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APPENDIX I: Information Sheet 
UNIVERSITY OF TASMANIA 
PARTICIPANT INFORMATION SHEET 
HEALTH AND MEDICAL 
RESEARCH 
 
Title of Project:  Khat Withdrawal, Craving and Relapse among Chronic Khat Users 
You are invited to participate in a study that investigates KHAT WITHDRAWAL, CRAVING 
AND RELAPSE.  The aim of this study is to examine the nature of withdrawal syndromes in 
chronic khat users, the role it plays in craving over the course of a cessation attempt and the 
extent of craving during quit attempts and its relationship with environmental cues. The research 
is being conducted by Samson Duresso in partial fulfilment of the requirements of a PhD in 
Psychology. Samson is being supervised by Dr. Raimondo Bruno, Dr. Allison Matthews, from 
the school of Psychology and Dr. Stuart Ferguson from the School of Medicine/Pharmacy, 
University of Tasmania. Samson Duresso can be contacted on +25192362504 or email: 
Samson.Duresso@utas.edu.au.   
 
1. ‘What is the purpose of this study?’ 
The purpose is to examine the nature of withdrawal syndromes in chronic khat users, the role it 
plays in craving over the course of a cessation attempt and the extent of craving during quit 
attempts and its relationship with environmental cues. 
 
2. ‘Why have I been invited to participate in this study?’ 
You are eligible to participate in this study because you are a student at Adama Science & 
Technology University and frequent khat user who is interested in quitting chewing  
 
3. What does this study involve?’ 
If you choose to participate in this study, you will be required to monitor your chewing habit for 
10 days before you begin to quit chewing, and for four [4] weeks after you quit; to take part in up 
to five [5] study visits at Adama Science & Technology University campus. Visit 1 will take 
approximately 30-45 minutes to complete, during which you will be assigned a quit date that will 
fall 10 days after this initial enrolment visit. For these first 10 days of the study, you will be 
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asked to monitor your chewing using a simple to use hand-held computer - similar in 
appearance to a mobile telephone. You will need to return this device at the end of the study 
(visit – 5). You will be asked to carry this device with you at all times until Visit 5. Each day you 
will be asked to indicate, by pressing a button on the phone, each time you chew khat, you will 
also be asked to complete 4-5 assessments at random times throughout your waking day. Each 
assessment will take approximately 1-2 minutes to complete. The researcher will provide training 
on how to use the study device and will be able to answer any questions that you might have 
regarding study participation.   
 
After Visit 1, each further study visit will take approximately 15-20 minutes, during which your 
study data will be downloaded from the monitoring device; and you may be required to provide 
urine sample.  During the quit day study visit (Visit 4), you will be instructed to quit chewing 
completely. At your final visit (Visit 5), you will be asked about your experiences in the study.  
In addition, participants who complete the entire study will be reimbursed $66, 50 for their time 
and out-of-pocket expenses. Your involvement in this study is not linked to your success at 
quitting khat – if you complete the study you will be reimbursed for your time regardless of 
whether you quit successfully or not.  
 
It is important that you understand that your involvement in this study is voluntary. While we 
would be pleased to have you participate, we respect your right to decline. There will be no 
consequences to you if you decide not to participate. If you decide to discontinue participation at 
any time, you may do so without providing an explanation. All information will be treated in a 
confidential manner, and your name will not be used in any publication arising out of the 
research. All of the research data will be kept in a locked cabinet at the School of Psychology 
(Tasmania), and on a password protected computer. Hard copy data will be kept for at least five 
(5) years from the date of the first publication of the study results. Electronic data will be 
securely stored until it is no longer necessary. 
 
4. Are there any possible benefits from participation in this study? 
It is possible that you may quit chewing as a part of this study. Due to the negative effects of 
continued chewing, this may lead to an improvement in your general health. Furthermore, the 
information we gather may be beneficial to other chewers who want to quit chewing. 
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5. Are there any possible risks from participation in this study?
There are no specific risks anticipated with participation in this study aside from those associated 
with quitting chewing (for example, it is possible that you will experience khat withdrawal 
symptoms and craving as a result of quitting chewing). However, if you find that you are 
becoming distressed you will be advised to talk to your regular GP (at Adama University) or 
alternatively, you may choose to contact a counsellor who you can talk to about your 
experiences. In Adams Science & Technology University, counselling services can be obtained 
via http://www.astu.edu.et/index.php/services/medical-and-clinical-services/health-center. 
6. What if I have questions about this research?
If you would like to discuss any aspect of this study please feel free to contact Dr. Raimondo 
Bruno (Raimondo.Bruno@utas.edu.au) or Dr Stuart Ferguson (stuart.ferguson@gmail.com) or 
Dr. Allison Matthews (Allison.Matthews@utas.edu.au) or Samson Duresso 
(Samson.Duresso@utas.edu.au or +251         ). The researchers would be happy to discuss any 
aspect of the research with you. When the study has been finalized the main outcomes will be 
published on the University of Tasmania’s website. 
This study has been approved by the Tasmanian Health and Medical Human Research Ethics 
Committee.  If you have concerns or complaints about the conduct of this study, you should 
contact the Executive Officer of the HREC (Tasmania) Network on (03) 6226 7479 or email 
human.ethics@utas.edu.au.  The Executive Officer is the person nominated to receive complaints 
from research participants. You will need to quote [REF.NO: H0013347].  
Thank you for taking the time to consider this study. If you wish to take part in it, please sign the 
attached consent form. This information sheet is for you to keep.  
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APPENDIX J: Consent Form 
 
UNIVERSITY OF TASMANIA 
CONSENT FORM 
 
Title of Project: Khat Withdrawal, Craving and Relapse among Chronic Khat Users 
 
  
1. I have read and understood the 'Information Sheet' for this project. 
2. The nature and possible effects of the study have been explained to me. 
3. I understand that the study involves monitoring my chewing using a simple to use hand-
held computer for 10 pre-quit and 28 post-quit days (explained below).   
4. In this study, I understand that I will be asked to carry this device with me at all times for 
the 10 pre-quit and 28 post-quit days of the study.  
5. I understand that I am required to return the study device at the end of the study (at visit 5) 
6. I understand that I will also be required to visit Adama Science & Technology University 
Research Centre up to five [5] times for study visits: once to enrol (this current visit), and 
a further four times over the course of the study. Aside from this enrolment visit (which 
will take up to 45 minutes), each future study visit will take approximately 15-20 minutes 
to complete. During each study visit I will also be required to provide a sample of my 
urine.  
7. I understand that if I complete the entire study I will receive $66, 50 as compensation for 
my time.  
8. I understand that participation involves the risk(s) that I may quit chewing as a part of this 
study and hence potentially experience withdrawal symptoms and craving.  
9. I understand that all research data will be securely stored on the University of Tasmania 
premises for at least five years and will then be destroyed when no longer required.  
10. Any questions that I have asked have been answered to my satisfaction. 
11. I agree that research data gathered from me for the study may be published provided that I 
cannot be identified as a participant. 
12. I understand that the researchers will maintain my identity confidential and that any 
information I supply to the researcher(s) will be used only for the purposes of the research. 
13. I agree to participate in this investigation and understand that I may withdraw at any time 
without any consequence, and if I so wish I may request that any data I have supplied to 
date be withdrawn from the research. 
14. I understand that this research has been approved by the Tasmanian Health and Medical 
Human Research Ethics Committee [project number: H0013347]. 
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Name of Participant: 
Signature: Date: 
 
Statement by Investigator  
 I have explained the project & the implications of participation in it to this 
volunteer and I believe that the consent is informed and that he/she understands 
the implications of participation  
If the Investigator has not had an opportunity to talk to participants prior to them 
participating, the following must be ticked. 
 The participant has received the Information Sheet where my details have been 
provided so participants have the opportunity to contact me prior to consenting to 
participate in this project. 
 
Name of investigator   
  
Signature of investigator      Date 
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APPENDIX K: Baseline Questionnaires 
 
    
Khat Chewing Habit 
 
 
 
 
 
 
 
 
 
 
The following questions ask about your use of khat in the last 6 months.  
How often do you 
chew khat? 
Never 
(Skip to 
Alcohol Use 
section) 
Monthly or 
less  
2 to 4 times a 
month 
2 to 3 times a 
week 
4 or more times 
a week 
How much (in 
grams or in bundle) 
khat leaves do you 
consume on a 
typical day when 
you are chewing 
khat?  
25 – 50gms 
(about half a 
bundle) 
50 – 
100gms 
(about a 
bundle) 
100 – 
150gms 
(about 1 and 
half bundle) 
150 – 
200gms 
(about 2 
bundles) 
More than 
200gms 
(2 bundles and 
more)  
How often do you 
chew 150gms/a 
bundle or more 
khat in a single 
session?  
Never 
Less than 
monthly 
Monthly Weekly 
Daily or almost 
daily 
What is the greatest 
amount of khat you 
have consumed in a 
single session? 
______ gms. Or ____ bundle 
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APPENDIX L: Baseline Questionnaires 
 
University of Tasmania 
Alcohol and substance use disorder Questionnaire (AUDIT) 
The following questions ask about your use of alcohol in the last 12 months. Please use 
number of bottles (330ml) or glasses (400ml) to help with your estimation. All information 
provided will be kept confidential. 
How often do you have a 
drink containing alcohol? 
Never 
(Skip to 
Inclusion 
Question 4) 
Monthly 
or less  
2 to 4 
times a 
month 
2 to 3 
times a 
week 
4 or more 
times a week 
How many drinks 
containing alcohol do you 
have on a typical day when 
you are drinking? 
1 or 2 
Bottles__ 
Glasses__ 
3 or 4 
Bottles__ 
Glasses__ 
5 or 6 
Bottles__ 
Glasses__ 
7 to 9 
Bottles__ 
Glasses__ 
10 or more 
Bottles__ 
Glasses__ 
How often do you have six 
or more bottles/glasses of 
drinks on one occasion? 
Never 
Less than 
monthly 
Monthly Weekly 
Daily or 
almost daily 
How often during the last 
year have you found that 
you were not able to stop 
drinking once you had 
started? 
Never 
Less than 
monthly 
Monthly Weekly 
Daily or 
almost daily 
How often during the last 
year have you failed to do 
what was normally 
expected of you because of 
drinking? 
Never 
Less than 
monthly 
Monthly Weekly 
Daily or 
almost daily 
How often during the last 
year have you needed a 
first drink in the morning to 
get yourself going after a 
heavy drinking session? 
Never 
Less than 
monthly 
Monthly Weekly 
Daily or 
almost daily 
How often during the last 
year have you had a feeling 
of guilt or remorse after 
drinking? 
Never 
Less than 
monthly 
Monthly Weekly 
Daily or 
almost daily 
How often during the last 
year have you been unable 
to remember what 
happened the night before 
because of your drinking? 
Never 
Less than 
monthly 
Monthly Weekly 
Daily or 
almost daily 
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Have you or someone else 
ever been injured because 
of your drinking? 
No 
Yes, but not in the 
last year 
Yes, during the 
last year 
Has a relative or friend or a 
doctor or other health 
worker, ever been 
concerned about your 
drinking or suggested you 
cut down? 
No 
Yes, but not in the 
last year 
Yes, during the 
last year 
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APPENDIX M: Baseline Questionnaires 
 
University of Tasmania 
 
Other Drugs Use 
 
Do you, or have you ever used marijuana in the past two weeks? Yes    No  
Have you used marijuana in the last two weeks? Yes    No  
Have you used any form of illicit drug (apart from marijuana) in the last two weeks? Yes    No 
 
Have you participated in another study within the last three months for which you had to 
consume any drugs?  Yes    No  
If yes, what drugs did you consume: 
.......................................................................................................................................... 
.......................................................................................................................................... 
 
Thank you for your participation 
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APPENDIX N: Baseline Questionnaires 
 
 
    
 
 
 
 
University of Tasmania 
The Kessler Psychological Distress Scale [K-10] 
Please indicate what best represents how you have been over the past four weeks. 
Please, choose the appropriate response for each item from: 
(1 = none of the time, 2 = A little of the time, 3 = some of the time, 4 = most of the time, 5 = All 
of the time) 
 
During the last four weeks about how often did you………... 
 
 1 2 3 4 5 
……. feel fatigued out for no good reason? 
     
……. feel nervous? 
     
…… feel so anxious that nothing could calm you down? 
     
…… feel hopeless? 
     
……. feel restless or fidgety? 
     
…… feel so restless you could not sit still? 
     
…… feel depressed? 
     
……. feel that everything was an effort? 
     
…… feel so sad that nothing could cheer you up? 
     
…… feel worthless? 
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APPENDIX O: Baseline Questionnaires 
 
 
 
                                      
University of Tasmania 
Fagerström Nicotine Dependence Scale (FTND) 
 
Please mark only one of the following: 
1. How often do you smoke tobacco (please mark)?  
 
 Never 
 Less than monthly 
 2-4 times a month 
 2-4 times a week 
 Daily or almost daily 
 
2. How soon after you wake up do you smoke your first cigarette? * 
Within 5 minutes  
6–30 minutes  
31–60 minutes  
After 60 minutes 
 
3. Do you find it difficult to refrain from smoking in places where it is forbidden for 
example at church, at the library, in the cinema, and so on? * 
Yes  
No 
 
4. Which cigarette would you hate to give up? * 
The first one in the morning  
All others 
 
5. How many cigarettes do you smoke a day? * 
10 or less  
11–20  
21–30  
31 or more 
 
6. Do you smoke more during the first two hours than during the rest of the day? * 
Yes  
No 
 
7. Do you smoke if you are so ill that you are in bed most of the day? * 
Yes  
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APPENDIX P: Ethics approval letter 1 
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APPENDIX Q: Ethics approval letter 2 
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APPENDIX R: Ethics approval letter 3 
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APPENDIX S: Khat survey Questionnaire (Amharic Version)  
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APPENDIX T: Withdrawal Questionnaire  
 
 
 
 
 
School of Medicine (Psychology) 
University of Tasmania 
Wakeup Report: Please mark (X) 
 
DATE:  __________________TIME: __________ 
 
 
  0 
(low) 
10 20 30 40 50 60 70 80 90 100 
(High) 
3 Quality of sleep?            
4 How refreshed do you 
feel? 
           
5 Have you had vivid and 
unpleasant dreams? 
           
6 Increased appetite?            
7 Decreased appetite?            
8 Khat craving?            
9 Cigarette craving?            
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  <15 mins 15 - 30 mins 30 - 60 mins >60 mins 
1 Good Morning! How 
long ago did you 
wake up? 
    
2 How long did it take 
for you to sleep? 
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School of Medicine (Psychology) 
University of Tasmania 
Random Prompts: Please mark (X) 
 
DATE:  __________________TIME: __________ 
 
 
Right now, your FEELINGS? 
 
  0 
(low) 
10 20 30 40 50 60 70 80 90 100 
(High
) 
1 Able to focus?            
2 Alert?            
3 Angry/frustrated?            
4 Loss of interest?            
5 Excited?            
6 Tired?            
7 Passive?            
8 Poor concentration?            
9 Poor memory?            
10 Happy?            
11 Irritable?            
12 Poor motivation?            
13 Nervous/anxious?            
14 Drowsy/sleepy?            
15 Restless?            
16 Depressed?            
17 Khat craving            
 
  Very 
bad 
Bad Neutral Good Very 
good 
  
1 Overall feeling?        
  Very 
low 
Low Moderate High Very 
high 
  
2 Arousal/energy level?        
  0 0.5 1 1.5 2 2.5 3 
3 Last time you had khat, how many (in 
bundle)? 
       
 
